See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · InformexUSA 2012 · New Orleans, Louisiana · February 14-17, 2012 · Booth 2514

Research Area · Cancer

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
71220 1,4-DPCA 331830-20-7 ≥98% 2007-06-22 43.515290055249 1-4-dpca 1,4-dihydrophenonthrolin-4-one-3-Carboxylic acid HIF-1.alpha. normoxic HIF-.alpha. prolyl HIF-PH inhibitors collagen fibrosis 4-hydroxylase normoxia hypoxic hypoxia-inducible factor HIF1.alpha. HIF1alpha HIFPH inhibition inhibits 43.515290055249
12700 15-deoxy-Δ12,14-Prostaglandin D2 85235-11-6 >95% 147.658839779006 15-deoxy-12-14-prostaglandin-d2 15-deoxy-Δ12,14-PGD2 PPARs prostaglandins peroxisome proliferator-activated receptors 15-deoxy-DELTA12,14-PGD2 15-deoxy-.DELTA.12,14-PGD2 15-deoxy-d12,14-PGD2 leukemia cells cancer 15d-pgd2 147.658839779006
10009742 15-hydroxy Prostaglandin Dehydrogenase Western Ready Control - ≥90% by SDS-PAGE 2007-04-03 53.421886345698 15-hydroxy-prostaglandin-dehydrogenase-western-ready-control 15-hydroxy PGDH blotting blots western WB oxidation enzymes tumors suppression cells proliferation 53.421886345698
10011263 15-Lipoxygenase-2 (human recombinant) - >95% 2008-03-25 46.314229588705 15-lipoxygenase-2-human-recombinant 15-LO-2; 15-LOX-2 arachidonic acids recombinant proteins 15-HETE 15-HpETE 46.314229588705
10011500 15-Lipoxygenase-2 Western Ready Control - 2008-06-25 21.089402310396 15-lipoxygenase-2-western-ready-control 15-LO-2; 15-LOX-2 WBs lipoxygenases 15LOX 15LO arachidonic acid AA 15(S)-hydroxyeicosatetraenoic acid 15(S)-HETE 15S-HETE western blots immunoblotting blotting 21.089402310396
34720 15(S)-HETE 54845-95-3 ≥98% 33.067837411207 15-s-hete soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated 15HETEs 33.067837411207
334720 15(S)-HETE-d8 84807-87-4 ≥99% deuterated product 39.003388581951 15-s-hete-d8 GC/MS deuterium isotopes 15-HETE-d8 standards 15S-HETE-d8 15(S)HETE-d8 deuterated GC-MS LC/MS LC-MS 15-HETEs 15(S)-HETEs 15S-HETEs 15(S)HETEs hydroxy fatty acids mass spectrometry 15HETE 39.003388581951
534721 15(S)-HETE EIA Kit - 73.417918968692 15-s-hete-eia-kit 15(S)-HETE ELISA Kit solid plates 15(S)-HETEs 15S-HETEs measures kits eias enzyme immunoassays ELISAs 15(S)HETEs 15HETEs assays 73.417918968692
10007251 15(S)-HETE Lipid Maps MS Standard 54845-95-3 ≥98% 2009-02-17 17.652116447088 15-s-hete-lipid-maps-ms-standard soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated MS mass spectrometry standards 15HETE 17.652116447088
10009799 17(S)-HDoHE - ≥98% 2007-03-12 10.232854511970 17-s-hdohe 17(S)-hydroxy Docosahexaenoic Acid resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 17(s)-hdohe 10.232854511970
13812 17β-hydroxy Wortmannin Exclusive - ≥98% ✓ 2010-05-18 31.334483732350 17-hydroxy-wortmannin phosphoinositide 3-kinase PI3K mTOR inhibitors inhibits inhibition inhibitory cancers 17-hydroxywortmannins 17-hydroxy wortmannins hydroxywortmannins PI3-K HWT phosphatidylinositol 31.334483732350
10954 1-NA-PP1 New 221243-82-9 ≥98% 2011-09-30 68.084160138534 1-na-pp1 PP1 Analog; 1-Naphthyl-PP1 inhibitors inhibits inhibition kinases mutated analogs sensitive v-Src vSrc c-Fyn cFyn CDK2 c-Abl cAbl mammalian yeast 1NMPP1 1NA-PP1 cells permeable tyrosine cell-permeable AS Src-family Src I338G v-Src-AS1 68.084160138534
10010093 1-Oleoyl Lysophosphatidic Acid Exclusive 65528-98-5 >95% ✓ 2007-08-29 19.801464088397 1-oleoyl-lysophosphatidic-acid Oleoyl-sn-3-Glycerophosphate; 1-Oleoyl LPA LPAS 1-oleoyl-LPAS agonists GPCR G-proteins cell proliferation smooth muscle contraction platelet aggregation reurite retraction 19.801464088397
10010094 1-Palmitoyl Lysophosphatidic Acid 22002-85-3 ≥98% 2010-11-29 5.657329650092 1-palmitoyl-lysophosphatidic-acid 1-Palmitoyl LPA (free acid) GPCR G-proteins cells proliferation smooth muscles contractions platelets aggregation 5.657329650092
10010290 1-Palmitoyl Lysophosphatidic Acid (sodium salt) Exclusive - >98% ✓ 2007-09-05 10.135558011049 1-palmitoyl-lysophosphatidic-acid-sodium-salt 1-Palmitoyl LPA 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphate monopalmitoylphosphatidic acid MPPA LPAS GPCRs biological responses 10.135558011049
10009962 2-(14,15-Epoxyeicosatrienoyl) Glycerol 848667-56-1 ≥95% 2008-04-03 28.374088397789 2-14-15-epoxyeicosatrienoyl-glycerol 2-14,15-EG 2-AG CYP450 metabolism mitogens cancers kidneys endocannabinoids cannabinoids cbs synthetic 28.374088397789
13373 2',3',5'-triacetyl-5-Azacytidine 10302-78-0 ≥95% 2010-08-05 7.381182834382 2-3-5-triacetyl-5-azacytidine inhibitors inhibits inhibition DNA methyltransferases epigenetics methylation myelodysplastic syndromes cancers prodrugs 5-azacytidine 5-azacitidine vidaza azacytidine azacitidine rapid absorption o rally 7.381182834382
10005229 2,3-DCPE (hydrochloride) - ≥98% 2006-09-15 13.960662983425 2-3-dcpe-hydrochloride apoptosis Bcl-XL p21 ERK cancers cells cycles proapoptotic in vitro S-phase arrest upregulate activates activation 13.960662983425
71200 2,4-DPD 41438-38-4 ≥98% 57.398581952118 2-4-dpd 2,4-Diethylpyridine dicarboxylate inhibits inhibition inhibitors proline-hydroxylases P564 HIF-PH HIF-1alpha HIF-1.alpha. alpha-keto glutarate .alpha.-keto a-keto cancer 57.398581952118
10008887 (+)-2,5-epi Goniothalesdiol Exclusive - ≥98% ✓ 2009-03-02 0E-12 -2-5-epi-goniothalesdiol tetrahydrofuran cytotoxic pesticide anticancers drugs antitumor styryl lactone 0E-12
11097 25-hydroxy Cholesterol New 2140-46-7 ≥98% 2012-02-08 114.684567219153 25-hydroxy-cholesterol 16505-96-7 oxysterol cholesterol SREBP sterols regulatory elements binding proteins atherosclerosis anticancer apoptosis immunosuppressive Bcl-2 caspases atherosclerosis antitumor tumors LXR-RXR ligands T cells macrophages 114.684567219153
11099 25-hydroxy Cholesterol-d6 New 88247-69-2 ≥99% deuterated form (d1-d6) 2012-01-27 104.017900552485 25-hydroxy-cholesterol-d6 deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 16505-96-7 oxysterol cholesterol SREBP sterols regulatory elements binding proteins atherosclerosis anticancer apoptosis immunosuppressive Bcl-2 caspases atherosclerosis antitumor tumors LXR-RXR ligands T cells macrophages 104.017900552485
13019 2-Hydroxyestradiol 362-05-0 ≥95% 2009-01-20 22.513756906077 2-hydroxyestradiol 2-HE2; NSC 61711 estradiols steroids metabolism catechol-O-methyltransferase COMT pre-eclampsia preeclampsia angiogenesis cancers anticancer HIF-1α HIF1α 22.513756906077
13021 2-Methoxyestradiol 362-07-2 ≥98% 2009-01-06 75.297608524072 2-methoxyestradiol Panzem; NSC 659853; 2-ME2; 2-Hydroxyestradiol 2-methyl ether estradiol steroids catechol-O-methyltransferase COMT pre-eclampsia preeclampsia angiogenesis cancers anticaner HIF-1α HIF1α 2-methoxyestradiol 75.297608524072
582261 2-Methoxyestradiol EIA Kit - 2010-12-09 168.073327194598 2-methoxyestradiol-eia-kit 2-Hydroxyestradiol 2-methyl ester; 2-ME2 metabolites estradiols antitumors antiangiogenics breast prostate cancers cardioprotective cytochromes P450 CYP450 P450-dependent hydroxylation 17β-estradiols 2-position O-methylation catechol-O-methyltransferases pre-eclampsia plasma urine urinary markers therapeutics supplements estrogen receptors pregnancy ELISAs EIAs enzymes immunoassays kits competitive quantification measures measurements sample matrices 168.073327194598
11046 2-NBDG New 186689-07-6 ≥98% (mixture of α and β) 2011-10-07 53.498560288221 2-nbdg NBD-Glucose fluorescence fluorescent probes glucose uptake cells viability contrast reagents neoplasia cancers diabetes flow cytometry microscopy 213484-93-6 53.498560288221
10010494 2-PCPA (hydrochloride) - >98% 2008-05-09 0.453985793211 2-pcpa-hydrochloride trans-2-Phenylcyclopropylamine; Tranylcypromine 2 PCPA 2PCPA LSD1 histones chromatin nucleosomes post-translational modifications posttranslational methylation demethylation inhibitors inhibits inhibition MAO A B I MAOA MAOB MAOI MAO-A MAO-B MAO-I depression anxiety parkinsons disease epigenetics monoamine oxidases lysine-specific demethylase 0.453985793211
10009651 2-thio-Acetyl MAGE 112014-15-0 ≥97% 2007-02-22 19.210096685083 2-thio-acetyl-mage KIAA1363 cancers colorimetric substrates activity inhibition inhibits inhibitory enzymatic activity 19.210096685083
10004185 3,4',5-Trismethoxybenzophenone Exclusive 94709-12-3 >95% ✓ 2004-07-21 34.352670349908 3-4-5-trismethoxybenzophenone antimitotics antimitosis resveratrol analogs phenolic antioxidants antiproliferative antiproliferatory inhibits inhibition inhibitors cell growth 34.352670349908
10727 3,5-dimethyl PIT-1 701947-53-7 ≥98% 2011-05-25 16.321319828115 3-5-dimethyl-pit-1 PIP3 PtdIns-(3,4,5)-P3 PH domain cancers inhibitors Akts PDK1 PTENs proteins binding inhibits inhibited inhibition DM-PIT-1 16.321319828115
10397 3-amino Benzamide New 3544-24-9 ≥98% 2011-10-07 2.289024419063 3-amino-benzamide 3-(Aminocarbonyl) Aniline; 3-Carboxamidoaniline poly(ADP-ribose) polymerases PARPs DNA repairs DNA strands breaks apoptosis inflammation atherosclerosis neruogenesis cancers angiogenesis signaling cellular responses inhibits inhibitor inhibition telomere shortening shortens stimulates mediated mediates PARP-mediated 2.289024419063
13574 3-bromo-5-phenyl Salicylic Acid Exclusive 4906-68-7 ≥95% ✓ 2010-08-10 12.693193370165 3-bromo-5-phenyl-salicylic-acid NSC 109116 Aldo-keto reductases AKR, oxidoreductases hydroxysteroid dehydrogenases HSDs 20α-HSD progesterones cancers steroids brain functions AKR1C1 AKR1C2 AKR1C3 AKR1C4 endothelial cells 12.693193370165
13828 3-Deazaneplanocin A 102052-95-9 ≥98% 2011-02-18 209.440418310971 3-deazaneplanocin-a DZNep; NSC 617989 EZH2 KMT6 methyltransferases histones cancer epigenetics panobinostat 3deazaneplanocin 3-cyclopentene-1,2-diol deriv Adenosine Adenocard 209.440418310971
13265 4-hydroxy Nonenal Alkyne Exclusive 1011268-23-7 ≥98% ✓ 2010-06-16 121.635972989564 4-hydroxy-nonenal-alkyne Click Tag™ 4-HNE alkyne lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT 121.635972989564
10495 4-iodo-SAHA 1219807-87-0 ≥98% 2011-01-10 30.252121546961 4-iodo-saha anti-cancers HDACs inhibitors anti-proliferation 4-Hydroxy-5-iodo-3-nitrophenyl)acetyl 4-Hydroxy-3-iodo-5-nitrophenyl)acetyl 5-Iodo-4-hydroxy-3-nitrophenacetyl 5 Iodo 4 hydroxy 3 nitrophenacetyl Nitrohydroxyiodophenylacetate Hydroxyiodonitrophenylacetate Hapten NIP Acetyl Acetyl Hapten NIP NIP Acetyl Hapten NIP-Hapten NIP Hapten 30.252121546961
10185 4-oxo-2-Nonenal Exclusive 103560-62-9 >98% ✓ 2004-01-21 65.065966850828 4-oxo-2-nonenal 4-ONE ROS Alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 65.065966850828
10004174 4-oxo 2-Nonenal-d3 Exclusive - ≥99% deuterated product ✓ 2004-03-10 33.350589318600 4-oxo-2-nonenal-d3 4-ONE-d3 ROS Alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 4-OH-2-nonenal-d3 4-hydroxy2nonenald3 internal standards mass spectrometry GC/MS LC/MS gc-ms ic-ms deuterium deuterateds 33.350589318600
10011049 4-phenyl-5-methyl-1,2,3-Thiadiazole 64273-28-5 ≥98% 2009-03-14 0.168508287293 4-phenyl-5-methyl-1-2-3-thiadiazole NSC 358739 cytochrome P450 CYP450 CYP2B4 CYP2E1 CYP1A2 inhibitors inhibits inhibition thiadiazoles fungicide herbicide plant growth regulator 0.168508287293
13379 5-bromo-3-phenyl Salicylic Acid 99514-99-5 ≥95% 2010-08-10 12.659381215469 5-bromo-3-phenyl-salicylic-acid Aldo-keto reductases AKR oxidoreductases hydroxysteroid dehydrogenases HSD 20α-HSD progesterone cancers steroids brain functions AKR1C1 AKR1C2 AKR1C3 AKR1C4 endothelial cells 12.659381215469
10009315 6-Aminonicotinamide 329-89-5 ≥98% 2008-11-21 2.086464088398 6-aminonicotinamide 6-AN; NSC 21206; SR 4388 inhibitors inhibits inhibition 6-phosphoguconate dehydrogenase cancers ATPs oxidative injury neurodegeneration cardiovascular 2.086464088398
10009856 7-AAD Cell Viability Assay Kit - 2008-10-29 28.530144918489 7-aad-cell-viability-assay-kit 7-Amino Actinomycin D Cell Viability Kit kits 7AAD measurement cells fixation blocking cytoxicity effects environmental toxins drug fluorescence fluorescent cell-based assays cell based assay cba 28.530144918489
600120 7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit - 2009-08-05 59.067738752959 7-aad-cfse-cell-mediated-cytotoxicity-assay-kit 7-Amino Actinomycin D/5-(6)-Carboxyfluorescein Diacetate Succinimidyl Ester 7-amino actinomycin D/5-(6)-carboxyfluorescein diacetates succinimidyls esters assays kits measuring measurement kits 5-(6) 5,6 5-6 7AAD cells cytoxicity cell-based cba cytolysis target effector T lymphocytes NK natural killer autoimmune systems pathological cancers multiple sclerosis granule exocytosis pathways Fas diseases graft host 51chromium 51Cr green fluorescent fluorescence probes red propidium iodide dead effector carboxyfluorescein succinimidyl esters dyes damaged DNA deoxyribonucleic acids quantify quantification single staining 59.067738752959
589320 8-hydroxy-2-deoxy Guanosine EIA Kit - 2008-05-21 619.932353985792 8-hydroxy-2-deoxy-guanosine-eia-kit 8-OH-dG ELISA Kit; DNA Damage EIA Kit solid plates oxidative injury stress aging cancers diabetes hypertension hydroxyl radicals peroxynitrite plasmas cells lysates tissues urine creatinine LC-MS liquid DNA damage kits EIAs chormatography mass spectrometry kits enzyme immunoassays elisas 8-OH-2-d 8OH2d 8 oxo deoxyguanine deoxyguanosine hydroxy ohdg 2 EIA/ELISA assays 619.932353985792
89300 8-hydroxy Guanosine - ≥98% 8.885138121547 8-hydroxy-guanosine oxidative injury RNA stress damage 7,8-dihydro-8-oxo-guanosine markers inhibitors growth 3868-31-3 8.885138121547
13653 ABT-869 796967-16-3 ≥98% 2010-12-09 33.831887966046 abt-869 Linifanib inhibitors RTK tyrosine kinases VEGF PDGF cancers KDR Flt1 Flt3 Flt4 CSF-1R KIT acute myeloid leukemia antiproliferative anti-proliferative ABT 869 ABT869 Indazoles 33.831887966046
10008051 Acid Phosphatase Assay Kit - 2006-09-20 5.593591160221 acid-phosphatase-assay-kit aps hydrolase eznymes prostate pap tartrate resistant assays 5.593591160221
10006908 Adipogenesis Assay Kit - 2006-08-18 82.688214714396 adipogenesis-assay-kit obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines endocrinology cell-based assays cell based assay cba 82.688214714396
10009381 Adipolysis Assay Kit - 2007-07-30 59.419943270406 adipolysis-assay-kit obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines lipolysis 3T3L1 kits assays FFA adipocytes endocrinology cell-based assay cell based assay cba 59.419943270406
11293 Aflatoxin B1 New 1162-65-8 ≥98% 2012-01-30 147.695977593616 aflatoxin-b1 NSC 529592; HSDB 3453; AFB1 11003-08-0 13214-11-4 27261-02-5 toxicology pathogens mycotoxins Aspergillus cancers HCC hepatocellular carcinomas p53 DNA adduct mold carcinogenic metabolism liver epoxide tumoors suppression genes food contaminant contamination D03.438.150.119.075 D03.830.219.119.07 NSC-529592 HSDB-3453 147.695977593616
11294 Aflatoxin B2 New 7220-81-7 ≥98% 2012-01-30 147.695977593616 aflatoxin-b2 Dihydroaflatoxin B1 dihydroaflatoxine B1 toxicology pathogens mycotoxins Aspergillus cancers HCC hepatocellular carcinoma p53 DNA adduct molds carcinogenic carcinogens liver epoxide tumors genes food contamination contaminants pathogens 147.695977593616
10010129 AG-041R Exclusive 199800-49-2 ≥98% ✓ 2008-12-16 40.045359116022 ag-041r CCKs gastrin receptors antagonist cancers proliferations apoptosis NS-398 NS398 NS 398 40.045359116022
10010592 AG-1296 146535-11-7 >98% 2008-05-09 5.001425414364 ag-1296 Tyrphostin AG-1296 tyrphostins AG1296 PDGFR PTK SCF inhibitors inhibits inhibition receptors kinases proteins platelet-derived platelet derived growth factors in vitro cancer glioma athrosclerosis restenosis AG1296 AG 1296 5.001425414364
10010244 AG-1478 153436-53-4 >98% 2008-04-22 9.154342541435 ag-1478 NSC 693255; Tyrphostin AG-1478 NSC 693255 EGFR PTK inhibitors inhibits inhibition kinases receptors cancers antitumor leioyoma myometrium 175178-82-2 AG1478 AG 1478 9.154342541435
10010248 AG-17 10537-47-0 ≥98% 2007-09-18 1.703761155971 ag-17 NSC 242557; Tyrphostin 9; Malonoben; Tyrphostin AG-17; SF 6847; GCP 5126; RG-50872 proteins tyrosine kinases PTK inhibitors inhibits antiproliferative epidermal growth factor EGF receptors proliferations carcinomas AG17 AG 17 SF6847 SF-6847 GCP-5126 GCP5126 1.703761155971
10010300 AG-18 118409-57-7 >98% 2007-12-20 2.417794305142 ag-18 RG-50810; Tyrphostin AG-18; Tyrphostin 23; TX 825; RG-50858 proteins tyrosines kinases PTKs inhibitors inhibition inhibits antiproliferative epidermal growth factors EGF receptors proliferations carcinoma cancers epidermoid cell lines A431 AG18 AG 18 A23 A-23 A23 RG50810 RG 50810 RG50858 RG 50858 TX-825 TX825 2.417794305142
10010315 AG-183 122520-90-5 >98% 2007-09-07 1.435570902393 ag-183 Tyrphostin 51 proteins tyrosine kinases PTKs inhibitors inhibition inhibits inhibition antiproliferative epidermal growth factors EGFs receptors proliferation carcinomas cancers epidermoid AG183 AG 183 1.435570902393
10010314 AG-213 122520-86-9 >97% 2008-02-05 2.375052737317 ag-213 Tyrphostin AG-213; Tyrphostin 47 protein tyrosine kinases PTKs inhibitors inhibits inhibition antiproliferative epidermal growth factors EGFs receptors proliferation carcinomas A431 epidermal AG213 Ag 213 118409-60-2 2.375052737317
10010568 AG-370 134036-53-6 >95% (cis/trans mixture) 2009-01-09 1.265759668508 ag-370 NSC 651712 PTK inhibitor tyrphostin tyrosine PDGF receptor kinase EGF receptor antiproliferative 1.265759668508
10010311 AG-490 133550-30-8 >98% 2007-12-01 9.933476058931 ag-490 PTK tyrosine kinase inhibitors inhibition inhibits antiproliferatives tyrphostins leukemia Jak-2 Jak2 AG490 9.933476058931
10010242 AG-494 133550-35-3 >98% 2008-02-08 1.845741252301 ag-494 protein tyrosine kinases PTKs inhibitors inhibits inhibition antiproliferative RG-13022 epidermal growth factors EGFs receptrors cancers proliferation 1.845741252301
10010312 AG-82 118409-58-8 >95% 2008-03-14 4.223517495395 ag-82 Tyrphostin AG-82; NSC 676484; RG-50875; Tyrphostin 25 proteins tyrosines kinases PTKs inhibitors inhibits inhibition antiproliferative epidermal growth factors EGFs receptors proliferation carcinomas blockers A431 AG82 AG 82 RG-50875 RG50875 A25 A-25 4.223517495395
10010243 AG-825 149092-50-2 >98% 2008-01-24 4.725808997632 ag-825 Tyrphostin AG-825 Her-2 Her-2/neu erbB tyrosine kinases EGF EGFR cancers anti-cancer prostate breast signal transduction inhibitors inhibition inhibits AG825 AG 825 4.725808997632
10793 AG-879 148741-30-4 ≥95% 2011-05-06 1.809287292817 ag-879 Tyrphostin AG-879 PTKs inhibitors tyrphostins tyrosine kinases antiproliferative NGF TrkA ErbB2 FLK-1 AG879 AG 879 inhibited inhibition 1.809287292817
10010313 AG-99 122520-85-8 >98% 2007-12-19 1.273508287292 ag-99 Tyrphostin 46 protein tyrosine kinase PTKs inhibitor inhibits inhibition antiproliferatives epidermal growth factors EGFs receptors proliferation carcinoma cancers blochers EGF-dependent A431 cell lines AG99 AG 99 1.273508287292
13145 AGK2 304896-28-4 ≥98% 2009-10-22 12.525055248618 agk2 sirtuins SIRT2 histones deacetylase HDAC cells cycle progression tumorigenesis cancers SIRT1 SIRT3 dopamine neurons α-synuclein Parkinson's diseases neurodegeneration 12.525055248618
19023 AH 23848 (calcium salt, hydrate) - ≥90% 2009-02-26 56.043558011050 ah-23848-calcium-salt-hydrate AH23848B AH 23848 TXBs thromboxane PGEs PGE2 receptors prostanoids TPs EP4 antagonist blockers inhibitors inhibits inhibition TXA2 platelets smooth muscle bronchial U-46619 U46619 fibroblasts cancers metastasis 81739-45-9 AH-23848 56.043558011050
10010241 AICAR 2627-69-2 >98% 2008-02-25 141.414828729282 aicar NSC 105823; Acadesine; AICA Riboside AMPK lipids metabolism glucose fatty acids sterol HMG-CoA reductases inflammation cytokine iNOS COX-2 MnSOD glia macrophages TNF-.alpha. IL-1.beta. IL-6 aminoimidazole carboxamide ribonucleotide 141.414828729282
160773 AIF Polyclonal Antibody - 0E-12 aif-polyclonal-antibody Programmed Cell Death Protein 8; Apoptosis-Inducing Factor Polyclonal Antibody apoptosis antibodies western blots blotting WB antisera antiserum factors cancers immunoblotting 0E-12
13733 Akt1 (Phospho-Ser473) Monoclonal Antibody (Clone 104A282) - 2010-01-11 1.178847671665 akt1-phospho-ser473-monoclonal-antibody-clone-104a282 antibodies Akts PKBs peptides Akt-1 Akt 1 protein kinase B serine threonine western blots blotting immunoblotting WB IP Immunoprecipitation IP 1.178847671665
13732 Akt1 Polyclonal Antibody - 2010-01-11 1.178847671665 akt1-polyclonal-antibody antibodies Akts PKBs peptides Akt-1 Akt 1 protein kinase B serine threonine western blots blotting immunoblotting WB 1.178847671665
13735 Akt2/3 Polyclonal Antibody - 2010-01-12 1.178847671665 akt2-3-polyclonal-antibody Akt-2 Akt 2 PKB proteins kinase B serine threonine signaling PI3-kinase cancers Western blots blotting immunoblotting WB Akt-3 Akt 3 2-3 1.178847671665
13734 Akt2 Monoclonal Antibody (Clone 95C567.1.2) - 2010-01-12 1.178847671665 akt2-monoclonal-antibody-clone-95c567-1-2 Akt-2 Akt 2 PKB proteins kinase B serine threonine signaling PI#-kinase cancers Western blots blotting immunoblotting WB 1.178847671665
13736 Akt3 Monoclonal Antibody (Clone 66C1247.1) - 2010-01-19 1.178847671665 akt3-monoclonal-antibody-clone-66c1247-1 Akt-3 Akt 3 western blot blotting immunoblotting WB Akts protein kinase B PKB serin threonine signaling proteins 1.178847671665
10010079 Akt (human recombinant) Western Ready Control Exclusive - ✓ 2008-08-26 6.245646408839 akt-human-recombinant-western-ready-control Protein Kinase B; PKB; AKT1 western blots proteins antibodies antiserum antisera WB kinases serine threonine hexahistidine his-tag his-tagged N-terminal immunoblotting blotting 6.245646408839
10009350 Aldehyde Reactive Probe (trifluoroacetate salt) 627090-10-2 ≥98% 2008-08-26 9.402541436464 aldehyde-reactive-probe-trifluoroacetate-salt O-(Biotinylcarbazoylmethyl) Hydroxylamine; ARP DNA damages AP sites synthesis mutations ROS biotin oxidative stress detection detecting 139585-03-8 9.402541436464
13144 Anacardic Acid 16611-84-0 ≥98% 2010-02-12 3.763515709289 anacardic-acid 6-pentadecyl Salicylic Acid HAT histones acetylation P300 pCAF transcription NF-κB IκBα p65 6-pentadecyl salicyclic acids NSC 623096 cyclogallipharic 229596 333857 3.763515709289
600300 Annexin V FITC Assay Kit - 2010-05-11 81.388892443806 annexin-v-fitc-assay-kit assays kits measures measurements apoptosis cells death cycles tissues homeostasis dysregulation neurodegenerative diseases ischemic damages autoimmune disorders cancers drugs discovery signaling pathways membranes phospholipids phosphatidylserines phosphatidylethanolamines leaflets bilayers externalizations residues plasma phospholipids binding proteins fluorochrome-labeled fluorochromes fluorescence microscopy flow cytometry FC plate readers TUNEL TdT-mediated dUTP Nick-End Labeling analysis ISEL in situ end labeling DNA laddering detection fragmentation FITC-conjugated fluoresceins 81.388892443806
160780 Apaf-1 Polyclonal Antibody - 2.007955801104 apaf-1-polyclonal-antibody Apoptosis Protease-Activating Factor 1 apoptosis cell death caspases CED-4 Apaf2 Apaf3 Apaf-2 Apaf-3 Apafs antibodies Apaf1 CED4 western blots blotting WB protease-activating factors proteases antisera antiserum cancers immunoblotting 2.007955801104
10575 Apicidin New 183506-66-3 ≥98% 2012-01-27 106.538339472068 apicidin OSI 2040 funfal toxins malaria HDAC HAT histones deacetylase transcriptions epigenetics anticancer anti-cancer antiproliferation antiparasitic anti-proliferation anti-parasitic apicomplexan parasites HDAC3 HDAC-3 NcoR HDAC3/NcoR class I HDACs p21 WAF1/Cip1 WAF1 Cip1 gelsolin cells cycle morphology inhibits inhibitors inhibitions chromatin cancers deacetylase modification 106.538339472068
10006797 Araguspongin B 123000-02-2 >90% 2005-09-09 53.000540208717 araguspongin-b membrane-permeable antagonists inositols inositol-1,4,5-triphosphates receptors marine products Pacific basin sponges vasodilatory properties signal transductions messengers IP3 promotes mobilization calcium Ca2+ intracellular stores antagonizes calcium-releasing actions cerebral microsomes Xestospongin C neuroscience 53.000540208717
160737 ARC Polyclonal Antibody - 10.826063535911 arc-polyclonal-antibody Apoptosis Repressor with CARD apoptosis cell death domain DD CARD caspase antibodies western blots blotting WB antisera antiserum cancers immunoblotting IP immunoprecipitation 10.826063535911
13321 ARP 100 704888-90-4 ≥98% 2009-10-07 1.460589318600 arp-100 MMP-2 Inhibitor III; CAY10609 matrix metalloproteinases MMP-2 MMP2 MMP 2 ECM cancers cells migration inhibitors gelatinase A MMPs proteases HT1080 tumors invasive 1.460589318600
13250 (−)-AS 115 926657-43-4 ≥98% 2009-05-18 4.425230202578 -as-115 KIAA1363 MAGE monoacylglycerol LPA LPC lysophosphatidylcholine lysophosphatidic acid lipids signaling cancers signalling 4.425230202578
10009650 (+)-AS 115 - ≥98% 2009-05-19 2.409834254143 -as-115 KIAA1363 MAGE monoacylglycerol LPA LPC lysophosphatidylcholine lysophosphatidic acid lipids signaling cancer 2.409834254143
700420 Ascorbate Assay Kit - 2010-09-01 196.081095601639 ascorbate-assay-kit L-Ascorbic Acid Assay Kit; Vitamin C Assay Kit kits assays measures measurements ascorbates six-carbon 6-carbon six 6 carbons lactones glucose livers mammalian species humans non-human primates guinea pigs gulonolactones oxidases acids 2-keto-1-gulonolactone diets dietary scurvy electrons donors enzymes collagen hydroxylations hydroxyls groups prolines lysines molecules carnitines fatty mitochondrias ATP adenosine triphosphates generations biosynthesis norepinephrines dopamines amides groups peptides hormones tyrosines metabolisms antioxidants chronics diseases cancers cardiovascular cataracts foods industry colors tastes odors plasmas serums urines fruits juices condensations reactions dehydroascorbic DHA o-phenylenediamines OPDA fluorescent fluorescences 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy TEMPOL condensed DFQ 3-(dihydroxyethyl)-furo[34-b]-quinoxaline-1-one OPD 196.081095601639
10946 Ash2L (human recombinant) - ≥90% 2011-06-29 39.250455289543 ash2l-human-recombinant Set1/Ash2 Histone Methyltransferase Complex Subunit Ash2 Isoform A; Absent, small, or homeotic discs 2-like epigenetics methyltransferases histones H3K4 genes regulations MLL proteins complex human homolog Drosophilia ash2 transcription 39.250455289543
13375 Atrazine 1912-24-9 ≥98% 2010-02-11 0.182320441989 atrazine herbicides plants cancers reproductive systems reproduction homones endocrines frogs genes expressions humans animals Gesamprim Atrazine 0.182320441989
600140 Autophagy/Cytotoxicity Dual Staining Kit - 2009-07-14 84.406214941364 autophagy-cytotoxicity-dual-staining-kit assays kits measuring measurement MDC cell-based autophagy cells cytotoxicity staining autofluorescent autofluorescence substances multilamellar body bodies ions trapping mechanisms membranes lipids probes autophagic vacuoles cultured degradation digestion intracellular lysosomes organelles misfolded proteins microorganisms cytoplasms double membranes autophagosomes autolysosomes homeostasis dysregulation cancers infections aging degenerative diseases stress death apoptosis 84.406214941364
10803 Autotaxin (human recombinant) - ≥95% 2011-04-04 24.261116022099 autotaxin-human-recombinant Ectonucleotide Pyrophosphatase/Phosphodiesterase-2; Lysophospholipase D; ENPP-2 lipids hydrolysis lysophophatidyl choline lysophophatidic acids secreated glycosylated 24.261116022099
700580 Autotaxin Inhibitor Screening Assay Kit - 2011-06-28 26.188143646409 autotaxin-inhibitor-screening-assay-kit ATX Inhibitor Screening Assay Kit kits assays measures measurements Ectonucleotides Pyrophosphatase-2 ENPP-2 Lysopholipases D hydrolysis lysophosphatidylcholines LPC lysophosphatidic acid LPA lipids mediators G protein-coupled receptors GPCRs neurogenesis angiogenesis smooth-muscles contraction platelets aggregations wounds healings ATX-LPA signaling tumors progression inflammation serums proteolytically peptides proteins N-glycosylation Asn53 Asn410 adipocytes cerebrospinal fluid multiple sclerosis livers fibrosis cancers genes chips analysis upregulated metastatic inhibits inhibition human 26.188143646409
10009644 BAY-43-9006 New 284461-73-0 ≥98% 2011-09-13 30.859047876037 bay-43-9006 Sorafenib; Nexovar® inhibitors raf-1 b-raf receptors tyrosine kinases VEGF VEGFR PDGF PDGFR cancers angiogenesis apoptosis tumors cells cellular proliferation Flt-3 c-KIT carcinoma growth factor tosylate 30.859047876037
11022 BIBF 1120 New 928326-83-4 ≥95% 2011-11-10 3.673118279570 bibf-1120 Vargatef™ receptors tyrosine kinases inhibitors vascular endothelial growth factor VEGFR platelet-derived growth PDGFR fibroblasts FGFR angiogenesis cancers pulmonary fibrosis diseases 3.673118279570
10011385 Bim/BOD (IN) Polyclonal Antibody - 2008-04-10 2.224364640884 bim-bod-in-polyclonal-antibody apotosis BH3 Bcl-2 Bcl-XL cancer immunoblotting WB IHC antibodies western blotting antiserum blots immunohistochemistry 2.224364640884
10960 Bisdemethoxycurcumin 24939-16-0 ≥98% 2011-08-09 5.449443726081 bisdemethoxycurcumin BDMC curcumin activators macrophages phagocytosis 1α,25-dihydroxyvitamin D, amyloid-β Alzheimer’s diseases cancers transcription genes expression p300 Wnt/β-catenin iNOS inflammation bisdemethoxy curcumin 33171-05-0 5.449443726081
11071 BRD2 bromodomain 1 (human recombinant) New - ≥95% 2011-10-21 29.246960993221 brd2-bromodomain-1-human-recombinant RNF3; Bromodomain containing 4; RING3 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomain epigenetics lysine inflammatory inflammation mitosis viral host 29.246960993221
11070 BRD2 bromodomain 2 (human recombinant) New - ≥95% 2011-10-21 29.246960993221 brd2-bromodomain-2-human-recombinant RNF3; RING3; Bromodomain containing 4 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomain epigenetics lysine inflammatory inflammation mitosis viral host 29.246960993221
11069 BRD2 bromodomains 1 and 2 (human recombinant) New - ≥90% 2011-12-20 54.677044294586 brd2-bromodomains-1-and-2-human-recombinant Bromodomain containing 2; RNF3; RING3 BET proteins BRD2 BRD3 BRD4 I-BET genes expressions histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysines regulations trandcription proteins domains nucleosomes BRDT BRD-T cells inflammatory inflammation mitosis viruses viral hosts binding binds molecules inhibitors inhibits inhibition humans diseases 54.677044294586
11068 BRD4 bromodomain 1 (human recombinant) New - ≥60% 2011-10-21 39.863421170213 brd4-bromodomain-1-human-recombinant MCAP; Bromodomain containing 4; HUNK1 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysine nucleosomes cellular inflammatory mitosis viral hosts 39.863421170213
11066 BRD4 bromodomain 2 (human recombinant) New - ≥95% 2011-10-21 31.569969842779 brd4-bromodomain-2-human-recombinant MCAP; Bromodomain containing 4; HUNK1 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysine nucleosomes cellular inflammatory mitosis viral hosts 31.569969842779
11052 BRD4 bromodomains 1 and 2 (human recombinant) New - ≥90% 2011-12-20 57.305076639599 brd4-bromodomains-1-and-2-human-recombinant HUNK1; MCAP; Bromodomain containing 4 BET proteins BRD2 BRD3 BRD4 I-BET genes expressions histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysines regulations trandcription proteins domains nucleosomes BRDT BRD-T cells inflammatory inflammation mitosis viruses viral hosts binding binds molecules inhibitors inhibits inhibition humans diseases 57.305076639599
10005270 C75 191282-48-1 >98% 2004-09-22 39.534110497237 c75 inhibits inhibitors inhibition fatty acids synthases FAS cerulenin cytotoxicity apoptosis cancers anorexigenic stable weight loss feeding endocrinology 39.534110497237
13285 Cannabidiol dimethyl ether 1242-67-7 ≥98% 2009-05-19 12.557320441989 cannabidiol-dimethyl-ether Cannabidiol-2',6'-dimethyl ether; CBDD 15-lipoxygenases 15-LOs dioxygenase fatty acids inflammation thrombosis cancer LDL oxidation inhibitions inhibition inhibiting cannabinoids cbs synthetic 12.557320441989
10487 Capecitabine 154361-50-9 ≥98% 2010-08-16 7.976427255985 capecitabine Ro 09-1978; Xeloda® Capecitibine Capecytabine Captabin 5-Fluorouracil 5-FU cancers prodrugs thymidine phosphorylase fluoropyrimidine carbamate inhibits inhibition inhibitors thymidylate synthase liver enzymes 158798-73-2 958887-39-3 Deoxyribonucleoside Cytosine Cytosine Deoxyribonucleoside Deoxyriboside Cytosine Cytosine Deoxyriboside Deoxycytidine CDR 7.976427255985
89800 Carnosol 5957-80-2 >96% 122.928681925809 carnosol antioxidants tumors herbs carcinogenesis rosemary Rosmarinus officinalis extracts polyphenolic inhibits inhibitors inhibition 122.928681925809
360745 Caspase-3 (human) Blocking Peptide - 0.575291117722 caspase-3-human-blocking-peptide Yama; ICE3; CPP32; Apopain control peptides blots blotting western cpp-32 ice-3 apoptosis effectors caspases cell death wb antibodies 0.575291117722
160790 Caspase-9 Polyclonal Antibody - 10.669451197053 caspase-9-polyclonal-antibody MCH6 Polyclonal Antibody; ICE-LAP6 Polyclonal Antibody; Apaf-3 Polyclonal Antibody apoptosis cell death Apaf-1 apafs caspase-3 caspases antibodies Apaf1 western blots blotting WB an tisera antiserum cancers immunoblotting 10.669451197053
13704 Cav3.2 Calcium Channel Monoclonal Antibody (Clone S55-10) - 2009-11-12 1.922651933701 cav3-2-calcium-channel-monoclonal-antibody-clone-s55-10 antibodies CACNA1H genes epilepsy up-regulations up regulations upregulations prostate cancers androgen-independent androgen independent western blotting blots WB fusion protein immunohistochemistry IHC immunocytochemistry ICC 1.922651933701
89740 CAY10398 Exclusive - >98% ✓ 47.516344996930 cay10398 reversible inhibitors histone deacetylase HD1 inhibits inhibitions CAY-10398 hdacs HDAC-1 HDACs HDAC 1 HDAC1 HDACIS 47.516344996930
70635 CAY10416 443919-96-8 >95% 2007-07-24 28.782914364640 cay10416 COX-2 cyclooxygenases 5-LO lipoxygenases inflammation inhibitors prostates cancers PC3 LNCaP carcinomas apoptosis inhibition inhibits chemotherapy cells lines 28.782914364640
10005019 CAY10433 537034-17-6 >98% 2005-01-05 53.218406657117 cay10433 BML-210; N-phenyl-N'-(2-Aminophenyl)hexamethylenediamide HDAC deacetylases histone inhibits inhibitors inhibition cancer cells differentiation gene expression regulation Trichostatin A nuclear extracts deacetylation transcription factors FOXO3 SIRT1 H2O2 hydrogen peroxides BML210 53.218406657117
10005033 CAY10444 Exclusive 298186-80-8 >98% ✓ 2004-10-05 67.442007366482 cay10444 BML-241 receptors antagonists S1P3 EDG3 sphingosines sphingosine-1 sphingosine1 phosphates Hela cells G-proteins CAY-10444 BML241 67.442007366482
10006546 CAY10465 Exclusive 688348-33-6 >98% ✓ 2005-09-09 22.942331491712 cay10465 resveratrol analogs analogues aryl hydrocarbons receptors agonists AhRs ligand-dependents ligands xenobiotics PDM 11 PDM11 PDM-11 estrogen dioxin poisonings stilbene xenobiotics polyaromatics soot coal tar 22.942331491712
10008872 CAY10503 - >98% 2007-08-02 87.804419889503 cay10503 apoptosis antiproliferation cancers differentiation HL60 cells cycles proliferative positive markers CD14 CD11b CD11c monocytic granulocytic 87.804419889503
10009078 CAY10505 328960-84-5 ≥98% 2009-11-04 8.324254143646 cay10505 phosphoinositide 3-kinase immunity autoimmune inflammation PI3Kγ PI3Kα PI3Kβ PI3Kδ casein kinases 2 CK2 phosphorylation PKB/Akt macrophages neutrophil recruitment cancer PI3s T2Ds PI3Ks PI3K.gamma. PI3Kg 8.324254143646
10009536 CAY10512 Exclusive 139141-12-1 >97% ✓ 2007-07-18 34.820911602210 cay10512 analogs resveratrol nuclear factors NFkB NF-.kappa.B immunity inflammation stress growth apoptosis trans-stilbene activation cancers NF-kB inhibition inhibtors inhibits atherosclerosis 34.820911602210
10010301 CAY10554 267654-00-2 >95% 2007-12-01 8.847974217311 cay10554 BML-259 cell cycle cdk5 cdk2 inhibitors inhibits inhibition cancers BML 259 BML259 CDKs neurodegenerative diseases 8.847974217311
10010043 CAY10561 Exclusive 933786-58-4 >98% ✓ 2008-03-06 27.155911602210 cay10561 Pyrazolylpyrrole ERK Inhibitor MEK Ras Raf ERK2 proliferation cell cycles cancers apoptosis inhibition inhibit inhibitors 27.155911602210
18218 CAY10572 845714-00-3 ≥98% 2009-03-02 11.357182320442 cay10572 PHA 767491 inhibits inhibition inhibitors cdc7 kinases pyrrolopyridinone DNA synthesis cells death cycles apoptosis p53 cancers cdk9 antitumor agents anti-tumor 11.357182320442
10011247 CAY10574 140651-18-9 >95% 2008-09-04 12.652707182320 cay10574 CDK2 cyclin E CDK9 inhibitors inhibits inhibition anticancer cell cycle CAN508 12.652707182320
10011256 CAY10577 300675-28-9 ≥95% 2008-09-02 0.867403314917 cay10577 inhibitors inhibits inhibition CK2 kinase cell signaling apoptosis cancers 0.867403314917
10011264 CAY10578 19231-60-8 ≥95% 2008-08-26 0.867403314917 cay10578 inhibitors inhibits inhibition kinase cell signaling CK2 apoptosis cancers isoindolineacetic acids 0.867403314917
16835 CAY10580 Exclusive 64054-40-6 ≥96% ✓ 2009-03-16 77.547532228361 cay10580 PGEs PGE2 receptors inhibitors inhibits inhibition antagonist blockers EP4 cAMPs bones fromation resorption cancers atherosclerosis 77.547532228361
16838 CAY10581 Exclusive 1018340-07-2 ≥97% ✓ 2009-05-08 2.949171270718 cay10581 indoleamine 2,3-dioxygenase IDO cancers inhibitors tumors inhibition inhibited naphthoquinones 2.949171270718
10012682 CAY10585 934593-90-5 ≥97% 2008-11-06 51.046418047881 cay10585 Hypoxia Inducible Factor-1α Inhibitor HIF-1α HIF1α hypoxia cancers transcriptions factors VEGFs erythropoietin inhibitors inhibits inhibition 51.046418047881
10009797 CAY10591 Exclusive 839699-72-8 >98% ✓ 2008-04-21 47.879042357274 cay10591 Sirtuin 1 Activator 3; SIRT1 Activator 3 p53 HDACs inhibits inhibitors inhibitions SIRTs sirtuins class III TNFalpha TNF.alpha. THP-1 cells anti-obesity anti-diabetic 47.879042357274
13206 CAY10593 Exclusive - ≥95% ✓ 2009-09-03 20.577944751381 cay10593 VU0155069 inhibitors inhibits inhibitions phospholipases D PLD PLD1 PLD2 phosphatidic acids PAs chemotaxis cells migration cancers breast lines tumors trans well assays 1130067-06-9 20.577944751381
13281 CAY10598 Exclusive 346673-06-1 ≥98% ✓ 2010-05-07 73.670928176795 cay10598 Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection 73.670928176795
10009796 CAY10602 374922-43-7 ≥95% 2009-07-15 19.213069367710 cay10602 SIRT1 Activator 1 SIRTs sirtuins inflammation deacetylase NF-kB NFkB NF-κB NFκB 19.213069367710
13146 CAY10603 1045792-66-2 ≥95% 2009-06-18 61.179438305709 cay10603 HDAC 6 inhibitors inhibits inhibition tubulin microtubule pancreatic cancers SAHA HDAC6 HDAC-6 HDACs HDACIs potent selective cells 61.179438305709
13291 CAY10616 Exclusive 586410-08-4 ≥98% ✓ 2009-12-01 20.623049723757 cay10616 resveratrols apoptosis cancers leukemia HL-60 cells HL60 HL 60 multidrug-resistance multidrug resistance multi-drug multi-drug-resistant daunorubicin etoposides citarabines phenols cytarabines HL60R 20.623049723757
13670 CAY10618 Exclusive 1202580-59-3 ≥95% ✓ 2011-03-18 15.319834254143 cay10618 NMPRTase Inhibitor nicotinamides phosphoribosyltransferases NAMPTs NAD+ cancers inhibitors autophagy inhibited inhibition inhibits 15.319834254143
13371 CAY10621 120005-55-2 ≥98% 2010-02-16 16.183024861878 cay10621 SKI 5C; SPHK 1 Inhibitor 5C sphingosines kinases Sphk sphingosine-1-phosphates S1P SphK1 SphK2 cancers inhibitors inhibits U937 cells proteins kinase C PKC SKI5C SKI-5C 16.183024861878
13836 CAY10625 137346-42-0 ≥95% 2010-06-23 1.388011049723 cay10625 apoptosis Smac Diablo Survivin cancers antagonists INCENP doxorubicin caspase-3 caspase-7 Aurora B kinases Borealin caspases cell-permeable antagonists smac/diable smac-diablo 1.388011049723
13838 CAY10626 Exclusive 1202884-94-3 ≥98% ✓ 2010-08-23 19.375744492190 cay10626 PI3Kα mTOR cancers signal transduction inhibitors inhibits inhibition phosphatidylinositol 3-kinase PtdIns PIs 19.375744492190
10743 CAY10650 Exclusive 1233706-88-1 ≥98% ✓ 2011-06-14 23.657458563536 cay10650 cPLA2α cPLA2 inhibitors inflammation anti-inflammatory dermatitis metabolite phospholipase cytosolic prostaglandins PGs leukotrienes synthesis 10662 CAY-10650 CAY10641 CAY-10641 23.657458563536
10004985 Caylin-1 - >98% 2005-09-09 14.983093922652 caylin-1 caylin1 mdm-2 cancer Nutlin-3 analogs p53 inhibits inhibitors inhibition interaction Mdm2 negative regulators activity chlorine substituents phenyl rings growth HCT-116 cells promotes 14.983093922652
10005002 Caylin-2 - >98% 2004-07-12 13.664419889502 caylin-2 apoptosis cancer p53 inhibits inhibitors induces apoptotic re-activation reactivation antioncogenic tumors xenografts HCT-116 caylin2 13.664419889502
13172 CBHA 174664-65-4 ≥98% 2009-06-24 33.912871516690 cbha Histone Deacetylase Inhibitor II; m-Carboxycinnamic Acid bis-Hydroxamide histones deacetylase HDACs HDAC1 HDAC3 apoptosis cancers neuroblastoma tumors retinoic acids inhibitors inhibits inhibition 33.912871516690
10787 CCG-100602 New 1207113-88-9 ≥98% 2011-11-22 14.999462860650 ccg-100602 Rho signaling signal transduction cancers inhibitors SRF serum response factors transcription CCG-1423 megakaryoblastic leukemia 1 MKL1 prostate analogs PC-3 CCG100602 CCG 100602 CCG1423 CCG 1423 cells DNA binding RHOA/C-mediated MKL-1 14.999462860650
10010350 CCG-1423 285986-88-1 >98% 2007-09-20 12.086362360782 ccg-1423 Rho signaling transduction cancers proliferations anti-proliferation anti-tumor serum response factor GTPase inhibits inhibitors inhibition signalling 12.086362360782
10012591 CCT018159 171009-07-7 ≥98% 2008-12-09 0.626408839779 cct018159 inhibitors inhibits inhibition cancers Hsp90s Hsp72 kinases tumor cells 17-AAG 17AAG CCT 018159 CCT-018159 0.626408839779
10004804 CD150 Monoclonal Antibody (Clone IPO-3) - 2005-03-21 1.395603130754 cd150-monoclonal-antibody-clone-ipo-3 SLAM; IPO-3; CDw150 type transmembrane glycoproteins signals signalling transduction neoplastic cells antibodies antisera antiserum antioncogenic immunohistochemistry IHC flow cytometry immunoprecipitation IP immunocytochemistry ICC receptors ligation Hodgkins lymphoma leukemia tumors cancer ipo3 cd-150 b-cells t-cells tonsils cancers FC 1.395603130754
10004837 CD27 Monoclonal Antibody (Clone 203.6) - 2005-09-16 7.419065796082 cd27-monoclonal-antibody-clone-203-6 antibodies antisera antiserum IHC immunohistochemistry ICC immunocytochemistry FACS flow cytometry type II transmembranes glycoproteins leukocytes proteins tetraspanin superfamily antigens alternative splicing isoforms human B cells pro-B plasma T macrophages neutrophils platelets erythrocytes Anti-CD37 immunophenotyping neoplasia hairy chronic lymphocytic non-Hodgkin's lymphoma expression lymphocytes T cells NK activated memory monocytes granulocytes dendritic B anti-CD45 mAB lymphoid malignancies malignant cancer FC 7.419065796082
10004835 CD34 Monoclonal Antibody (Clone ICO-115) - 2005-09-16 4.512881427964 cd34-monoclonal-antibody-clone-ico-115 antibodies antisera antiserum ICC immunocytochemistry FACS flow cytometry type I transmembranes glycoproteins proteins antigens isoforms stem cells embryonic fibroblasts neurons Anti-CD34 differential staining acute leukemias cancers malignant malignancies ICO115 FC 4.512881427964
10208 CD34 Monoclonal FITC Antibody (Clone ICO-115) - 2008-07-23 30.117716390423 cd34-monoclonal-fitc-antibody-clone-ico-115 antibodies antiserum antisera flow cytometry immunofluorescence FC IF transmembranes glycoproteins leukemias stem cell lines 30.117716390423
10004718 CD37 Monoclonal Antibody (Clone IPO-24) - 2005-09-16 4.867584128578 cd37-monoclonal-antibody-clone-ipo-24 antibodies antisera antiserum IHC immunohistochemistry ICC immunocytochemistry FACS flow cytometry type III transmembranes glycoproteins leukocytes proteins tetraspanin superfamily antigens alternative splicing isoforms human B cells pro-B plasma T macrophages neutrophils platelets erythrocytes Anti-CD37 immunophenotyping neoplasia hairy chronic lymphocytic non-Hodgkin's lymphoma expression lymphocytes T cells NK activated memory monocytes granulocytes dendritic B anti-CD45 mAB lymphoid malignancies malignant cancer FC 4.867584128578
10004597 CD45 Monoclonal Antibody (Clone BRA-55) - 2005-08-23 4.867584128578 cd45-monoclonal-antibody-clone-bra-55 antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry ICC immunocytochemistry FACS flow cytometry type transmembranes glycoproteins leukocytes antigens alternative splicing isoforms CD45RA CD45RB CD45RC CD45RO expression lymphocytes cells NK activated memory monocytes granulocytes dendritic anti-CD45 mAB lymphoid malignancies malignant cancer BRA55 immunoblotting FC 4.867584128578
10009852 CD4/CD8 Monoclonal FITC/PE Antibody (Clone RIV7/OKT-8) - 2008-09-03 0.485303867403 cd4-cd8-monoclonal-fitc-pe-antibody-clone-riv7-okt-8 antibodies antisera antiserum FC flow cytometry human whole blood cells lysis white CD4-CD8 CD4+CD8 IF immunofluorescence 0.485303867403
10004604 CD95 Monoclonal Antibody (Clone IPO-4) - 2004-06-17 1.484942909760 cd95-monoclonal-antibody-clone-ipo-4 APO-1; Fas; Tumor Necrosis Factor Receptor Superfamily, Member 6; TNFRSF6; Apoptosis Antigen; APT glycoproteins blots blotting antibodies antisera antiserum DNA binding anti-oncogenic apoptosis cancers p53 re-activator reactivator induces apoptotic re-activation reactivation antioncogenic immunocytochemistry immunohistochemistry IHC icc FC flow cytometry 1.484942909760
10009349 Cell Cycle Phase Determination Kit - 2007-04-20 60.504257134467 cell-cycle-phase-determination-kit assays kits measures measurements microscopy flow cytometry plate readers regulators cells transcription factors DNA proteins division proliferation induction inhibition fixation permeabilization staining sub-G1 G0 G2 S propidium iodide apoptosis cancer cell-based assay cell based assay cba 60.504257134467
11092 Ceranib-2 New - ≥98% 2011-12-19 45.494857785963 ceranib-2 ceramides ceramidase sphingosines sphingosine-1-phosphate S1P cells proliferation cancers paclitaxel tumors inhibitors lipids inhibits inhibition endogenous ovarian SKOV3 growth toxicity fatty acids N-acyl malignant apoptosis S1P non-lipid increases increased 45.494857785963
10005647 Cerulenin 17397-89-6 ≥98% 2004-09-01 65.388204419889 cerulenin tumor cells fatty acid synthases FAS inhibits inhibitors inhibition cytotoxicity apoptosis cancer diet obesity D02.065.327 65.388204419889
10009853 CFSE Cell Division Assay Kit - 2010-01-15 62.013578410539 cfse-cell-division-assay-kit derivative carboxyfluorescein diacetate, succinimidyl ester CFDA-SE cells proliferation growth factors receptors surfaces signaling molecules transcription factors DNA deoxyribonucleases proteins divisions cascades human pathological diseases cancers cell-tracing fluorescent fluorescence dyes proliferative activity parent generations daughter acetate groups molecules cleaved background unstained staining CFSE-labeled radioactivity radioactive labeling divisions inductions inhibitors inhibits inhibitions in vitro models flow cytometry fluorochromes fluorescein 62.013578410539
13156 Chaetocin 28097-03-2 ≥95% 2010-10-18 13.291246044912 chaetocin histones methyltransferases HMTs genes expressions epigenetics inhibitors oxidative stress cancers theoredoxin reductase-1 TrxR1 inhibits inhibition chetocin chaetocin A (+)-chaetocin piperazines 13.291246044912
10011286 Chenodeoxycholic Acid 474-25-9 ≥95% 2009-02-25 26.271690607734 chenodeoxycholic-acid Ulmenide; Kebilis; Anthropodeoxycholic Acid; Hekbilin; Fluibil; CDCA FXR biles acids cholesterol oxidative stress glutathione cancers atherosclerosis diabetes hyperlipidemia CDA 26.271690607734
13686 Chidamide 743420-02-2 ≥98% 2010-08-10 75.017168815223 chidamide HDACs histones deacetylase H3 acetylation colons cancers cells inhibitors inhibits inhibiton LoVo HT-29 HT29 HT 29 cycle arrest chidamides oncogenic signalling signaling kinases Benzamides 75.017168815223
70930 Chlorogenic Acid 327-97-9 ≥95% 28.736887661141 chlorogenic-acid NSC 407296; Heriguard; 3-O-Caffeoylquinic acid antioxidants acids plants metabolism polyphenolic 28.736887661141
13501 Chromosome Associated Protein-C Polyclonal Antibody (aa 281-297) - 2009-09-22 0E-12 chromosome-associated-protein-c-polyclonal-antibody-aa-281-297 CAP-C antibodies SMC WB western blots immunoblotting blotting hCAP-C hCAPC hCAP C hSMC1 hCAP-E hCAP E hCAPE hSMC3 chromosomes structured maintenance 0E-12
13503 Chromosome Associated Protein-C Polyclonal Antibody (aa 47-61) - 2009-09-22 0E-12 chromosome-associated-protein-c-polyclonal-antibody-aa-47-61 CAP-C antibodies SMC WB western blots immunoblotting blotting hCAP-C hCAPC hCAP C hSMC1 hCAP-E hCAP E hCAPE hSMC3 structural maintenance chromosomes 0E-12
10012583 cis-ACCP 777075-44-2 ≥95% 2009-02-10 0E-12 cis-accp MMP2 MMPs MMP 2 MMP9 MMP-9 9 tumors cancers extracellular matrix type IV collagen cell migration artritis osteoprosis 0E-12
13199 cis-trismethoxy Resveratrol 94608-23-8 ≥98% 2009-03-25 19.907465469613 cis-trismethoxy-resveratrol cis-Trimethoxy Stilbene resveratrol anti-mitotic growth inhibitors colon cancers tubulin polymerization polyamines putrescine spermidine cis-Trimethoxy resveratrol 3,5,4'-trimethoxystilbene 3,5,4'-trimethoxy-cis-stilbene trismethoxy inhibitor inhibition caco-2 caco 2 cells AHR antagonists aryl hydrocarbon receptors 19.907465469613
10599 Cl-Amidine Exclusive New 913723-61-2 ≥95% ✓ 2011-08-29 30.807158042066 cl-amidine inhibitors PAD4 PAD-4 cancers epigenetics amidines proteins arginine deiminase 4 arthritis PADs cytotoxic HL-60 HL60 HT-29 mice joints auto antibodies HL 60 MCF7 MCF-7 MCF 7 HT29 citrulline IgG HT 29 cells lines ClA mouse serum autoantibodies auto-antibodies PAD3 PAD-3 3 PAD1 PAD-1 1 30.807158042066
580110 Clusterin (human) EIA Kit - 2011-08-02 2.154696132597 clusterin-human-eia-kit Apolipoprotein J; Apo-J; pADHC-9; TRPM-2; AAG4; SGP-2; CLI; KUB-1 apolipoproteins Up-regulated in Azheimer's diseases brains Ku70-binding proteins 1 sulfated glycoproteins 2 aging-associated genes 4 complement lysis inhibitors testosterone-repressed prostate messages secreted disulfide-linked heterodimeric amyloid lipids bacteria leptin immunoglobulins endocytic receptors LDLs low-density lipoprotein-related LPR2 LPR8 8 endocytosis tissues mammals mammalian cells plasma serums semen cultures media medium developmental remodeling apoptotic neurodegeneration injury stress inhibits inhibition apoptosis carcinogenesis genes CLU ELISAs EIAs enzymes immunoassays kits measures measurements human supernatants 2.154696132597
9000760 Colchicine 64-86-8 ≥98% 2011-05-25 1.970441988950 colchicine microtubules polymerization mitosis anti-proliferation anti-inflammatory gout uric acids antiinflammatory antiproliferation 1.970441988950
10007412 Combrestatin A4 117048-59-6 ≥98% 2007-07-26 22.155548189072 combrestatin-a4 CRC 87-09; Combretastatin A4; CA4 inhibitors inhibition inhibits tubulin polymerization tumors CSA4 CSA-4 IMR32 neuroblastomas Hs746T carcinomas CFPAC-1 CFPAC1 MCF-7 MCF7 cancers inhibitory CA4 cells growth pancreatic breast gastric CA-4 combretastin 22.155548189072
360107 COX-2 (human) Blocking Peptide - 34.308563535911 cox-2-human-blocking-peptide Prostaglandin H Synthase 2; Cyclooxygenase 2; PGHS-2 peptides prostaglandins PGHS-2 COX2 PGHS2 western blots blotting synthases controls immunohistochemistry IHC cyclooxygenases WB antibodies 34.308563535911
160112 COX-2 Monoclonal Antibody (Clone CX229) - 92.953200736648 cox-2-monoclonal-antibody-clone-cx229 PGHS-2; Prostaglandin H Synthase 2; Cyclooxygenase 2 prostaglandins inflammation cancers arthritis western blots blotting immunohistochemistry IHC WB immunocytochemistry ICC antibodies cox2 pghs2 pghs-2 synthases cyclooxygenases antisera antiserum cyclooxygenase immunoblotting 92.953200736648
160126 COX-2 (mouse) Polyclonal Antibody - 119.955016574585 cox-2-mouse-polyclonal-antibody PGHS-2; Prostaglandin H Synthase 2; Cyclooxygenase 2 immunohistochemistry IHC Western blotting WB antibodies blots cox2 PGHS2 PGHS-2 synthases prostaglandins mouse cyclooxygenases antisera antiserum cancers immunoblotting 119.955016574585
10010096 COX-2 (mouse) Polyclonal FITC Antibody Exclusive - ✓ 2008-04-23 31.123784530387 cox-2-mouse-polyclonal-fitc-antibody Prostaglandin H Synthase 2; PGHS2; Cyclooxygenase 2 antibodies prostaglandins thromboxanes prostacyclins arachidonic acids FC flow cytometry ICC immmunocytochemistry WB western blots blotting immunoblotting IF immunofluorescence 31.123784530387
700200 COX Fluorescent Activity Assay Kit - 2008-07-24 77.425905102372 cox-fluorescent-activity-assay-kit Cyclooxygenase Fluorescent Activity Assay Kit cyclooxygenases synthases enzymes cox-1 cox1 cox-2 cox2 prostaglandins PGs synthase-1 synthase-2 pghs-1 pghs1 pghs-2 pghs2 assays kits peroxidase activity cellular homeostasis antiinflammatory NSAIDs nonsteroidal anti-inflammatory drugs fluorescence human recombinant ovine isozyme-specific inhibits inhibitors inhibition ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 77.425905102372
81025 Curcumin 458-37-7 ≥90% 16.412881705262 curcumin Turmeric Yellow; Indian Saffron anti-oxidant anti-imflammatory NOS nitric oxide synthase 16.412881705262
81025.1 Curcumin (technical grade) 458-37-7 ≥65% 7.585303867404 curcumin-technical-grade Turmeric Yellow; Indian Saffron anti-oxidant anti-imflammatory NOS nitric oxide synthase 7.585303867404
10011388 Cu/Zn SOD (human) Polyclonal Antibody - 23 kDa 2008-04-03 147.019160220994 cu-zn-sod-human-polyclonal-antibody SOD1; Cu/Zn Superoxide Dimutase SOD1 SOD2 SOD3 EC-SOD oxidative stress ROS superoxide antibodies antiserum WB western blots immunoblotting IP EIA IHC immunohistochemistry neurochemistry immunoprecipitation enzyme immunoassays neurochemistry blotting 147.019160220994
10004600 Cytokeratin Monoclonal Antibody (Clone C-11) - 2008-06-05 19.639745856353 cytokeratin-monoclonal-antibody-clone-c-11 pan-Cytokeratin cytokeratins pan-cytokeratins antibodies antiserum antisera isoforms western blots WB flow cytometry FC immunocytochemistry ICC immunohistochemistry IHC immunoblotting proteins blotting 19.639745856353
10568 Cytokeratin Monoclonal APC Antibody (Clone C-11) - 2011-03-04 14.601144435675 cytokeratin-monoclonal-apc-antibody-clone-c-11 pan-Cytokeratin cytokeratins pan-cytokeratins antibodies antiserum antisera isoforms flow cytometry FC proteins immunofluorescence IF 14.601144435675
10349 Cytokeratin Monoclonal FITC Antibody (Clone C-11) - 2010-04-14 18.471082872928 cytokeratin-monoclonal-fitc-antibody-clone-c-11 pan-Cytokeratin cytokeratins pan-cytokeratins antibodies antiserum antisera isoforms western blots WB flow cytometry FC immunofluorescence IF immunoblotting proteins blotting 18.471082872928
10478 Cytokeratin Monoclonal PE Antibody (Clone C-11) - 2010-10-28 2.473370165746 cytokeratin-monoclonal-pe-antibody-clone-c-11 pan-Cytokeratin cytokeratins pan-cytokeratins antibodies antiserum antisera anti-serum anti serum anti-ser anti sera isoforms flow cytometry FC immunoblotting proteins blotting IF immunofluorescence 2.473370165746
63500 Cytotrienin A 189010-85-3 ≥95% 2009-07-06 18.517292817679 cytotrienin-a anti-tumor anti-cancer apoptosis ROS caspace-3 p36 MBP kinase JNK 18.517292817679
13305 D 4476 301836-43-1 ≥98% 2009-07-29 37.654309392265 d-4476 Casein Kinase I Inhibitor inhibitors inhibits inhibition casein kinases 1 CK1 Ck1δ TGF-β TGFβ type-1 receptors ALK5 PKD1 p38α MAPK kinases phosphorylation FOXO1a RhoB p53 Smad3 D4476 37.654309392265
13202 Daidzin New 552-66-9 ≥98% 2011-09-30 3.056718891729 daidzin NPI 031D; Daidzoside isoflavones soy kudzu anti-oxidants cancers oxidants stress atherosclerosis inhibitor inhibits inhibition mitochondrial aldehydes dehydrogenases 2 alcohols plants anticarcinogenic anti-carcinogenic anti carcinogenic antioxidants antidipsotropic dipsotropic anti-dipsotropic anti-atherosclerosis antiatherosclerosis atherosclerosis 1329-08-4 28572-56-7 NPI-031D NPI031D 7-glucoside glucosides 3.056718891729
160755 DcR2 Polyclonal Antibody - 0E-12 dcr2-polyclonal-antibody TRUNDD; TRAIL-R4 apoptosis cell death TNF DR4 DR5 DcR1 TRID TRAIL antibodies western blots blotting WB antisera antiserum immunoblotting 0E-12
10005432 DDA 25152-84-5 ≥98% 2004-07-22 14.664872928177 dda trans-2,4-Decadien-1-al; Decadienealdehyde lipoxygenases diatoms alkyls linoleic acids dihomo-gamma-linolenic dihomo-g-linolenic arachidonic dihomo-.gamma.-linolenic carcinoma Caco2 apoptosis 14.664872928177
10010706 (−)-Deguelin 522-17-8 ≥98% 2008-09-18 15.940441988951 -deguelin (-)-cis-Deguelin rotenoids flavonids cancers antiproliferative chemoprevention parkinsons diseases Akt PKB PI3K COX-2 COX2 apoptosis PI3-K 15.940441988951
10961 Demethoxycurcumin New 22608-11-3 ≥98% 2011-09-23 5.123579797029 demethoxycurcumin DMC curcumin cancers transcription genes expressions p300 Wnt/β-catenin iNOS inflammation proliferation cells p300 coactivator inhibits lipopolysaccharides inhibitor inhibition 5.123579797029
700390 Demethylase (Jumonji-type) Activity Assay Kit - 2010-05-26 19.279241393965 demethylase-jumonji-type-activity-assay-kit kits assays measures measurements histones nucleoproteins chromatins DNA deoxynucleic acids eukaryotic nucleus nucleosomal H3 H4 H2B H2A octamers amino termini acetylation phosphorylation ubiquitination methylation replication repair transcriptional activation repression dysregulation tumors suppressor genes cancers inhibitors enzymes catalyzes epigenetic marks methyls lysines arginines residues demethylases 1 JMJC JHDM1 JHDM2 JHDM3 JARID1 UTX/UTY cupin 2-oxoglutarate 2OG iron Fe(II) oxygenases hydroxylation JMJD2A JMJD2B JMJD2C JMJD2D JMJD2E JMJD2F fluorescence-based fluorescent cells lysates formaldehydes peptides substrates oxidation/decarboxylation acetoacetanilides ammonia H3K9(Me)3 19.279241393965
700400 Demethylase (LSD-type) Activity Assay Kit - 2010-08-05 16.587374375164 demethylase-lsd-type-activity-assay-kit kits assays measures measurements histones proteins nucleoproteins chromatins structures DNA deoxyribonuclease eukaryotics nucleus nucleosomals core particles H3 H4 H2B H2A octamers amino termini post-translationally acetylation phosphorylations ubiquitination methylations replication repair transcriptional activation repression dysregulation tumor suppressor genes cancers enzymes catalyze epigenetic marks therapeutics drugs development lysine-specific demethylases LSD1 KDM1 p110b BHC110 NPAO LSD2 flavin adenines dinucleotides FAD-dependent amines oxidases monoamines MAOs polyamines PAOs demethylates monomethylateds dimethylateds lysines 4 K4 repression deacetylases co-repressor complexes 1/2 CtBP neuronal CoREST p53 LYS370 53BP1 apoptosis C-terminal domains CW-type zinc finger motif zince-binding sites chromatin-remodeling fluorescence-based formaldehyde N-terminal tail acetoacetanilides ammonia 16.587374375164
10165 D-erythro-MAPP 143492-38-0 >98% 2004-02-23 22.528196513942 d-erythro-mapp (1S,2R-D-erythro-2-N-myristoylamino)-1-phenyl-1-propanol ceramides inhibitors sphingolipids HL60 HL-60 cancer cells G0/G1 G0-G1 inhibits ceramidase 22.528196513942
10012577 Diallyl Trisulfide 2050-87-5 ≥98% 2009-04-07 20.051926335174 diallyl-trisulfide DATS; NSC 651936 garlic hydrogen sulfides H2S cancers tumors smooth muscle cholesterol atherosclerosis donors supresses colon synthesis genes expression adenocarcinomas HCT-15 cells PC-3 xenografts 20.051926335174
10009081 Didox Exclusive 69839-83-4 ≥98% ✓ 2007-01-16 19.257632202051 didox antioxidants hydroxamic acids apoptosis cancers cells polyhydroxylated aromatic ocidative injury brains HIV dementia bcl-2 19.257632202051
10006876 Diethylstilbestrol 56-53-1 ≥98% 2005-10-03 4.034618784530 diethylstilbestrol synthetics receptors agonists pregnant pregnancies linked breasts cancers congenital abnormalities abnormality offspring 3H-estradiols binding affinities affinity sexes hormones globulins SHBG estrogens 4.034618784530
10009986 Dimethoxycurcumin 160096-59-3 ≥90% 2007-08-03 13.053412092002 dimethoxycurcumin curcumins cancers ASCJ9 antitumors anti-tumor phytochemicals turmeric inhibits inhibition inhibitory growth expression cells ASC-J9 13.053412092002
62237 Diphenyl-1-pyrenylphosphine 110231-30-6 ≥98% 2006-07-25 80.386255371393 diphenyl-1-pyrenylphosphine DPPP hydroperoxides oxidative stress injury fluorescence fluorescent lipids cholesterols LDL oxidation DPPPO DPPP=O atherosclerosis 80.386255371393
10005276 DL-threo-PDMP (hydrochloride) 80938-69-8 >98% 2004-08-10 2.303591160220 dl-threo-pdmp-hydrochloride analogs analogues inhibits inhibitors inhibition cytotoxicity glucosylceramides synthases chirality stereoisomers sphingosine 2.303591160220
71210 DMOG 89464-63-1 ≥98% 128.936662983425 dmog Dimethyloxallyl Glycine nuclear receptors cancer hypoxia HIF-1alpha Hif1α HIF-1α HIF1α Pro-angiogenic proangiogenic factors HIF-PH HIFPH prolyl hydroxylase inhibits inhibitors inhibition 128.936662983425
10009851 D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt) - >98% 2007-06-04 8.561325966850 d-myo-inositol-1-3-4-5-6-pentaphosphate-ammonium-salt 1,2,4,5,6-IP5 (sodium salt); Ins(,1,3,4,5,6)P5 inositols phosphate IP5 signal transduction InsP phosphitidylinositol phospholipase C PLC phosphioinositide 3-kinase PI3-K Akt cancer angiogenesis PKB protein kinase B 8.561325966850
660990 DNA Laddering Kit - 3.107679558011 dna-laddering-kit kits assays apoptosis 3.107679558011
589324 DNA Methylation EIA Kit - 2009-04-23 97.498509021493 dna-methylation-eia-kit 5-methyl-2-deoxy Cytidine ELISA Kit solid plates DNA deoxyribonucleic acids CpG islands dinucleotides genes genomes cancers genomic hypomethylation hypermethylation tumors suppressors malignancy carcinogenesis plasma blood urine leukemia tissues differentiation aging methyltransferases DNMTs DNMT1 DNMT3a DNMT3b nucleosides analogs azacitidine decitabine zebularine drugs suppression competitive assays EIAs ELISAs culture supernatants sample matrices 97.498509021493
13479 DNA Methyltransferase 1 Monoclonal Antibody (Clone 60B1220.1) - 2009-06-29 1.436863106199 dna-methyltransferase-1-monoclonal-antibody-clone-60b1220-1 DNMT1 WB Western blots immunoblotting IHC ChIP IP DNMT 1 blotting immunohistochemistry immunoprecipitation 1.436863106199
13481 DNA Methyltransferase 2 Monoclonal Antibody (Clone 102B1259.2) - 2009-07-13 0.197316495659 dna-methyltransferase-2-monoclonal-antibody-clone-102b1259-2 DNMT2 WB Western blots immunoblotting DNMT-2 monoclonals blotting DNMT 2 blotting 0.197316495659
13480 DNA Methyltransferase 2 Polyclonal Antibody - 2009-07-13 0.235255524861 dna-methyltransferase-2-polyclonal-antibody DNMT2 WB Western blots immunoblotting DNMT 2 blotting DNMT-2 0.235255524861
13483 DNA Methyltransferase 3a Monoclonal Antibody - Biotinylated (Clone 64B814.1) - 2009-07-15 0.197316495659 dna-methyltransferase-3a-monoclonal-antibody-biotinylated-clone-64b814-1 DNMT3a ELISA DNMT3a Enzyme-linked immunosorbent assays 0.197316495659
13484 DNA Methyltransferase 3a Monoclonal Antibody (Clone 64B1446) - 2009-07-15 0.197316495659 dna-methyltransferase-3a-monoclonal-antibody-clone-64b1446 DNMT3a WB Western blots immunoblotting DNMT3a blotting ICC immunocytochemistry IHC immunohistochemistry 0.197316495659
13482 DNA Methyltransferase 3a Monoclonal Antibody (Clone 64B814.1) - 2009-07-01 0.235255524861 dna-methyltransferase-3a-monoclonal-antibody-clone-64b814-1 DNMT3a WB Western blots immunoblotting DNMT3a blotting ICC immunocytochemistry 0.235255524861
13485 DNA Methyltransferase 3b Monoclonal Antibody (Clone 52A1018) - 2009-07-01 0.235255524861 dna-methyltransferase-3b-monoclonal-antibody-clone-52a1018 DNMT3b WB Western blots immunoblotting DNMT3b immunoprecipitation immunofluorescence immunocytochemistry ChIP immunohistochemistry IHC IP ICC IF blotting 0.235255524861
10770 DNA Methyltransferase 3L (human recombinant) - ≥95% 2011-06-08 6.548414160016 dna-methyltransferase-3l-human-recombinant DNMT3L; DNMT3-Like Protein DNA methyltransferases s-adenosylmethionine CpG methylation lysines proteins DNMT3a DNMT3b histones cysteine ADD PWWP mTase 6.548414160016
10006305 D-NMAPPD Exclusive 35922-06-6 ≥98% ✓ 2005-02-23 23.075789236751 d-nmappd CAY10466; (1R,2R)-B13 ceramides inhibitors cancers cells inhibits inhibition ceramidase apoptosis colorectal keratinocytes melanoma lines viability inducers induces 23.075789236751
700210 DPP (IV) Inhibitor Screening Assay Kit - 2009-05-27 101.732861418047 dpp-iv-inhibitor-screening-assay-kit Dipeptidyl exopeptidases IV DPPIV DPP4 enzymes CD26 cluster of differentiation T-cells activation antigens adenosine deaminase complexing 2 membrane-bound glycoproteins immune regulation signal transduction apoptosis kidneys small intestines placentas humans serums seminal fluids proteolytic derivatives serines X-prolines X-alanines dipeptides N-terminus N-terminal polypeptides growth factors chemokines neuropeptides vasoactive inhibitors inhibits inhibition oral antidiabetic agents glucose homeostasis glucoregulatory hormones glucose-dependent insulinotropics GIP glucagon-like peptide-1 GLP-1 gastric therapeutics Type 2 tumors cancers markers neoplasms assays kits measures measurements fluorescences fluorescent fluorogenics substrates Gly-Pro-Aminomethylcoumarin AMC 101.732861418047
11178 DPY-30 (human recombinant) New - ≥95% 2012-01-05 89.286952396897 dpy-30-human-recombinant DPY-30-like protein; hDPY-30; SAF19 epigenetics methyltransferase histones H3K4 genes regulations MLL proteins subunits Ash2L MLL sore complex DPY30 methylation C. elegans XX mutations XO growth development homodimer monomers WDR5 WDR-5 WDR 5 RbBP5 basal rates DPY-30L DPY30L hDPY30 SAF-19 89.286952396897
10010302 DRB 53-85-0 ≥98% 2008-01-21 2.614201688497 drb Benzimidazole; NSC 401575 cancers HIV P53 apoptosis CDK7 CDK9 CTD CKI CKII adenosine inhibitors inhibits inhibition transcription RNA polymerase cell cycles adenocarcinoma transactivator tat 2.614201688497
10007963 E-64 66701-25-5 ≥98% 2009-11-12 54.998232044198 e-64 inhibitors cysteine proteases cathepsins papain calpain irreversible inhibition inhibited E64 E 64 54.998232044198
10007964 E-64c 76684-89-4 ≥98% 2006-08-02 52.925580110497 e-64c EP 475; Loxistatin Acid; NSC 694279 E-64 cysteine protease cell cycle inhibitor E-64d 52.925580110497
13533 E-64d 88321-09-9 ≥98% 2010-08-16 15.763895027624 e-64d EP 453; EST; NSC 694281; Loxistatin; E-64c ethyl ester; Aloxistatin cysteine protease proteins degradation lysosome inhibitors inhibits inhibition calpain cathepsin E64d E 64d 64 207396-71-2 cells cancers carcinomas A431 E-64d Morphinans 15.763895027624
10005732 EAF2 Blocking Peptide - >75% 2004-09-01 0E-12 eaf2-blocking-peptide ELL-Associated Factor 2; U19 WB western blots blotting IHC immunohistochemistry immunoblot formalin-fixed paraffin-embedded sections apoptosis inhibits ihibitors inhibition prostate tumors testosterone antibodies paraffins signaling signalling controls peptides 0E-12
10005190 EAF2 Polyclonal Antibody - 2004-08-12 2.012088397790 eaf2-polyclonal-antibody ELL-Associated Factor 2; U19 WB western blots blotting IHC immunohistochemistry immunoblots formalin-fixed paraffin-embedded sections apoptosis inhibits inhibitors inhibition prostate tumors testosterone suppressive supression leukemogenesis cancers endocrinology immunoblotting 2.012088397790
10628 EED (human recombinant) - 95 2010-12-03 0E-12 eed-human-recombinant Embryonic Ectoderm Development 0E-12
10569 Ellagic Acid 476-66-4 ≥95% 2010-10-13 6.173474524248 ellagic-acid Lagistase; TBBD; Gallogen polyphenols, antioxidants, cancers inflammation cytochrome P450s CYP450 epigenetics genes expression histones modifications alizarin yellow G 91006 elagostasine 77415-21-5 124590-32-5 PRMTs inflammatory anti-carcinogenic anti-mutagenic organ-preserving antimutagenic antiinflammatory Acid Benzoaric Benzoaric Acid Acid Ellagic Ellagic Acid 6.173474524248
10112 (±)-Enterolactone 78473-71-9 ≥95% 6.983867403315 -enterolactone HPMF lignans plants antioxidants cancer oxidative injury stress enterobacterial 6.983867403315
500520 Enterolactone EIA Kit - 2005-03-15 122.405021485574 enterolactone-eia-kit solid plates steroids measures kits eias enzyme immunoassays ELISAs endocrinology assays enterolactones mammalian lignans phytoestrogens estrogen-like diphenols diphenolics intestinal intestines bacterias plant matairesinol secoisolariciresinol diets dietary acute coronary hormone-dependent cancers osteoporosis serums plasmas fiber 122.405021485574
10477 EP2 Receptor Polyclonal PE Antibody - 2010-07-07 24.681933701657 ep2-receptor-polyclonal-pe-antibody Prostaglandin E2 Receptor 2; PGE2 Receptor 2 R-phycoerythrin immunofluorescent FL-2 FL2 FL 2 channels G-protein coupled G protein flow cytometry FC immunofluorescence IF EP1 EP2 EP3 EP4 cAMP smooth muscles mRNA tissues lungs placenta placenta spleen intestines kidneys sensory neurons 24.681933701657
600410 EP4 Receptor (rat) STEP Plate Assay Kit (cAMP method) - 2011-06-28 6.746537753222 ep4-receptor-rat-step-plate-assay-kit-camp-method cell-based assays cells CBAs kits measures measurements prostaglandins E2 PGE2 prostanoids G protein-coupled receptors proteins GPCRs EP1 EP2 EP3 signals transductions mechanisms tissues localizations regulation expression intestines lungs kidneys thymus uterus brains cyclics AMP adenosines monophosphates pathways phosphatidylinositols 3-kinases G1 smooth muscles relaxation gastric secretions intestinal epithelial transportation adrenal aldosterone uterine immunity inflammation human colon cancers colorectal carcinogenesis in vivo neuroprotective excitotoxic injury injuries agonists antagonists therapeutics diseases surface transfections and expression protocols transient technology technologies University of Michigan UM U of M Originus, Inc. USPT United States patents 6897067 6902933 7056741 DNA deoxyribonucleic recombinant proteins cells receptor-mediated endocytosis solution-phase efficiency multiple plasmids constructs intracellular 6.746537753222
600490 EpiTrek SET7/9 SAM-Screener Assay Kit New - 2011-12-21 66.516449355432 epitrek-set7-9-sam-screener-assay-kit SET7/9 SAM-Binding Site Inhibitor Screening kits assays measures measurements chromatins posttranslational modifications histones DNA deoxyribonucleic acids lysines methylations epigenetics regulations genomes mono-methyltransferases MTs domains S-adenosyl-L-methionines SAM AdoMet co-factors epsilons amino groups Dot1 KMT7 domain-containing non-histones H3 TAF10 p53 viral Tat estrogens receptors alpha .alpha. α substrates humans diseases catalytic catabolism fluorescence polarizations fluorescent probes binding pockets endogenous cofactors sinefungin peptides high-throughput 66.516449355432
10924 Epothilone B 152044-54-7 ≥95% 2011-07-27 17.617403314917 epothilone-b macrolides inhibitors inhibits inhibition tubulin microtubules polymerization cancers cells cycle mitotic arrest mitosis Hs578T HeLa KB3-1 KB31 KBV-1 KBV1 cytoskeletal 17.617403314917
10007806 Epoxomicin 134381-21-8 ≥98% 2008-12-09 46.601679558011 epoxomicin BU 4061T inhibitors inhibits inhibition proteins degradation 20S proteasomes antitumors bones formation Parkinsons diseases anti-tumors 46.601679558011
13184 (±)-Equol 94105-90-5 ≥98% 2009-09-03 4.849244935543 -equol phytoestrogens estrogens daidzen genistein receptors cancers nonsteroidal ERα ERβ ERalpha ER.alpha. ERbeta ER.beta. breast cells proliferation 7,4'-homoisoflavone NV 07α 07alpha 66036-38-2 4.849244935543
10010238 Erbstatin Analog 63177-57-1 ≥98% 2008-06-06 0.934806629835 erbstatin-analog Methyl 2,5-dihydoxycinnamate analogs EGF EGFR inhibitors inhibits inhibition tyrosine kinase DNA synthesis cell cycle proliferation cancers 0.934806629835
10483 Erlotinib 183321-74-6 ≥98% 2010-08-11 35.239654848584 erlotinib Tarceva™; CP 358,774; NSC 718781 tyrosine kinase inhibitor inhibits inhibiting epidermal growth factor receptors EGFR cancers tumor cyclin-dependent cyclin dependent kinase 2 CDK-2 CDK 2 CDK2 JAK-2 JAK2 JAK JAK2V617F CP-358,774 CP-358774 CP 358774 CP358774 CP358,774 NSC-718781 NSC718781 OSI-744 OSI744 R-1415 R1415 R 1415 OSI 744 Quinazolines 35.239654848584
10006329 EUK 134 81065-76-1 ≥98% 2005-03-02 23.664198895028 euk-134 salen manganese SOD ROS catalse stroke oxidative injury porphyrin scavengers peroxynitrites superoxides hydrogen peroxides arteries artery cerebral H2O2 infarct volumes EUK 134 EUK-134 EUK134 23.664198895028
13487 EZH1 Polyclonal Antibody - 2009-07-14 0E-12 ezh1-polyclonal-antibody Western blots WB immunoblotting blotting 0E-12
10022 F16 36098-33-6 ≥98% 14.918618784530 f16 apoptosis induces apoptotic mitochodrial membranes tumors inhibitors fluorescent F-16 cancer inhibits fluorescence lipophilic binding HER-1/EGFR-expressing inhibition cells breast 14.918618784530
10010019 FABP2 Polyclonal Antibody - 2007-10-02 22.575615627466 fabp2-polyclonal-antibody I-FABP; Intestinal-Fatty Acid Binding Protein; Fatty Acid Binding Protein 2 WB western blots fatty acids FABPs lipophilic ligands metabolism polymorphism FABP2 IFABP obesity diabetes antibodies antiserum diabetic antisera atherosclerosis endocrinology blotting immunoblotting 22.575615627466
10010364 FABP5 (human recombinant) - >95% 2007-08-08 16.979712707182 fabp5-human-recombinant Keratinocyte FABP; Psoriasis-Associated FABP; Fatty Acid Binding Protein 5; Epidermal-FABP; E-FABP; DA11 FABP proteins lipophilic ligands uptake metabolism cellular membranes FABP-5 FABPs cytosolic fatty acids bladders carcinoma prostates atherosclerosis endocrinology 16.979712707182
10009551 FABP7 (human recombinant) - >90% 2007-06-27 4.380059498512 fabp7-human-recombinant B-FABP; Brain-FABP; Fatty Acid Binding Protein 7 cytosolic FABPs amino acids lipophilic ligands tissues metabolism pathways docosahexanoic fatty binding proteins atherosclerosis endocrinology 4.380059498512
10610 F-Amidine (trifluoroacetate salt) Exclusive New - ≥95% ✓ 2011-09-23 18.138630420943 f-amidine-trifluoroacetate-salt proteins arginine deiminase 4 PAD4 cancers arthritis inhibitors histones genes expression cysteine PAD1 PAD3 cytotoxic HL-60 MCF7 HT-29 877617-46-4 PADs PAD-1 PAD-3 PAD-4 peptidyl arginine 18.138630420943
10010501 Farnesyl Thiosalicylic Acid 162520-00-5 ≥96% 2008-06-02 21.011473296501 farnesyl-thiosalicylic-acid Salirasib; FTS ras inhibitors inhibition inhibits cancer anti-cancer anticancer prenylation farnesylation signal transduction oncogene atherosclerosis farnesylthiosalicylic acid 21.011473296501
13175 Farnesyl Thiosalicylic Acid Amide Exclusive 1092521-74-8 ≥96% ✓ 2009-02-26 9.088825966851 farnesyl-thiosalicylic-acid-amide Salirasib Amide; FTS Amide Ras degradation cells signaling signalling tumors glioblastoma cancers inhibitors inhibits inhibition 9.088825966851
13287 FK-866 658084-64-1 ≥98% 2009-07-21 71.532939226519 fk-866 K 22.175 nicotinamides phosphoribosyltransferase NAMPT NamPRT PBEF visfatin mononucleotides adenine dinucleotide NAD+ inhibitors inhibitis inhibition cancers apoptosis SIRT1 autophagy FK866 FK 866 K22.175 K 22175 K22175 NamPRT PBEF visfatin carcinoma cells autophagy 71.532939226519
700380 Formaldehyde Assay Kit - 2010-05-14 10.852180195495 formaldehyde-assay-kit CH2O; Methanal HCHO kits assays measures measurements formaldehydes resins cells tissues fluids demethylation/methylation methionine-homocysteines cycles microsomal cytochromes CYP450-dependent oxidations xenobiotics oxidative deamination methylamines semicarbazides amines oxidases SSAO-mediated diabetes diabetic wood kerosene gas cigarettes emissions leukemia nasopharyngeal cancers quantification urine prostate bladder breath breast fluorescence-based acetoacetanilides ammonia fluorescent 10.852180195495
10011269 Fulvestrant 129453-61-8 ≥98% 2009-02-24 20.630497237568 fulvestrant ICI 182,780; Faslodex® estrogen receptors ER ERα agonist antagonist activator breast cancers hippocampus neurons ICI182780 ZD182780 ZD9238 ZM182780 20.630497237568
10353 G9a (human recombinant) - ≥70% 2011-03-08 23.814971331651 g9a-human-recombinant EHMT2; Euchromatic Histone-Lysine N-Methyltransferase 2; KMT1C lysines methylation methyltransferases genes silencing repression proteins recombinants set domain-containing pluripotency H3K9 GLP 23.814971331651
10755 G9a-like protein (human recombinant) New - ≥95% 2011-10-13 10.710138235697 g9a-like-protein-human-recombinant Eu HMTase 1; EHMT1; GLP; Euchromatic Histone-Lysine N-Methyltransferase 1; KMT1D lysine methylation methyltransferase genes silencing repression SET domain histones modifications GLP H3K9 BIX-01294 UNC0638 inhibitors inhibits inhibition SAR monomethylate dimethylate BIX01294 BIX 01294 UNC-0638 UNC 0638 10.710138235697
700500 G9a Methyltransferase Inhibitor Screening Assay Kit - 2011-03-10 33.356077348066 g9a-methyltransferase-inhibitor-screening-assay-kit EHMT2 Methyltransferase Inhibitor Screening Assay Kit kits assays measures measurements methylations molecules proteins signals transductions biosynthesis proteins repair genes silencing chromatin regulation S-adenosylmethionine SAM methyltransferases enzymes enzymatic cofactors ATP adenosine triphosphates AdoMet donors methyls groups DNA deoxyribonucleic acids Alzheimer's diseases depression Parkinson's multiple sclerosis livers failures cancers methylations lysines transcriptional activation respression histones functions SET domain-containing mammalian monomethylates dimethylates 9 27 H3 embryogenesis genomic imprinting lymphocytes lung cells HIV-1 H3K9 viral latency GLP G9a-like EHMT1 tumors suppressors p53 373 feedback inhibition methylation reactions 33.356077348066
10008346 Gabapentin 60142-96-3 ≥98% 2006-04-20 25.639433701658 gabapentin Neurontin® antiepileptic drugs Gamma-aminobutyric acids GABA neurotransmitters receptors spinal cord analogs anticonvulsants analgeics neuropathics pain syndromes Complex Regional types CRPS1 multiple sclerosis dysesthesias cancers HIV infections CNS central nervous systems calcium channels .gamma.-aminobutyric g-aminobutyric neurochemistry 25.639433701658
13841 GANT 61 500579-04-4 ≥98% 2011-04-20 102.909143646409 gant-61 NSC 136476 Hedgehog transcription factors genes expression GLI cancer glioblastomas antagonists development regulation GANT61 GANT-61 pyridines pyrimidines NSC136476 NSC-136476 TFs 102.909143646409
10566 Garcinol New 78824-30-3 ≥95% 2011-10-25 11.209988941663 garcinol Camboginol inhibits inhibitors inhibition histones acetyltransferases HATs p300 PCAF GCN5 neurogenesis stem cells apoptosis cancers antiinflammatory anti-inflammatory inflammation neuroscience genes expressions regulations epigenetics 11.209988941663
10782 Gcn5 (human recombinant) New - ≥80% 2011-12-05 30.464175950137 gcn5-human-recombinant Lysine acetyltransferase 2A; General control of amino acid synthesis protein 5-like 2; KAT2A; STAF97 epigenetics modifications histones acetylation cancers GNAT N-acetyltransferases enzymes STAGA TFTC SAGA ATAC H3K14 H3K9 H3K18 H4K8 H4K16 H3 H2B KAT2B p300/CBP associated factors Spt-Ada-GCN5-aceytltransferase Ada Two-A containing CoASH Gcn-5 N-acetyltransferases enzymatic subunits complexes proteins 30.464175950137
13166 Gefitinib 184475-35-2 ≥98% 2010-02-11 29.522580740204 gefitinib Iressa™; ZD1839 EGFR-TK EGFRs TKs epidermal growth factors inhibitors cancers signal transduction tyrosine kinases inhibits inhibited NSCLC Quinazolinones 29.522580740204
13355 Geldanamycin 30562-34-6 ≥98% 2010-07-29 28.262476142641 geldanamycin NSC 122750 NSC 212518 antibiotics heat shock proteins 90 Hsp90 GRP94 gp96 genes expression cells proliferation apoptosis angiogenesis c-jun adenocarcinoma cancers AP-1 steroids receptors 2,5-Cyclohexadiene-1,4-Diones 1,4-Benzoquinones 1,2-Benzoquinones p-Benzoquinones-o-Benzoquinones Benzoquinones Benzodiones Quinones 28.262476142641
10005167 Genistein 446-72-0 ≥98% 2004-08-04 8.321025168815 genistein isoflavonoids phytoestrogenics legumes glycosides carcinogenic tumors inhibits inhibition inhibitors estrogenic isoflavones uterine DES diethylstilbestrol histones H2B endocrine tyrosine chemopreventitive 8.321025168815
700300 Glucose-6-Phosphate Dehydrogenase Activity Assay Kit - 2011-07-28 88.633117496585 glucose-6-phosphate-dehydrogenase-activity-assay-kit G6PDH Activity Assay Kit kits assays measures measurements Glucose 6 six phosphates Glucose-6-phosphates dehydrogenases cytosolic enzymes catalyzes pentose pathway ribose-5-phosphates precursor RNA ribonucleic acids DNA deoxyribonucleic ATP adenosine triphosphates CoA coenzymes A NAD nicotinamides adenine dinucleotides FAD flavin NADPH phosphates energy cells fatty oxidations lipids biosynthesis substrates oxidases macrophages polymorphonuclear leukocytes oxygen radicals pathogens intracellular metabolic de novo amino red blood RBC mitochondria pentose oxidative damage stress hemolytic anemia neonatal hyperbilirubinemia acute hemolysis chronic X-linked sex-linked hereditary genetics defect mutations G6PD genes malaria Plasmodium falciparum upregulated rat mouse murine obesity hyperglycemia hyperinsulinemia mediator insulin resistance post-translationally preneoplastic lesions tumors suppressors p53 human dimers fluorescence-based erythrocytes lysates tissues homogenates cultures samples 6-phospho-D-gluconate fluorometrics fluorescent 88.633117496585
600450 Glycolysis Cell-Based Assay Kit Exclusive New - ✓ 2011-08-18 95.030094243709 glycolysis-cell-based-assay-kit CBAs assays kits measures colorimetric colorimetric-based L-lactate culture media mediums cellular metabolic pathways glucose metabolisms cells ATP adenosines triphosphates oxygen exercise erythrocytes mitochondria glucoeogenesis intracellular molecules amino acids insulin glycolytic neurons aerobic energy muscles anaerobic cancers lactate pyruvate tricarboxylic acids cycles oxidizes carbon dioxide CO2 water H2O tumor aggressiveness embryonic stem activity hypoxia-inducible transcriptional factors HIF-1 extracellular inhibition inhibits inhibitors chemotherapeutic strategies strategy metabolomic drugs discovery anticancer 95.030094243709
10948 GN25 New 1227401-27-5 ≥98% 2011-11-30 109.977679558011 gn25 tumors suppressors p53 cancers K-Ras Snail inhibitors mutations exocytosis cells proliferatiion analogs MKN-45 MKN45 MKN 45 A549 HCT116 GN-25 GN 25 genes humans 2-thio-dimethoxy naphthoquinone binding tumors 109.977679558011
10008886 (+)-Goniothalesdiol Exclusive 204975-45-1 ≥98% ✓ 2009-03-02 0E-12 -goniothalesdiol antitumor gonoiothalaus borneensis leukemia P338 cells tetrahydrofuran 0E-12
10007206 GPR40 Blocking Peptide - 2007-04-12 2.269558011050 gpr40-blocking-peptide immunohistochemistry peptide insulin diabetes breast cancer 2.269558011050
10007205 GPR40 Polyclonal Antibody - 2007-04-04 14.011123388582 gpr40-polyclonal-antibody Free Fatty Acid Receptor; FFAR1; G Protein-Coupled Receptor 40 immunohistochemistry antibody insulin diabetes breast cancer endocrinology IHC 14.011123388582
10008313 GW 610 872726-44-8 ≥98% 2006-05-10 24.835635359116 gw-610 NSC 721648 antitumors benzothiazoles inhibits inhibitors inhibition cancers antiproliferative isoflavones quercetin genistein cells MCF-7 MDA 468 NCI 60 24.835635359116
10010556 H-89 127243-85-0 ≥98% 2008-07-08 23.672541436465 h-89 5-Isoquinolinesulfonamide; Protein Kinase Inhibitor H-89 inhibitors inhibits inhibition PKA cAMP cell signaling protein kinase S6K1 MSK1 ROCK-II ROCKII PKB.alpha. PKBalpha PKBa MAPKAP-K1b MAPKAPK1b H89 H 89 23.672541436465
10010249 H-8 (hydrochloride) 113276-94-1 ≥98% 2008-07-17 12.649364640884 h-8-hydrochloride Protein Kinase Inhibitor H-8 PKA PKG PKC MLCK cyclin C CDK8 cyclin H CDK7 p36 signal transduction inhibitor inhibits inhibition transcription 84478-11-5 12.649364640884
10010559 HA-1077 (hydrochloride) 203911-27-7 ≥98% 2008-09-03 68.667826887661 ha-1077-hydrochloride Eril; Fasudil; AT-877 protein kinase inhibitors inhibits inhibition ROCK-II ROCKII PRK2 MSK1 MAPKAP-K1b vasodilation hypertension diabetes renal nephropathy cancers 105628-07-7 AT877 AT 877 hydrochloride dihydrochloride monohydrochloride HCl HA1077 HA 1077 68.667826887661
10006515 HAT Inhibitor Screening Assay Kit - 2006-12-06 10.728093362226 hat-inhibitor-screening-assay-kit Histone Acetyltransferase Inhibitor Screening Assay Kit therapeutics histones p300/CBP-Associated Factors pCAF GNAT GCN5-related N-acetyltransferases acetylates lysines N-terminal terminus tails H3 H4 tumors suppressor genes PTEN human cancers apoptosis fluorescence fluorescent inhibitors fluorometric assays 10.728093362226
10576 HC Toxin 83209-65-8 ≥95% 2010-11-10 39.746995856353 hc-toxin Toxin I (Helminthosporium carbonum) inhibitors histones deacetylases HDACs cancers genes regulation regulates regulators epigenetics HC-toxins cell-permable cells permable 15-lipoxygenase-1 15-LO-1 LOs lipoxygenase 15 1 tetrapeptides peptides helminthosporium carbonums cochliobolus maize pathogens Isomerases Amino Acid Acid Isomerases Amino Racemases Amino Acid Amino Acid Isomerases Acid Racemases Amino Amino Acid Racemases 39.746995856353
13504 HDAC11 Polyclonal Antibody - 2009-07-31 1.729558011049 hdac11-polyclonal-antibody Histone Deacetylase 11 wb western immunoblotting HDACs HAT histones antibodies peptides blots blotting 1.729558011049
10009231 HDAC1 (human recombinant) - >10% by SDS-PAGE 2006-12-06 51.021581730582 hdac1-human-recombinant Histone Deacetylase 1 HDAC 1 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus GST-tagged baculovirus Sf9 51.021581730582
10011564 HDAC1 Inhibitor Screening Assay Kit - 2008-04-10 29.985732044198 hdac1-inhibitor-screening-assay-kit HDAC 1 histones deacetylases lysines residues chromatin condensation transcriptional repression fluorescence deacetylation fluorescent inhibits inhibition enzymes license:cyclex fluorometric assays cancer 29.985732044198
13491 HDAC1 Polyclonal Antibody - 2009-07-24 0.652209944751 hdac1-polyclonal-antibody Histone Deactylase 1 HDAC-1 HDACs HDAC 1 antibodies WB western blots HATs immunoblotting blotting 0.652209944751
10009377 HDAC2 (human recombinant) - >70% by SDS-PAGE 2006-12-06 30.421429588227 hdac2-human-recombinant Histone Deacetylase 2 HDAC 2 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 30.421429588227
10009232 HDAC3/NCOR2 (human recombinant) - ≥50% 2006-12-06 40.672561755170 hdac3-ncor2-human-recombinant Histone Deacetylase 3 HDAC 3 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 40.672561755170
13493 HDAC3 Polyclonal Antibody - 2009-07-19 0.652209944751 hdac3-polyclonal-antibody Histone Deacetylase 3 HDACs antibodies HATs histones acetyltransferase deacetylases western blotting WB IP immunoprecipation ChIP immunoblots immunoblotting blots 0.652209944751
13494 HDAC4 Polyclonal Antibody - 2009-07-17 0.652209944751 hdac4-polyclonal-antibody Histone Deacetylase 4 WB Western blots immunoblotting IP ChIP antibodies HDACs HATs histones immunoprecipitation blotting 0.652209944751
10009379 HDAC5 (human recombinant) - >90% by SDS-PAGE 2006-12-06 33.230785738620 hdac5-human-recombinant Histone Deacetylase 5 HDAC 5 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators extranuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class IIa yeast Hda 1 catalytic domains amino acids N-terminal N-terminus nucleus cytoplasm cells chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 33.230785738620
10009465 HDAC6 (human recombinant) - >80% 2007-06-14 34.513968909042 hdac6-human-recombinant GenBank Accession No. BC069243; Histone Deacetylase 6 HDAC 6 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways proteins Class II cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers N-terminal N-terminus GST-tagged Sf9 34.513968909042
13499 HDAC6 Polyclonal Antibody - 2009-07-14 2.647434885556 hdac6-polyclonal-antibody Histone Deacetylase 6 HDAC-6 HDACs HDAC 6 antibodies WB western blots IP ChIP immunoblotting blotting immunoprecipitation 2.647434885556
13500 HDAC7 (Phospho-Ser155) Polyclonal Antibody - 2009-07-29 1.823204419889 hdac7-phospho-ser155-polyclonal-antibody Histone Deacetylase 7 antibodies MMP AR receptors matrix metalloproteinase androgens Nur77 histones deacetylases N-terminal immunoblotting blots western blotting WB 1.823204419889
19380 HDAC8 (human recombinant) - ≥95% 2009-04-03 29.468397298332 hdac8-human-recombinant HDAC 8 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 29.468397298332
700230 HDAC8 Inhibitor Screening Assay Kit - 2009-05-15 16.052417127071 hdac8-inhibitor-screening-assay-kit Histone Deacetylase 8 Inhibitor Screening Assay Kit histone deacetylases inhibits inhibitors inhibition angiogenesis cycling apoptosis differentiation tumors proliferation anticancers genes epigenetic trichostatin A human class I tissues nucleus cytosolic smooth muscle neuroblastoma pathogenesis kits assays measures measurement fluorescent fluorescence-based 16.052417127071
10009466 HDAC9 (human recombinant) - >95% 2007-06-14 19.766168896397 hdac9-human-recombinant GenBank Accession No. NM 178423; Histone Deacetylase 9 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 HDAC 9 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 19.766168896397
10011563 HDAC Activity Assay Kit - 2008-04-10 38.377202410849 hdac-activity-assay-kit histones deacetylases lysines residues chromatin condensation transcriptional repression fluorescence deacetylation fluorescent inhibits inhibition enzymes license:cyclex fluorometric assays cancer 38.377202410849
600150 HDAC Cell-Based Activity Assay Kit - 2009-11-09 34.181590699816 hdac-cell-based-activity-assay-kit Histone Deacetylase Cell-Based Activity Assay Kit assays kits measuring measurement histones deacetylases lysines residues chromatin condensation transcriptional repression fluorescence deacetylation fluorescent inhibits inhibition enzymes fluorometric assays cancer modulators whole cells proteins lysine-specific HDAC1 homogenous inhibitor/activator TSA 34.181590699816
100024 Hepsin Blocking Peptide (aa 241-260) - 15.729889502762 hepsin-blocking-peptide-aa-241-260 antibodies western blots blotting WB antisera antiserum ICC IHC protease immunohistochemistry immunocytochemistry apoptosis cancer peptides controls 15.729889502762
100022 Hepsin Polyclonal Antibody (aa 241-260) - 12.009696132596 hepsin-polyclonal-antibody-aa-241-260 antibodies western blots blotting WB antisera antiserum protease immunohistochemistry apoptosis IHC cancer formalin fixed paraffin embedded immunoblotting 12.009696132596
10006084 Hesperetin 520-33-2 ≥98% 2005-02-16 10.879016574585 hesperetin hesperitin hesperidin atherosclerosis citrus nutraceuticals flavonoids flavanoids hypocholesterolemic ACAT2 ACAT-2 mRNA transcription inhibits inhibition inhibitors ApoB proteins histamines azelastine atherosclerosis 10.879016574585
16834 Hexadecanal-d5 - ≥99% deuterated compound 2009-03-02 64.385497237569 hexadecanal-d5 Palmitaldehyde; 16-Hexadecanal deuterated deuterium sphingosine-1-phosphate S1P palmitic acids S1P lyase 1 plasmalogen cell proliferation GC/MS GC-MS LC/MS LC-MS mass spectrometry 64.385497237569
300003 HIF-1α (C-Term) Blocking Peptide - 2005-04-15 56.402320441989 hif-1-c-term-blocking-peptide Hypoxia Inducible Factor 1α HIF-1alpha factors HIF1.alpha. antibodies peptides cancer hypoxia transcription factors low-oxygen hypoxic stimulus cytoplasmic accumulation cells nucleus stress-adaptive proteins oxidative physiology tumors EPAS-1 family phosphorylation prolyl hydroxylases western blotting blots signaling signalling WB controls proteins 56.402320441989
10006421 HIF-1α (C-Term) Polyclonal Antibody - 2005-04-15 73.687000789266 hif-1-c-term-polyclonal-antibody Hypoxia Inducible Factor-1α HIF-1alpha factors antibodies western blots blotting WB antisera antiserum cancers hypoxia transcription factors low-oxygen hypoxic stimulus cytoplasmic accumulation cells nucleus stress-adaptive proteins oxidative physiology tumors EPAS-1 family phosphorylation prolyl hydroxylases immunoblotting HIF1 HIF1alpha HIF1 alpha HIF-1 alpha 73.687000789266
10347 HIF-1α Monoclonal Antibody (Clone H1α67) - 2011-05-09 50.193591160220 hif-1-monoclonal-antibody-clone-h1-67 Hypoxia Inducible Factor-1α WBs western blots IHC immunohistochemistry antibodies HIF-1alpha HIF1a HIF-1a antisera serum cancers H1α67 transcription factors oxidative tumors EPAS-1 EPAS1 EPAS 1 DMOG 2,4-DPD desferrioxamine CoCl2 50.193591160220
10006910 HIF-1α Transcription Factor Assay Kit - 2007-10-31 62.566878453038 hif-1-transcription-factor-assay-kit Hypoxia Inducible Factor-1α tf HIF-1alpha factors HIF1.alpha. cancers basic-helix-loop-helix bHLH cellular oxygen homeostasis cells tissues ischemia infections embryos tumors drugs target breast prostate cardiovascular diseases nuclear extracts whole lysates assays kits ELISAs enzyme-linked immunosorbent double stranded dsDNA HIF1 HIF1alpha HIF1 alpha HIF-1 alpha 62.566878453038
13535 Histone H2A Polyclonal Antibody - 2009-07-31 2.300153417652 histone-h2a-polyclonal-antibody H1 H2B H3 H4 histones antibodies DNA WB western blots immunoblotting ELISA enzyme-linked immunosorbent assays blotting 2.300153417652
13538 Histone H2B (C-Term) Polyclonal Antibody - 2009-08-04 1.151600931464 histone-h2b-c-term-polyclonal-antibody histones antibodiesarginine lysine DNA WB western blots immunoblotting blotting 1.151600931464
13539 Histone H2B (N-Term) Polyclonal Antibody - 2009-08-04 1.151600931464 histone-h2b-n-term-polyclonal-antibody histones antibodies WB western blots immunoblotting DNA arginine lysine blotting 1.151600931464
13540 Histone H3 (Phospho-Ser28) Monoclonal Antibody (Clone 117C826) - 2009-08-10 1.213258603108 histone-h3-phospho-ser28-monoclonal-antibody-clone-117c826 PHH3 H1 H2B H3 H4 histones antibodies WB western blots immunoblotting serine phosphos phosphorylation blotting 1.213258603108
10530 Histone H3 Trimethyl Lys9 Peptide - 2010-06-29 5.313711702662 histone-h3-trimethyl-lys9-peptide H3K9(Me)3 Peptide JMJD2A JMJC JMJD2D acetylation methylation phosphorylation genes transcription substances regulation H3K9Me3 5.313711702662
13543 Histone H4 Polyclonal Antibody - 2009-08-10 0.358922651933 histone-h4-polyclonal-antibody antibodies H1 H2A H2B H3 amino acids WB western blots immunblotting blotting 0.358922651933
11512 HMGB1 Monoclonal Antibody (Clone IMG19N10B7) New - 2012-01-16 131.388888888888 hmgb1-monoclonal-antibody-clone-img19n10b7 High Mobility Group Protein B1; HMG1 high mobility groups proteins family DNA-binding domains inflammation mediators DNA nuclear bindings sterile infection-associated responses Toll-like receptor 4 TLR4 advanced glycation endproducts RAGE IHC immunohistochemistry Western blot blotting flow cytometry FC WB 131.388888888888
11514 HMGB1 Monoclonal Antibody (Clone IMG19N12A1) - 77.222222222222 hmgb1-monoclonal-antibody-clone-img19n12a1 High Mobility Group Protein B1; HMG1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 77.222222222222
11513 HMGB1 Monoclonal Antibody (Clone IMG19N15F4) New - 2012-01-16 131.388888888888 hmgb1-monoclonal-antibody-clone-img19n15f4 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear binding sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 131.388888888888
11515 HMGB1 Polyclonal Antibody (aa 100-150) New - 2012-01-20 134.722222222222 hmgb1-polyclonal-antibody-aa-100-150 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 134.722222222222
11516 HMGB1 Polyclonal Antibody (aa 25-75) New - 2012-01-30 143.055555555555 hmgb1-polyclonal-antibody-aa-25-75 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 143.055555555555
13295 HNHA 926908-04-5 ≥98% 2009-09-03 41.124732088047 hnha Histone Deacetylase Inhibitor VI inhibitors inhibits inhibition histones deacetylase HDACs cancers fibrosarcoma HT1080 cells hyperacetylation p21 genes expressions transcription cycles arrest tumor growth murine xenograph human umbilical vein endothelial HUVECs tubes formation migration vascular endothelial factors VEGF retinal neovascularization angiogenesis 41.124732088047
10011384 Hsc70 (Hsp73) Polyclonal Antibody - 2008-03-26 0.660405156537 hsc70-hsp73-polyclonal-antibody Heat Shock Cognate 70 heat shock stress protein antibodies antiserum WB immunoblotting western blots immunoprecipation immunofluorscence IP IF blotting 0.660405156537
10011383 Hsp40 Polyclonal Antibody - 40 kDa 2008-03-26 0.619129834254 hsp40-polyclonal-antibody Heat Shock Protein 40; HDJ1 DnaJ WB translation folding unfolding translocation degradation heat shock stress chaperone antibodies antiserum Hsps immunoblotting western blots blotting 0.619129834254
10202 Hsp90α (human recombinant) - ≥80% 2010-03-16 4.087652956823 hsp90-human-recombinant Hsp86; Heat Shock Protein 90α heat shock proteins molecular chaperones Hsp90.alpha. Hsp90AA1 HspCAL4 HspN 90kDa cytosolic class A member 2 heat-shock 1 Hsp90AA2 Hsp86 Hsp90a 4.087652956823
10342 Hsp90β (human recombinant) - ≥85% 2010-03-16 4.650139746506 hsp90-human-recombinant Hsc90; Hsp90 AB1; Heat Shock Protein 90β heat shock proteins molecular chaperones Hsp90.beta. 90kDa alpha cytosolic class B member 1 Hsp90beta Hsp90AB1 Hsp90b 4.650139746506
10005673 HU-331 137252-25-6 ≥95% 2005-09-09 28.665938203397 hu-331 cannabidiols analogs antiproliferative activity endocannabinoids central CB1 peripheral CB2 non-CB receptor-mediated pharmacology receptors memory weight loss appetite neurodegeneration tumor surveillance analgesia inflammation hydroxylquinone antineoplastic human cancer cells lines inhibits inhibitors inhibition growth Raji Jurkat lymphomas in vitro HT-29 colon carcinomas neuroscience neurochemistry cannabinoids cbs sythetic 28.665938203397
13624 Icariin 489-32-7 ≥97% 2010-02-11 1.738950276242 icariin PDE5 inhibitors flavonoids differentiation cancers proliferation flavonols E brevicornum horny goat weed BMP2 ED erectile dysfunction 2-Phenyl-Benzopyrans 2 Phenyl Benzopyrans 2-Phenyl-Chromenes 2 Phenyl Chromenes Bioflavonoids Flavonoids 1.738950276242
10008207 IGFBP5 Polyclonal Antibody - 2007-07-19 18.782697974217 igfbp5-polyclonal-antibody IGF-Binding Protein 5; IBP-5; Insulin-like Growth Factor Binding Protein 5 IGF-1 cell growth differentiation apoptosis receptors kidney heart placenta skeletal cancers amino acids neuroblastoma mammary glands antibodies wb western blots immunocytochemistry IGF1 IGFBP-5 endocrinology blotting immunoblotting 18.782697974217
13139 Imatinib (mesylate) 220127-57-1 ≥98% 2009-04-21 48.968448587074 imatinib-mesylate CGP57148B; Glivec; Gleevec; STI-571 inhibitors tyrosine kinase cancer chronic myelogenous leukemia CML c-ABL kits c-kit platelet-derived growth factor receptors imatinib mesilate 152459-95-5 75-75-2 gleevec 48.968448587074
10739 Isoliquiritigenin 961-29-5 ≥98% 2011-04-01 40.539204419889 isoliquiritigenin GU 17; ISL antioxidants flavonoids chemoprevention quinones reductase-1 reductase1 hepatoprotection hepatoma cells flavanoids 40.539204419889
13325 Iso-Olomoucine 101622-50-8 ≥98% 2011-07-27 2.253867403315 iso-olomoucine cyclin dependent kinases Cdks cells cycles dopamine inhibitors inhibits inhibition inactive controls regulators iso olomoucine transporter diseases neurodegenerative signaling rats dorsal striatal synaptosomes cancers neuroscience 2.253867403315
13288 Itraconazole 84625-61-6 ≥95% 2011-02-22 81.891915285451 itraconazole hedgehogs signaling cancer antifungal inverse agonist patched smoothened Canditral Cladosal 100 Itralek Itrizole Oriconazole Orungal R 51211 Sempera Spherazole CR IR Sporal Sporamelt Sporanox Sporonox Traconal Triasporin Janssen-Cilag Brand of Itraconazole Janssen Cilag Brand of Itraconazole Janssen Brand of Itraconazole Itraconazole Janssen Brand Itraconazole Sporanox R-51211 R 51211 Orungal R51211 81.891915285451
13659 IWR-1-endo 1127442-82-3 ≥98% 2010-03-23 11.352596685083 iwr-1-endo Wnt cancers embryonic developments tissues homeostasis embryogenesis tumorigenesis stem cells β-catenin genes expression transcription inhibitors inhibits inhibition proteasomes Apc Axin2 Ck1 Gsk3β IWR-1-exoendo-1,3(4)-beta-D-glucanase Endo-1,3(4)-beta-Glucanase Endo-1,3(4)-B-Glucanase beta-(1-3,1-4)glucanase 11.352596685083
13598 IWR-1-exo 1127442-87-8 ≥98% 2010-03-23 9.123314917128 iwr-1-exo Wnt cancers embryonic developments tissues homeostasis embryogenesis tumorigenesis stem cells β-catenin genes expressio Cellobiohydrolase, 1,4-beta-D-Glucan 1,4-beta-D-Glucan Cellobiohydrolase 1,4 beta D Glucan Cellobiohydrolase 1,4-beta-Cellobiosidase, Cellulose Cellulose 1,4-beta-Cellobiosidase Cellulose 1,4 beta Cellobiosidase Beta-Glucancellobiohydrolase Beta Glucancellobiohydrolase Exo-Cellobiohydrolase Exo Cellobiohydrolase Cellobiohydrolase II Cellobiohydrolase I Cellobiohydrolase A Cellobiohydrolase Exoglucanase II CEL1 Protein CbhI Proteinn transcription inhibitors inhibits inhibition controls 9.123314917128
10011246 Janex 1 202475-60-3 ≥98% 2008-12-17 2.433149171271 janex-1 WHI-P131 inhibitors inhibits inhibition JAK3 apoptosis leukemias anti-inflammatory antiinflammatory lymphocytes WHIP131 Janex 1 2.433149171271
9000059 (±)-Jasmonic Acid methyl ester 39924-52-2 ≥95% (mixture of isomers) 2009-04-01 4.540696132596 -jasmonic-acid-methyl-ester (±)-Methyl Jasmonate cancers plants apoptosis survival inflammation hexokinase jasmonic acids jasmonates stress hormones proteins inhibitors inhibition inhibited mitochondrial hexokinase anti-inflammatory 4.540696132596
10009172 JC-1 Mitochondrial Membrane Potential Assay Kit - 2007-04-12 200.206973901921 jc-1-mitochondrial-membrane-potential-assay-kit apoptosis cells mitochondria caspases cytochrome C electrons transport transmembranes Dym DELTApsim .DELTA..psi.m fluorscence fluorescent cationic dyes rhodamine-123 Rh123 DiOC6 cytofluorimetric lipophilic tetrachloro-1,1',3,3'-tetraethylbenzimidazoylcarbocyanine iodide green red J-aggregates monomeric assays kits measures measurements microscopy flow cytometry plate readers fluorometric cancer JC1 cell-based assays cell based assay cba JC 1 200.206973901921
10641 JGB1741 Exclusive 1256375-38-8 ≥98% ✓ 2011-06-20 17.711065509076 jgb1741 ILS-JGB-1741 inhibitors SIRT1 breasts cancers cells proliferation apoptosis p53 histones acetylation genes energy homeostasis regulation deacetylases sirtuins NAD+ inhibits inhibition SIRT2 SIRT3 ILS JGB 1,741 1741 SIRTs JGB-1741 JGB-1,741 17.711065509076
10336 JMJD2A (human recombinant) - ≥95% 2010-12-01 7.241041831097 jmjd2a-human-recombinant JHDM3A; KDM4A; Jumonji Domain Containing 2A lysine (K)-specific demethylase 4A Epigenetics Histone Demethylase chromatin regulator dioxygenase JmjC 7.241041831097
700360 JMJD2A Inhibitor Screening Assay Kit - 2010-05-25 17.088756906076 jmjd2a-inhibitor-screening-assay-kit Jumonji Domain Containing 2A Inhibitor Screening Assay Kit kits assays measures measurements histones nucleoproteins chromatins DNA deoxynucleic acids eukaryotic nucleus nucleosomal H3 H4 H2B H2A octamers amino termini acetylation phosphorylation ubiquitination methylation replication repair transcriptional activation repression dysregulation tumors suppressor genes cancers inhibitors enzymes catalyzes epigenetic marks methyls lysines arginines residues demethylases 1 JMJC JHDM1 JHDM2 JHDM3 JARID1 UTX/UTY cupin 2-oxoglutarate 2OG iron Fe(II) oxygenases hydroxylation JMJD2A JMJD2B JMJD2C JMJD2D JMJD2E JMJD2F fluorescence-based fluorescent cells lysates formaldehydes peptides substrates oxidation/decarboxylation acetoacetanilides ammonia H3K9(Me)3 trimethylated 17.088756906076
10335 JMJD2D (human recombinant) - ≥75% 2011-02-09 6.456906077347 jmjd2d-human-recombinant Jumonji Domain Containing 2D; KDM4D; Lysine-Specific Demethylase 4D epigenetics histones demethylases chromatin regulators dioxygenases JmjC proteins jumanjis 6.456906077347
700370 JMJD2D Inhibitor Screening Assay Kit - 2010-05-25 10.251830410761 jmjd2d-inhibitor-screening-assay-kit Jumonji Domain Containing 2D Inhibitor Screening Assay Kit kits assays measures measurements histones nucleoproteins chromatins DNA deoxynucleic acids eukaryotic nucleus nucleosomal H3 H4 H2B H2A octamers amino termini acetylation phosphorylation ubiquitination methylation FLJ10251 replication repair transcriptional activation repression dysregulation tumors suppressor genes cancers inhibitors enzymes catalyzes epigenetic marks methyls lysines arginines residues demethylases 1 JMJC cupin 2-oxoglutarate 2OG iron Fe(II) oxygenases hydroxylation JMJD2A JMJD2B JMJD2C JMJD2D JMJD2E JMJD2F fluorescence-based fluorescent cells lysates formaldehydes peptides substrates oxidation/decarboxylation acetoacetanilides ammonia H3K9(Me)3 trimethylated 10.251830410761
10008131 JNJ-10198409 627512-69-0 ≥98% 2006-10-18 13.686453038674 jnj-10198409 PDGF-BB tyrosine kinases inhibits inhibition inhibitors growth factors receptors platelet-derived antiangiogenic antiproliferative coronary artery smooth muscle cells antagonists ATP binding hydrolysis tumors angiogenesis 13.686453038674
11511 JNK2 Polyclonal Antibody New - 2011-11-18 6.666666666667 jnk2-polyclonal-antibody SAPK1a; p54a; c-Jun Amino Terminal Kinase 2; MAPK9 antibody c-Jun kinases JNKs MAP phosphorylation JNK1 JNK3 nuclear signals transduction proteins transcription factors p53 Western blots WB blotting JNKs JNK-1 JNK-2 JNK-3 6.666666666667
10741 (±)-JQ1 Exclusive New 1268524-69-1 ≥98% ✓ 2011-12-08 102.817204168322 -jq1 BET bromodomain inhibitors BRD4 BRD2 transcriptions cancers BRD-4 BRD-2 BRDs extra terminal domains proteins BRD4 BRD2 BRD3 BRD-3 inflammatory genes viral hosts expressions mitosis 102.817204168322
10009458 JTE-013 383150-41-2 ≥98% 2007-01-18 97.558465316145 jte-013 reverses inhibition inhibits coronary artery smooth muscles lipids cells proliferation cytoskeletal morphogenesis GPCRs protein-coupled receptors antagonists S1P2 humans rats EDG5 sphingosines sphingosine-1-phosphates sphingosine1 inhibitors JTE013 FDG-5 cancers 97.558465316145
10010239 Kenpaullone 142273-20-9 >98% 2007-09-04 12.153692449355 kenpaullone NSC 664704; 9-Bromopaullone GSK-3.beta. cyclin-dependent kinase cyclin CDK inhibitors inhibits inhibition proliferations cell cycle cancers 12.153692449355
10012659 Ki16425 355025-24-0 ≥95% 2008-11-06 131.153265807243 ki16425 LPA1 LPA2 LPA3 LPA4 LPA5 lysophosphatidic acids cancers antagonist receptors selective 131.153265807243
10640 KM 233 Exclusive 628263-22-9 ≥98% ✓ 2011-07-07 35.974917127071 km-233 KM233 KM-233 CBs cannabinoids CB2 agonists recptors CB1 gliomas anti tumors cancers 35.974917127071
10011011 KT 5720 108068-98-0 ≥98% 2009-01-20 124.005146014206 kt-5720 PKAs cAMPs signaling proteins kinase inhibitors inhibits inhibition phosphorylase kinase PDK1 MEK MSK1 PKα GSK3β KT5720 KT-5720 124.005146014206
10010329 Lavendustin C 125697-93-0 ≥98% 2008-07-08 13.559254143646 lavendustin-c HDBA; NSC 666251 EGFR kinases tyrosine pp60c-src pp60csrc CamKII SOD neutrophil activation erbstatin inhibitor inhibits inhibition Lavendustin-C 13.559254143646
10008882 LDH Cytotoxicity Assay Kit - 2006-12-15 268.896420652618 ldh-cytotoxicity-assay-kit Lactate Dehydrogenase Cytotoxicity Assay Kit cells death apoptosis necrosis measuring measurement cystolic enzymes cells membranes integrity cancer cell-based assays cell based assay cba 268.896420652618
10010265 LFM-A13 244240-24-2 >98% 2008-01-23 9.567366482504 lfm-a13 BTK Bruton's Tyrosine kinases signal transduction leukemia cancers polo-like anti-cancer chemosensitivity apoptosis CD95 9.567366482504
10245 LSD1 (human recombinant) - ≥50% 2009-06-03 5.056248573124 lsd1-human-recombinant AOF2; NPAO; Lysine-Specific Demethylase 1; BHC110; p110b; KDM1 recombinant humans E.coli histones tumors suppressor CoREST lysine specific demethylase 1 proteins enzymes 5.056248573124
700120 LSD1 Inhibitor Screening Assay Kit - 2008-10-16 24.037149821254 lsd1-inhibitor-screening-assay-kit Lysine-Specific Demethylase 1 lysines 4 demethylases histones residues repression transcription chromosomal DNA chromosomes inhibits inhibitors inhibition tumors suppressors activity cells cycles progression cancers fluorescent fluorescence enzymes enzymatic reactions H2O2 hydrogens peroxides peptides N-terminal tails H3 horseradish peroxidases ADHP resorufins assays 24.037149821254
13554 LSD1 Polyclonal Antibody (aa 100-150) - 2009-08-10 0.156169429097 lsd1-polyclonal-antibody-aa-100-150 Amine Oxidase (flavin containing) Domain 2 WIRM N-terminal antibodies WB western blots immunoblotting CoREST histones HDACs LSD1 AOF2 amine oxidase flavin containing domain 2 peptide affinity blotting 0.156169429097
13553 LSD1 Polyclonal Antibody (aa 400-450) - 2009-08-10 0.156169429097 lsd1-polyclonal-antibody-aa-400-450 antibodies WB western blots immunoblotting lysine histones demethylase FAD-binding SWIRM domains blotting 0.156169429097
13486 LSD1 Polyclonal Antibody (aa 450-500) - 2009-08-11 0.133859510655 lsd1-polyclonal-antibody-aa-450-500 WIRM N-terminal antibodies WB western blots immunoblotting CoREST histones HDACs LSD1 blotting 0.133859510655
13555 LSD1 Polyclonal Antibody (aa 800-850) - 2009-08-13 0.156169429097 lsd1-polyclonal-antibody-aa-800-850 WIRM N-terminal antibodies WB western blots immunoblotting CoREST histones HDACs LSD1 immunohistochemistry IHC paraffin AOF2 amine oxidase flavin containing domain 2 blotting 0.156169429097
10007502 Luminex® Thromboxane B2 Kit - 2009-07-13 32.902615101289 luminex-thromboxane-b2-kit Luminex® TXB2 Kit thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays 32.902615101289
10009768 LY293111 Exclusive 161172-51-6 ≥98% ✓ 2009-02-09 90.203204419890 ly293111 Etalocib; VML 295 LTBs LTB4 receptors inflammation antagonist benzophenone neutrophil chemotaxis pancreatic cancers 90.203204419890
13341 LY364947 396129-53-6 ≥98% 2009-07-23 46.636381215470 ly364947 TGF-β RI Kinase Inhibitor; HTS 466284 TGF-β receptor inhibitors antagonists Smad p38 MAPK MLK-7 cells growth fibroblasts NIH 3T3 cells phosphorylation fibronectin PAI-1 uPA matrigel invasion MDA-MB-231 cells transforming factors LY 364947 LY-364947 HTS-466284 HTS466284 HTS 466284 ALK5 Inhibitor I TβR-I inhibitor Transforming Growth Factor-β Type I Receptor Kinase Inhbitor [3-(Pyridin-2-yl)-4-(4-quinoynyl)]-1H-pyrazole 46.636381215470
600310 Lysosome/Cytotoxicity Dual Staining Kit - 2010-06-15 46.559723756905 lysosome-cytotoxicity-dual-staining-kit lysosomes membrane-bound acidic intracellular compartments cells waste products fats carbohydrates proteins macromolecules mobilize recycle organelles microorganisms animals leukocytes degradative enzymes hydrolases pH 5 cytoplasm homeostasis Tay-Sachs diseases arthritis neurodegeneratives Parkinson's brains cathepsin D genes therapeutics kits assays measures measurements 4-Nitro-7-(1-piperazinyl)-2,1,3-benzoxadiazole NBD-PZ membranes permeable carboxylic acids luminal cultured propidium iodides death chloroquine inhibitors positive controls fluorescence fluorescent microscopy plates reader detections flow cytometry 46.559723756905
13174 M 344 251456-60-7 ≥98% 2009-07-24 55.830465776549 m-344 D237; Histone Deacetylase Inhibitor III; MS 344 HDACs inhibitors inhibits inhibitions histones deacetylases HDAC1 HDAC6 cancers squamous carcinoma radiation cells cycles arrest apoptosis endometrial ovarian M344 MS344 M-344 MS-344 55.830465776549
10010497 Manumycin A 52665-74-4 ≥98% 2008-06-25 19.969640883978 manumycin-a UCF 1C; NSC 622141 farnesyltransferase inhibitors inhibits inhibition cancer antitumor anti-tumor signal transduction Ras farnesylation NF-.kappa.B NF-kB NF-kappaB 19.969640883978
10009645 Maslinic Acid Exclusive 4373-41-5 >98% ✓ 2007-11-02 15.264751381216 maslinic-acid 2α-Hydroxyoleanoic Acid; Crategolic Acid cancer apoptosis antiproliferative antioxidant HIV inhibition inhibitor inhibits leukemia cells astrocytoma CaCo-2 colon HIV-1 aids 15.264751381216
10005174 Matairesinol 580-72-3 >95% 2004-07-28 145.052863720074 matairesinol lignans plants antioxidants cancer oxidative injury stress enterobacterial fiber dietary enteric isoprostanes enterolactone 145.052863720074
13847 MEK2 Polyclonal Antibody - 2010-11-18 0E-12 mek2-polyclonal-antibody MAP Kinase/ERK Kinase 2; MAPKK2; MAP Kinase Kinase 2; Dual Specificity MAP Kinase Kinase 2 MEKs MEK-2 MEK2 MAPKs kinases MAP ERKs phosphorylation antibodies serine cytokines growth factors tranduction mitogenic signals western blots blotting immunoblotting 0E-12
13778 Metastasis Associated 1 Family Member 2 Polyclonal Antibody - 2010-05-04 19.357888275015 metastasis-associated-1-family-member-2-polyclonal-antibody p53 Target Protein in Deacetylase Complex; MTA2; MTA-L1 Protein; PID WB IHC western blotting blots immunoblotting immunohistochemistry MTA-2 MTA 2 MTA-1 MTA 1 MTA-3 MTA 3 HDAC2 HDAC-2 HDAC 2 HDAC1 HDAC-1 HDAC 1 proteins chromatin deacetylase activity activities northern p53 19.357888275015
9000332 Methylcarbamyl PAF C-8 Exclusive - ≥98% ✓ 2009-02-25 13.493591160221 methylcarbamyl-paf-c-8 Methylcamyl PAF Methylcamyl PAF C-8 Methylcamyl PAF C-16 PAF C-16 PAF-AH Platelet aggregation c-myc c-fos MAP kinase Mitogen-activated kinase G1 Cell cycle PAF 13.493591160221
700140 Methyltransferase Colorimetric Assay Kit - 2009-04-07 30.658435598239 methyltransferase-colorimetric-assay-kit MT Colorimetric Assay Kit assays kits measures measuring monitoring monitors MTs methylation signal transduction biosynthesis repair gene silencing chromatin regulation S-adenosylmethionine SAM-dependent methyltransferases enzymatic cofactors AdoMet donor modifications DNA Alzheimer's diseases depression Parkinson's multiple sclerosis liver failure cancers enzyme-coupled AdoHcy positive control S-adenosylhomocysteine 30.658435598239
700150 Methyltransferase Fluorometric Assay Kit - 2009-04-08 40.252933552579 methyltransferase-fluorometric-assay-kit MT Fluorometric Assay Kit assays kits measures measuring monitoring monitors MTs methylation signal transduction biosynthesis proteins repair gene silencing chromatin regulation S-adenosylmethionine SAM-dependent methyltransferases enzymes enzymatic cofactors AdoMet donor proteins modifications DNA Alzheimer's diseases depression Parkinson's multiple sclerosis liver failure cancers enzyme-coupled AdoHcy positive control S-adenosylhomocysteine 40.252933552579
10007188 Microcystin-LR 101043-37-2 >95% 2005-07-20 20.820000000000 microcystin-lr Cyanoginosin-LR proteins phosphatases inhibitors microcystins toxins hepatotoxic cyclics heptapeptides cyanobacteria poisonings humans livestock fresh water blue-green algae endemic PP-2A inhibits enzymes PP-1 serine/threonine nodularins okadaic acids 20.820000000000
10006317 Mifepristone 84371-65-3 >98% 2005-01-25 109.514550118389 mifepristone RU-486 progesterones estrogens estradiol cancers apoptosis RU486 uterine uterus pregnancy hormones receptors glucocorticoids steroids PR GR HRE response elements binding endocrinology 109.514550118389
63280 Miltefosine 58066-85-6 >98% 10.653204419889 miltefosine HePC CTP:phosphocholines cytidylyl transferases antimetastatic ceramides apoptosis inhibits inhibitors inhibition cancers 10.653204419889
13208 Mirin 299953-00-7 ≥95% 2009-04-15 39.269558011050 mirin DNA damage ATM histone nuclease MRN Mre11 Rad50 Nbs1 repair 39.269558011050
13600 MK 0457 639089-54-6 ≥98% 2010-08-16 8.036187845304 mk-0457 Tozasertib; VX 680 mitosis aurora kinase inhibitors inhibits inhibition MK0457 MK-0457 MK-457 MK457 cells cycles cancers apoptosis tumor A B C MK 0457 VX-680 VX680 Piperazines 8.036187845304
10658 MLL1 (human recombinant) New - ≥95% 2011-12-21 83.972052383875 mll1-human-recombinant Lysine Methyltransferase 2A; ALL1; Mixed Lineage Leukemia 1; KMT2a; HRX epigenetics methyltransferase histones H3K4 genes regulations MLL proteins complex subunits Ash2L WDR5 RbBP5 DPY30 mixed lineage leukemia methylation lysine HOX Pol II WAR c-terminal SET1 WIN binds binding DPY-30 WARD genomic 83.972052383875
10756 MLL1/WAR complex (human recombinant) New - ≥90% 2012-01-04 88.276851386796 mll1-war-complex-human-recombinant Mixed-Lineage Leukemia-1; MLL Core Complex epigenetics methyltransferases histones H3K4 genes regulations MLL proteins complex subunits Ash2L WDR5 RbBP5 DPY-30 upregulate transcriptions catalytic basal RNA polymerases chromosomes Pol II N-terminus leukemia Hox menin 88.276851386796
10945 MLL1/WARD complex (human recombinant) New - ≥90% 2012-01-04 88.276851386796 mll1-ward-complex-human-recombinant Mixed-Lineage Leukemia-1; KMT2A; MLL Core Complex epigenetics methyltransferases histones H3K4 genes regulations MLL proteins complex subunits Ash2L WDR5 RbBP5 DPY-30 upregulate transcriptions catalytic basal RNA polymerases chromosomes Pol II N-terminus leukemia Hox menin WAR 88.276851386796
10011389 Mn SOD (rat) Polyclonal Antibody - 2008-03-27 131.577940733300 mn-sod-rat-polyclonal-antibody Manganese Superoxide Dismutase SOD1 SOD2 SOD3 EC-SOD oxidative stress superoxide ROS WB IP IHC EIA western blots immunoprecipitation immunohistochemistry immunoblotting blotting enzyme immunoassays 131.577940733300
10212 Monoacylglycerol Lipase (FL) Polyclonal Antibody - 2010-03-23 29.409715864245 monoacylglycerol-lipase-fl-polyclonal-antibody MAGL; MGL WB western blots hydrolases antibodies antiserum antisera hydrolysis immunohistochemistry IHC immunoblotting MGL monoacylglycerol neuroscience neurochemistry MAGL monoglycerol blotting 29.409715864245
10004910 Mouse Macrophage Microsomal Immunoblot Control - 2004-11-09 30.565807243707 mouse-macrophage-microsomal-immunoblot-control Mouse macrophage microsomes protein western blots blotting microsomes immunoblots immunoblotting positive controls COX-2 COX2 PGHS-2 PGHS2 cyclooxygenases prostaglandins synthases cultures SDS-PAGE 30.565807243707
13284 MS-275 209783-80-2 ≥98% 2009-11-05 58.348134847554 ms-275 Entinostat; SNDX 275 inhibitors histone deacetylases HDACs HDAC1 HDAC3 HDAC8 cyclin-dependent kinase inhibitor 1A p21 CIP1 WAF1 cell growth differentiation tumors cancers apoptosis adriamycin PARP Hsp90 ms275 MS 27-275 SNDX-275 SNDX275 MS27275 58.348134847554
10009365 MTT Cell Proliferation Assay Kit - 2007-02-15 103.767765500307 mtt-cell-proliferation-assay-kit assays kits screen measures measurements cells cellular growth factors signaling signalling molecules transcription DNA pathological cancers aging cycles progression regulatory cytokines mitogens drugs inductions inhibitors inhibits inhibitions in vitro plasma membranes formazan intracellular NAD(P)H-oxidoreductases NADPH-oxidoreductases proteins enzymes enzymatic cleavage microtiter plates tertrazolium salts mitochondrial dehydrogenases cancer cell-based assay cell based assay cba 103.767765500307
600330 Multi-Parameter Apoptosis Assay Kit - 2010-08-18 97.464420435746 multi-parameter-apoptosis-assay-kit assays kits measures measurements apoptosis cells death cycles tissues homeostasis dysregulation neurodegenerative diseases ischemic damages autoimmune disorders cancers drugs discovery signaling pathways membranes phospholipids phosphatidylserines phosphatidylethanolamines leaflets bilayers externalizations residues plasma phospholipids binding proteins fluorochrome-labeled fluorochromes annexin V fluorescence microscopy flow cytometry FC plate readers TUNEL TdT-mediated dUTP Nick-End Labeling analysis ISEL in situ end labeling DNA deoxyribonucleic acids mitochondrial transmembranes tetramethylrhodamines ethyls esters TMRE lipophilics probes laddering detection fragmentation FITC-conjugated fluoresceins 97.464420435746
13779 MutL Protein Homolog 1 Monoclonal Antibody (Clone 164C819) - 2010-04-29 4.707845303867 mutl-protein-homolog-1-monoclonal-antibody-clone-164c819 HNPCC; MLH1 antibodies western blots bloting immunobloting WB Mut-L Mut L MLH 1 MLH-1 DNA genes cancers colons 4.707845303867
10012600 Myricetin 529-44-2 >98% 2009-02-20 15.424088397790 myricetin NSC 407290; Cannabiscetin flavonoid antioxidant oxLDL CD36 atherosclerosis cancers JAK1 STAT3 MEK1 15.424088397790
10008581 Myristoleic Acid methyl ester 56219-06-8 >98% 2007-04-17 0.552486187845 myristoleic-acid-methyl-ester cytotoxic Serenoa S. repens apoptosis necrosis prostate cancers cheese whey fatty acids Candida C. albicans MIC minimal inhibitory concentration in vivo esters hydrophobic 0.552486187845
579040 Nampt/Visfatin (mouse/rat) EIA Kit - 2011-08-08 31.252213966681 nampt-visfatin-mouse-rat-eia-kit Nicotinamide Phophoribosyltransferase/Visfatin Pre-B-Cell Colony-Enhancing Factor/Visfatin immunometric kits measures measurements EIA enzymes immunoassays nicotinamides phosphoribosyltransferases coenzymes salvage pathways adenine dinucleoties NAD+ cellular metabolisms pre-B-cell cells colony enhancing factors PBEF visceral fats plasmas obesity insulin receptors proteins intracellular extracellular mesangial kidneys glucose uptake diabetic nephropathy exercise skeletal muscles NAD+-dependant sirtuin-dependant circadian oscillations cancers apoptosis serums body mass index mass inflammation livers cirrhosis beta .beta. β leukocytes tissues mouse 31.252213966681
13055 Naphthofluorescein 61419-02-1 ≥98% 2009-03-20 0.670534069981 naphthofluorescein CCG 8295 furin matrix metalloproteinase MTA-MMP MMP2 motility invasion cancer metastasis MMP inhibitors naphthafluorescein 0.670534069981
10387 Naringenin-4'-O-β-D-Glucuronide 158196-35-1 ≥88% 2010-04-23 0E-12 naringenin-4-o-d-glucuronide flavanone inhibits inhibition inhibitor CYP1A2 CYP 1A2 cytochrome P450 158196-35-1 0E-12
10388 Naringenin-7-O-β-D-Glucuronide - ≥98% 2010-04-24 0E-12 naringenin-7-o-d-glucuronide 158196-34-0 inhibits inhibition cytochrome P450 inhibitor CYP1A2 0E-12
10584 (−)-Neplanocin A Exclusive 72877-50-0 ≥98% ✓ 2011-03-25 55.264554064720 -neplanocin-a S-adenosylhomocysteines hydrolases SAH inhibitors S-adenosylmethionines SAM methyltransferases antitumor antiviral cancer virus methylation Neplanocin A neplanocinA anti-tumor 55.264554064720
13755 NF-κB (p50) Monoclonal Antibody (Clone 2J10D7) - 2010-02-05 11.545441988950 nf-b-p50-monoclonal-antibody-clone-2j10d7 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors cytokines UV radiations stress injury bacterial viral cells growth differentiation proliferation apoptosis inflammation DNA AIDS cancers arthritis western blots blotting immunoblotting IHC WB immunohistochemistry 11.545441988950
13754 NF-κB (p50) Polyclonal Antibody - 2010-04-27 11.545441988950 nf-b-p50-polyclonal-antibody NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors DNA p65 N-terminal binding western blots blotting immunoblotting WB antibodies 11.545441988950
13756 NF-κB (p65) Monoclonal Antibody-biotin (Clone 112A1021) - 2010-02-11 22.794680347277 nf-b-p65-monoclonal-antibody-biotin-clone-112a1021 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB biotins biotinylated biontinylation 112A1021 clones 22.794680347277
13752 NF-κB (p65) Monoclonal Antibody (Clone 112A1021) - 2010-02-11 25.778105761641 nf-b-p65-monoclonal-antibody-clone-112a1021 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting flow cytometry FC WB immunohistochemistry IHC 25.778105761641
13751 NF-κB (p65) NLS Polyclonal Antibody - 2010-02-11 24.958658247829 nf-b-p65-nls-polyclonal-antibody Nuclear Factor-κB (p65) Nuclear Localization Signal NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB transcription factors N-terminal C-terminal terminals terminus signals tissues nuclear receptors western blots blotting immunoblotting WB immunocytochemistry ICC antibodies 24.958658247829
13757 NF-κB (p65) Polyclonal Antibody (aa 2-17) - 2010-02-11 18.005414364640 nf-b-p65-polyclonal-antibody-aa-2-17 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 2 7 18.005414364640
13753 NF-κB (p65) Polyclonal Antibody (aa 538-546) - 2010-02-11 22.794680347277 nf-b-p65-polyclonal-antibody-aa-538-546 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 538 546 22.794680347277
10011250 NH125 278603-08-0 ≥95% 2008-11-21 5.868977900552 nh125 antibacterial histidine kinase cancer cell cycle eEF-2K drug resistance imidazoles 5.868977900552
10649 Niclosamide 50-65-7 ≥95% 2011-01-12 1.259751381215 niclosamide antihelminthic helminth tapeworms inhibitors STAT3 cancers proliferation anti-helminthic salicylanilide Du 145 DU145 DU-145 Niclosamide, 2-Aminoethanol (1:1) Aventis Brand of Niclosamide Bayer Brand of Niclosamide Clonitralide Niclosamide Bayluscide Bayer 2353 Trédémine Niclocide Radewerm Phenasal Bayer 73 Yomesan Fenasal 1.259751381215
10010422 Nilotinib 641571-10-0 ≥98% 2009-10-23 33.306325966850 nilotinib AMN107 tyrosine kinases inhibitors therapy cancer Bcr/Abl chronic myeloid leukemia MLL philadelphia chromosomes acute lymphoblastic ALL imatinib gleevec genes expression DNA helicase complex cyclins cyclin-dependent cells proliferation 33.306325966850
10006966 Nitrotyrosine Monoclonal Antibody - Biotinylated - 2005-04-15 16.365000000000 nitrotyrosine-monoclonal-antibody-biotinylated antibodies western blots blotting WB antisera antiserum peroxynitrite western blots blotting nitric oxide nitration proteins NO superoxide alzheimer's diseases oxidative injury stress IHC immunohistochemistry IP immunoprecipitation EIA enzyme immunoassay species independent detection immunoblotting Enzyme-linked immunosorbent assays 16.365000000000
10005705 NO-Indomethacin Exclusive 301838-28-8 >98% ✓ 2004-10-20 6.229944751381 no-indomethacin NCX 2121 inhibition inhibitors NSAIDs non-steroidal anti-inflammatory drugs inhibits nitric oxides cancer chemopreventative donor gastrointestinal NOs PaCa-2 PaCa2 pancreatic analgesic 6.229944751381
10011255 NSC 210902 51726-83-1 ≥95% 2008-09-15 4.363314917128 nsc-210902 Inhibitor inhibits inhibition CK2 kinase cell signaling apoptosis cancers NSC210902 4.363314917128
13196 NSC 23766 (hydrochloride) 1177865-17-6 ≥98% 2010-07-20 18.902101493759 nsc-23766-hydrochloride 733767-34-5 GTPases cells cycles growth proliferations cell-cell adhesions motility differentiation guanine nucleotides exchange factors GEFs inhibitors inhibits inhibition cell migration Aminoquinolines angiogenesis leukemia cancers gene expression Rac1 Inhibitor 18.902101493759
13303 NSC 663284 383907-43-5 ≥98% 2010-04-01 14.200414364641 nsc-663284 Cdc25 Phosphatase Inhibitor II; DA-3003-1 dual specificity phosphatases CDC25 Cdc25A Cdc25B Cdc25C proto-oncogenes cancers inhibitors VHR PTP1B MKP-1 Cdk1 Cdk2 cells proliferation tumors inhibits inhibition Cdcs potent cell-permeable irreversible 14.200414364641
10758 NSD2 (human recombinant) New - ≥90% 2012-02-01 90.000000000000 nsd2-human-recombinant KIAA1090; Multiple myeloma SET domain-containing protein; WHSC1; Protein trithorax-5; Nuclear Receptor SET domain-containing protein 2; TRX5; MMSET; Wolf-Hirschorn Syndrome Candidate 1; Histone-lysine N-methyltransferase NSD2 isoform 1 NSD2 SET-Domains Lysine methyltransferases chromatin WHSC1 MMSET WHSCH1-like multiple myeloma translocations histones H3 H4 H3K36 H4K44 H4K20 53BP1 dimethylation DNA damages NSDs NSD-2 90.000000000000
13308 NU 7026 154447-35-5 ≥95% 2009-09-21 33.867375690607 nu-7026 DNA-PK Inhibitor II; LY293646 DNA-dependent proteins kinase DNA-PK strand breaks ionizing radiation DNA repair inhibitors inhibitis inhibitions PI3K ATM ATR PAPR-1 PARP1 cytotoxicity topoisomerase II leukemia mitoxantrone NU-7026 NU 7026 ataxia telangiectasia mutated Rad3 related Rad3-related Rad 3 Rad-3 DNA-Dependent Protein Kinase 33.867375690607
18585 (−)-Nutlin-3 - ≥98% 2008-08-06 213.659815837938 -nutlin-3 Nutlin 3a P53 cellular stress proliferation cells cycle apoptosis tumor suppressor MDM2 agents Nutlin-3 enantiomer a 213.659815837938
10009816 (+)-Nutlin-3 - ≥98% 2008-08-11 96.811767955801 -nutlin-3 Nutlin 3b p53 cellular stress proliferation cells cycle apoptosis tumer suppressor MDM2 inactive inhibitors inhibits inhibition Nutlin-3 enantiomer b 96.811767955801
10004372 (±)-Nutlin-3 548472-68-0 >98% 2004-04-06 82.894925626859 -nutlin-3 apoptosis cancers p53 inhibits inhibitors induces apoptotic re-activation reactivation antioncogenic tumors xenografts license:hoffmanlaroche Nutlin3 nutlins 82.894925626859
13641 NVP-AEW541 (hydrochloride) - 98% 2010-07-28 41.811016574586 nvp-aew541-hydrochloride 475488-34-7 IGF-1R Insulin-like growth factor I receptors tyrosine kinases angiogenesis cells proliferation cancers inhibitors inhibition inhibits 701294-63-5 Ins-R NWT-21 Pyrroles 41.811016574586
10565 NVP-BEZ235 915019-65-7 ≥98% 2010-10-12 41.065404920432 nvp-bez235 phosphatidylinositols 3-kinases PI3Ks Akt/PKB mTORs cancers inhibitors inhibits inhibition angiogenesis genes expressions apoptosis differentiation rapamycin phosphatidyls inositols phosphatidylinositols-3-kinase Imidazoles BEZ235 41.065404920432
11176 O6-methylguanine-DNA Methyltransferase (human recombinant) New - ≥80% 2011-12-06 26.666666666667 o6-methylguanine-dna-methyltransferase-human-recombinant MGMT DNA repair cancers 06-demethylases suicide enzymes guanine thymine cytosine replication mutations cysteine oligo nucleotides PvuII dsDNA full-length full length demethylating thymine 26.666666666667
10010547 O-Arachidonoyl Glycidol Exclusive 439146-24-4 >98% ✓ 2008-03-31 18.812883977900 o-arachidonoyl-glycidol 2-AG 2-arachidonoyl glycerol 2-oleoylglycerol N-arachidonoylethanolamine anandamide AEA FAAH endocannabinoid obesity pain neurodegenerative diseases monoacylglycerol lipase inhibits inhibitors inhibitions MAGL MGL cannabinoids 18.812883977900
10010299 Oleoyl 3-carbacyclic Phosphatidic Acid Exclusive - ≥95% ✓ 2009-10-14 14.945676795580 oleoyl-3-carbacyclic-phosphatidic-acid 3-ccPA 18:1 cyclic phosphatidic acids cPAs lysophosphatidic LPA ccPA 3ccPA oleate transcellular migration MM1 cells mesothelial autotoxin cancer survival growth migration invasion metastasis antagonist LPA1 LPA2 LPA3 476310-24-4 14.945676795580
10010240 Olomoucine 101622-51-9 >98% 2007-09-13 11.602888713496 olomoucine inhibitors inhibits inhibition cyclin-dependent kinases cdks spinal cord injury SCI G1 cell cycle 11.602888713496
14070 ONO-8711 216158-34-8 ≥98% 2011-06-15 21.005331491712 ono-8711 ONO 8711 ONO8711 prostaglandins EPs EP1 receptors potent PGs antagonists AH-6809 AH 6809 AH6809 14060 14050 SC-19220 SC19220 SC 19220 21.005331491712
13176 Oxamflatin 151720-43-3 ≥95% 2010-11-16 52.416104972376 oxamflatin Metacept 3 HDACs histones deacetylases genes expressions morphology motility apoptosis cells cycles cancers reducing reduction proliferation Acids Hydroxamic Hydroxamic Acids Acid Hydroxamic Hydroxamic Acid 52.416104972376
600008 p53 Cell-Based Activation/Translocation Assay Kit - 2009-03-10 12.195120728462 p53-cell-based-activation-translocation-assay-kit p53 dsDNA double-stranded tumors suppressors proteins guardians of the genomes cells cellular responses genotoxic stresses activity cycles arrests apoptosis senescence humans cancers mutations inactivated binding ubiquitination acetylation phosphorylation sumoylation neddylation methylation glycosylation damages oncogenes ribosomal cell-matrix matrices adhesion hypoxia p21 WAF1 Cip1 MDM2 GADD45 Cyclin G Bax IGF-BP3 bcl-2 Bcl-XL cyclins B1 MAP4 survivin HPV16 PARP-1 WT1 E1b/E4 degradation nucleus cytoplasms proteasomes promoter carcinogenesis endogenous wild-type heterogenous autosomal dominant disorders Li Fraumeni Syndromes nuclear extracts assays cell-based assay cell based assay cba 12.195120728462
600030 p53 Designer Transcription Factor Assay Kit - 2009-01-08 21.460007812935 p53-designer-transcription-factor-assay-kit dsDNA double-stranded tumors suppressors proteins guardians of the genomes cells cellular responses genotoxic stresses activity cycles arrests apoptosis senescence humans cancers mutations inactivated binding ubiquitination acetylation phosphorylation sumoylation neddylation methylation glycosylation damages oncogenes ribosomal cell-matrix matrices adhesion hypoxia p21 WAF1 Cip1 MDM2 GADD45 Cyclin G Bax IGF-BP3 bcl-2 Bcl-XL cyclins B1 MAP4 survivin HPV16 PARP-1 WT1 E1b/E4 degradation nucleus cytoplasms proteasomes promoter carcinogenesis endogenous wild-type heterogenous autosomal dominant disorders Li Fraumeni Syndromes nuclear extracts ELISAs assays enzyme-linked immunosorbent TFs T.F. factors assays 21.460007812935
10004806 p53 Monoclonal Antibody (Clone BP53-12) - 2004-06-17 8.119675329104 p53-monoclonal-antibody-clone-bp53-12 proteins WB western blots blotting antibodies antisera antiserum DNA anti-oncogenic apoptosis cancers p53 apoptotic antioncogenic flow cytometry immunocytochemistry ICC IHC immunohistochemistry transcription factors cellular stress damage hypoxia shock guardian of the genome special:month specialdiscount:15 specialstart:2008-01-01 specialend:2008-01-31 immunoblotting FC 8.119675329104
10004807 p53 (Phospho-Ser392) Polyclonal Antibody - Affinity-purified 2004-05-18 13.309417936269 p53-phospho-ser392-polyclonal-antibody phosphorylateds proteins WB western blots blotting antibodies antisera antiserum DNA binding anti-oncogenic apoptosis cancer p53 re-activator reactivator induces apoptotic re-activation reactivation antioncogenic phospho-specific immunoblotting 13.309417936269
10005291 p53 Product Pack - 2004-09-08 20.094964190710 p53-product-pack DNA binding anti-oncogenic apoptosis cancer p53 re-activators reactivators induces apoptotic re-activation reactivation antioncogenic packs 20.094964190710
600060 p53 Total and p53 (Phospho-Ser392) Dual Staining Assay Kit - 2009-03-10 8.749264374872 p53-total-and-p53-phospho-ser392-dual-staining-assay-kit kits assays measuring measurements tumors treatments DyLightTM (-)-Nutlin-3 positive ontrols p53(Phospho-Ser392) dsDNA double-stranded suppressors proteins guardians of the genomes cells cellular responses genotoxic stresses activity cycles arrests apoptosis senescence cancers mutations inactivated binding ubiquitination acetylation phosphorylation sumoylation neddylation methylation glycosylation damages oncogenes ribosomal cell-matrix matrices adhesion hypoxia p21 WAF1 Cip1 MDM2 GADD45 Cyclin G Bax IGF-BP3 bcl-2 Bcl-XL cyclins B1 MAP4 survivin HPV16 PARP-1 WT1 E1b/E4 degradation nucleus cytoplasms proteasomes promoter carcinogenesis endogenous autosomal Li Fraumeni Syndromes nuclear extracts cell-based assays cell based assay cba 8.749264374872
600020 p53 Transcription Factor Assay Kit - 2008-10-27 25.557699041823 p53-transcription-factor-assay-kit dsDNA double-stranded tumors suppressors proteins guardians of the genomes cells cellular responses genotoxic stresses activity cycles arrests apoptosis senescence humans cancers mutations inactivated binding ubiquitination acetylation phosphorylation sumoylation neddylation methylation glycosylation damages oncogenes ribosomal cell-matrix matrices adhesion hypoxia p21 WAF1 Cip1 MDM2 GADD45 Cyclin G Bax IGF-BP3 bcl-2 bcl-X cyclins B1 MAP4 survivin HPV16 PARP-1 WT1 E1b/E4 degradation nucleus cytoplasms proteasomes promoter carcinogenesis endogenous wild-type heterogenous autosomal dominant disorders Li Fraumeni Syndromes nuclear extracts ELISAs assays enzyme-linked immunosorbent TFs T.F. factors assays 25.557699041823
10009317 PAC-1 315183-21-2 >98% 2007-07-12 17.072633517495 pac-1 Procaspase-activating Compound 1 in vitro procaspase-3 apoptosis cancers cells death drugs treatment acivators procaspases PAC1 17.072633517495
10461 Paclitaxel 33069-62-4 ≥98% 2010-08-23 24.396629834254 paclitaxel Taxol®; NSC 125973 Microtubules cancers cervical HeLa lung A549 breast MCF-7 colon HT-29 ovarian OVG-1 pancreatic PC-Sh carcinomas chemotherapy mitotic arrest apoptosis JNK BCL-2 p53 Pacific yew tree c-Jun cyclin-dependent kinases multipolar spindle formation Abraxane Capxol Mitotax Onxal QW 8184 Yewtaxan Tocosol Taxus Liberte Genexol-PM Genetaxyl EndoTAG 1 Ebetaxwl DHP 107 ABI 007 Bristol-Myers Squibb Brand of Paclitaxel Bristol-Myers Brand of Paclitaxel Paclitaxel (4 alpha)-Isomer Lemery Brand of Paclitaxel Ivax Brand of Paclitaxel Bull Brand of Paclitaxel 7-epi-Taxol 7 epi Taxol Paclitaxel NSC-125973 NSC 125973 Bris Taxol NSC125973 Taxol A Anzatax Praxel Paxene Taxol Onxol 24.396629834254
10500 PAD4 (human recombinant) - ≥95% 2010-05-27 33.019177029619 pad4-human-recombinant Peptidylarginine Deiminase 4; Protein Arginine Deiminase 4 guanidino modifying enzymes citrillination histones deiminase MS multiple sclerosis Alzheimer's diseases glaucoma IOP intraocular pressure cancers peptidylarginine deiminase 33.019177029619
700560 PAD4 Inhibitor Screening Assay Kit - 2011-05-04 27.041660720405 pad4-inhibitor-screening-assay-kit Protein Arginine Deiminase 4; Peptidylarginine Deiminase 4 kits assays measures measurements proteins arginines deiminases PADs guanidine-modifying enzymes peptidylarginine deiminase amidinotransferases nucleus homodimers transcriptional coregulator catalyzes residues citrulline calcium-dependent substrates histones H2A H3 H4 post-translational modifications genes regulations autocitrullination inhibits enzymatic activity cells rheumatoid arthritis citrulline-containing immune response autoantibodies tissues multiple sclerosis Alzheimer's diseases glaucoma cancers human deiminates N-α-benzoyl-L-arginine ethyl esters BAEE kinetic ammonia detectors fluorescent fluorescence 27.041660720405
10007358 Palmitic Acid methyl ester 112-39-0 >99% 2006-02-17 10.507046710195 palmitic-acid-methyl-ester MP; Methyl Palmitate esters saturated fatty acids synthesized synthesis plants animals acetyl coenzymes CoA energy storage 16-carbon dietary fats plasma lipoproteins expression COX-2 cyclooxygenase-2 cyclooxygenases proteins acylation lipids anchoring signaling signalling molecules 10.507046710195
10010298 Palmitoleoyl 3-carbacyclic Phosphatidic Acid Exclusive 910228-13-6 ≥95% ✓ 2009-11-03 12.582146196344 palmitoleoyl-3-carbacyclic-phosphatidic-acid 3-carbacyclic PA; 3-ccPA 16:1 cyclic phosphatidic acids cPAs lysophosphatidic LPA ccPA 3ccPA palmitoleate transcellular migration MM1 cells mesothelial autotoxins cancer survival growth migration invasion metastasis NPP2 ENPP2 ectonucleotide pyro phosphatase/phosphodiesterase 2 12.582146196344
10010293 Palmitoyl 3-carbacyclic Phosphatidic Acid Exclusive 476310-22-2 ≥95% ✓ 2009-10-07 15.891406328478 palmitoyl-3-carbacyclic-phosphatidic-acid 3-ccPA 16:0 cyclic acids cPAs lysophosphatidic LPA ccPA 3ccPA palmitate transcellular migration MM1 cells mesothelial autotoxins cancers survival growth migration invasion metastasis 15.891406328478
13557 PARP (Cleaved) Monoclonal Antibody - 2009-08-11 16.591970534070 parp-cleaved-monoclonal-antibody poly ADP ribose polymerase ADP-ribose DNA western blots immunoblotting WB flow cytometry intracellular antibodies FC blotting 16.591970534070
10994 Paxillin (Phospho-Tyr118) Polyclonal Antibody New - 2012-01-13 68.888888888889 paxillin-phospho-tyr118-polyclonal-antibody proteins LIM domains ERK-regulated scaffolds vinculin-binding phosphorylation Western blots blotting WB ERKs binds binding vinculin JNK 68.888888888889
10009115 pCAF Histone Acetyltransferase - ≥95% 2006-10-18 29.754956756611 pcaf-histone-acetyltransferase HAT; p300/(CREB binding protein) Associated Factor proteins binding GCN5 nuclear acetyltransferases C-terminal C-terminus acetyl-lysine N-terminal N-terminus histones H3 H4 transcriptional activators MyoD E2F1 p53 acetylates PTEN K125 K128 catalytic cleft in vivo enzymes cancers 29.754956756611
10004805 PCNA Monoclonal Antibody (Clone IPO-38) - 2004-08-27 4.435215469613 pcna-monoclonal-antibody-clone-ipo-38 Nuclear Antigen of Proliferating Cells; Proliferating Cell Nuclear Antigen WB western blots blotting IHC immunohistochemistry immunoblots proliferating cells nuclear antigens ipo38 flow cytometry immunocytochemistry ICC mitosis DNA polymerases holoenzymes antibodies antisera antiserum cancers immunoblotting FC 4.435215469613
10007185 PCSK9 (human) Polyclonal Antibody - 2005-11-30 20.565274927650 pcsk9-human-polyclonal-antibody Proprotein Convertase Subtilisin Kexin 9; NARC-1 atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases family lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols livers kidneys lungs spleens jejunums ileums colons muscles golgi tissues atherosclerosis immunoblotting 20.565274927650
10008811 PCSK9 (mouse) Polyclonal Antibody - 2007-01-22 16.655783658040 pcsk9-mouse-polyclonal-antibody Proprotein Convertase Subtilisin Kexin 9; NARC-1 immunoblot neural apoptosis regulated convertase 1 atherosclerosis proteins antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols atherosclerosis PCSK-9 immunoblotting 16.655783658040
10009581 PCSK9 (murine) Blocking Peptide - 2007-01-22 9.708347145488 pcsk9-murine-blocking-peptide Proprotein Convertase Subtilisin Kexin 9; NARC-1 neural apoptosis regulated convertase 1 proteins antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols cancer cells 9.708347145488
13034 PD 0325901 391210-10-9 ≥98% 2009-03-13 51.778168546128 pd-0325901 MEK ERK RAS RAF MAPK tumors stem cells cancers differentiation signaling GSK3 kinase inhibitors inhibits inhibition pd325901 pd 325901 PD0325901 51.778168546128
9000988 PD 166326 New 185039-91-2 ≥98% 2011-11-30 100.167394485229 pd-166326 inhibitors cancers c-abl c-src Bcl/Abl tyrosine receptors kinases cells signaling leukemia CML chronic myelogenous leukemia PD-166326 PD166326 pyridopyrimidine STI571 mesylate 100.167394485229
13032 PD 173074 219580-11-7 ≥98% 2009-07-29 50.597762456167 pd-173074 fibroblast growths factors receptors FGFRs FGFR1 tyrosine kinase activity activities activation signals propagation inhibitors inhibition inhibits autophosphorylation PDGFR c-Src cSrc c Src EGFR InsR MEK PKC FGFR2 FGFR3 FGFR4 FGFR5 angiogenesis cancers tumors self-renewal self renewal stems cells ERK1/2 ERK-1/2 ERK 1/2 50.597762456167
10012431 PD 184161 Exclusive 212631-67-9 ≥98% ✓ 2009-06-09 35.417814273821 pd-184161 MEK inhibitors MAP kinase ERK signaling cancer MEK 1/2 inhibition inhibited ERK 1/2 potent selective pd184161 35.417814273821
10006726 PD 98059 167869-21-8 >98% 2005-09-12 31.844700799717 pd-98059 potent selective MAPK mitogen-activated proteins kinases family serines threonines cellular PD-98059 programs cells proliferation differentiation movement death noncompetitive inhibits inhibitors inhibition pathways activation MAPKK1 Raf MEK MAPKK2 MAPKK-1 PD98059 MAPKK-2 ERK 31.844700799717
10006341 PDM 11 Exclusive - >98% ✓ 2005-03-23 22.117226519337 pdm-11 resveratrol analogs analogues aryl hydrocarbons receptors anatagonists AhRs ligand-dependents ligands xenobiotics PDM11 PDM-11 estrogen dioxin poisonings stilbene xenobiotics polyaromatics soot coal tar 22.117226519337
10006342 PDM 2 Exclusive 688348-25-6 >98% ✓ 2005-03-29 22.271790055248 pdm-2 AhRs antagonists stilbenes dioxins aryl hydrocarbons receptors ligand-dependent transcription factors resveratrol analogs ligands xenobiotics PDM2 PDM-2 estrogen poisonings xenobiotics polyaromatics soot coal tar cancers 22.271790055248
62595 PDMP (hydrochloride) 73257-80-4 >98% 2004-08-10 9.413159402496 pdmp-hydrochloride analogs analogues inhibits inhibitors inhibition cytotoxicity glucosylceramides aynthases chirality stereoisomers sphingosine 9.413159402496
10005983 Pentafluorobenzenesulfonyl fluorescein 728912-45-6 >98% 2005-02-22 18.825911602210 pentafluorobenzenesulfonyl-fluorescein fluoresceins hydrogen peroxides oxidative stress fluorescents probes ROS reactive oxygen species perhydrolysis H2O2 18.825911602210
500290 Phagocytosis Assay Kit (IgG FITC) - 2009-04-09 159.949601011710 phagocytosis-assay-kit-igg-fitc kits assays measuring measurement ingestion killing phagocytic leukocytes defense pathogens microbe-innate immune cytoskeletal rearrangement membrane trafficking microbial mechanisms pro-inflammatory anti-inflammatory cytokines chemokines apoptosis antigen immune systems pathological Multiple Sclerosis Alzheimer's diseases atherosclerosis bacterial fungal infections in vitro fluorescently opsonizing latex beads fluorescently-labeled flow cytometry cytometric analysis quantification cell-based cell based cba 159.949601011710
600540 Phagocytosis Assay Kit (IgG PE) New - 2012-01-10 160.725041052793 phagocytosis-assay-kit-igg-pe kits assays measuring measurement ingestion killing phagocytic leukocytes defense pathogens microbe-innate immune cytoskeletal rearrangement membrane trafficking microbial mechanisms pro-inflammatory anti-inflammatory cytokines chemokines apoptosis antigen immune systems pathological Multiple Sclerosis Alzheimer's diseases atherosclerosis bacterial fungal infections in vitro fluorescently opsonizing latex beads fluorescently-labeled flow cytometry cytometric analysis quantification cell-based cell based cba phycoerythrins probes fluorescence 160.725041052793
10007191 PH Domain Leucine-rich Repeat Protein Phosphatase 1 Polyclonal Antibody - 2006-01-04 3.916111878452 ph-domain-leucine-rich-repeat-protein-phosphatase-1-polyclonal-antibody Suprachiasmatic Nucleus Circadian Oscillatory Protein; SCOP; PLEKHE1 Protein; PHLPP1; KIAA0606 Protein proteins diseases antibodies antisera antiserum western blots blotting immunocytochemistry ICC immunohistochemistry IHC cancers WB immunoblotting PH Domain Leucine-rich Repeat Protein Phosphatase Polyclonal Antibody 3.916111878452
10007192 PH Domain Leucine-rich Repeat Protein Phosphatase Blocking Peptide - 2006-01-30 2.861933701657 ph-domain-leucine-rich-repeat-protein-phosphatase-blocking-peptide Suprachiasmatic Nucleus Circadian Oscillatory Protein; SCOP; PLEKHE1 Protein; PHLPP; KIAA0606 Protein western blotting blots signaling signalling WB IHC ICC immunohistochemistry formalin-fixed paraffin-embedded immunocytochemistry proteins kinases Akt cells growth death serine residues Ser473 C-terminal hydrophobic motifs human cancers dephosphorylates dephosphorylation reduces activity apoptosis apoptotic colon glioblastomas lines tumors brain 2.861933701657
10735 Phthalazinone pyrazole Exclusive 880487-62-7 ≥98% ✓ 2011-07-27 2.012523020258 phthalazinone-pyrazole inhibitors inhibits inhibition auroras kinases cells cycle cancers centrosomes mitosis spindles cancers proliferation cells growth phosphorylation Auroroa-A Aurora-B Aurora-C A B C HCT116 HCT-116 Colo 116 HCT 116 Colo116 Colo-116 MCF7 MCF-7 MCF 7 2.012523020258
10009209 PI-103 371935-74-9 >98% 2007-01-19 30.913743906402 pi-103 phosphoinositides PI3-kinases Phosphatidylinositols cancers Glioma DNA-PK mTOR inhibitors inhibits inhibition anti-proliferatives proliferation PI103 30.913743906402
10010177 PI3-Kinase α Inhibitor 2 Exclusive 371943-05-4 >98% ✓ 2007-08-02 27.583552911176 pi3-kinase-inhibitor-2 PI3Kα Inhibitor 2; Phosphatidylinositol 3-Kinase α Inhibitor 2 phosphoinositides 3-kinases PI3-kinase phosphatidylinositols cancers proliferations inhibits inhibitors inhibition PI3-K PI3K inhibitory A375 melanoma cell proliferation 27.583552911176
13326 Pifithrin-α 63208-82-2 ≥95% 2009-07-16 31.221263812155 pifithrin p53 apoptosis DNA damage cyclin D1 C8 cells HUVECs endothelial cells dependent independent inactivator 31.221263812155
10748 Pifithrin-μ 64984-31-2 ≥98% 2011-06-20 17.587941988950 pifithrin PFT-μ; 2-Phenylethynesulfonamide p53 apoptosis Bcl-xL Bcl-2 mitochondria inhibitors nutlin heat shock proteins 70 HSP70 PES PAS pifithrin-mu pifithrin mu PFTμ PFTu 2-phenylacetylenylsulfonamide 2-phenylacetylenesulfonamide BclxL Bc12 17.587941988950
10009210 PIK-75 372196-67-3 ≥98% 2010-03-10 16.997085716132 pik-75 p110α PI3K insulin signaling signals cancers inhibitors inhibits inhibition signalling p110a phosphatidylinositol 3-kinase phosphorylation Akt activation mTORC1 PIP2 PIP3 p110β p110α p110γ p110beta p110 alpha p110.beta. p110.alpha. p110gamma p110.gamma.p110g Mixtures, Sulfonamide Sulfonamide Mixtures Sulfonamides 16.997085716132
89130 Pimonidazole 70132-50-2 >98% 2008-04-23 12.871988950276 pimonidazole NSC 380540; Ro 03-8799 hypoxia hypoxic cells radiosensitizer tumors marker hypoxia hypoxyprobe 12.871988950276
10006284 PINK1 Blocking Peptide - 2005-01-18 7.573020257827 pink1-blocking-peptide PTEN Induced Putative Kinase 1; PARK6; BRPK antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides phosphatases tensin homolog dephosphorylates lipids human cancers tumor-suppressive pathway mRNA mitochondria C-terminus Parkinson's diseases phosphatidylinositols phosphates 7.573020257827
10006283 PINK1 Polyclonal Antibody - 2004-12-28 20.473591160220 pink1-polyclonal-antibody PTEN Induced Putative Kinase 1; PARK6; BRPK proteins antibodies antisera antiserum wb western blots blotting IHC immunohistochemistry Parkinson's diseases cancers tumor-suppressive phosphatases tensin homologs dephosphorylates human signaling signalling pathway mRNA mitochondria c-terminus phosphatidyl inositols phosphates special:month specialdiscount:15 specialstart:2008-05-01 specialend:2008-05-31 immunoblotting 20.473591160220
11006 Piperlongumine New 20069-09-4 ≥98% 2011-10-24 59.638557257660 piperlongumine Piplartine 2859-009- 11042-67-4 25343-05-9 Keap1 Nrf2 antioxidants ROS cancers redox platelet aggregation tumorigenesis 59.638557257660
13368 Piroxicam 36322-90-4 ≥95% 2010-01-06 17.139206349206 piroxicam NSC 666076; Larapam; Feldene inflammation NSAIDs inhibitors cyclooxygenases COX-1 COX-2 analgesic pain arthritis cancers Artrooxicam Baxo Bruxicam CP 16171 Geldene Neoxicam Reudene Roxicam Roxiden Sasulen Solocalm Uphaxicam Zunden inhibition inhibited inflammatory Piroxicam CP-16171 CP 16171 Feldene CP16171 17.139206349206
10728 PIT-1 Exclusive 53501-41-0 ≥98% ✓ 2011-03-25 14.824756906077 pit-1 PIP3 PtdIns-(3,4,5)-P3 PH domains cancers inhibitors Akt PDK1 PTENs proteins binding pituitary-specific transcription factors pit-1 pituitary-specific pit 1 GHF-1 GHF 1 pit-oct-unc pit oct unc POU growth hormones 14.824756906077
10459 PKC 412 120685-11-2 ≥98% 2010-07-27 31.461705033762 pkc-412 CGP 41251; N-Benzoylstaurosporine; Midostaurin; CGP 41231 inhibitors inhibits inhibition PKC412 PKC-412 serine/threonine serine threonine tyrosines kinases PKCα PKCβ PKCγ PKC-α PKC-β PKC-γ Syk Flk-1 Flk1 Akt PKA c-Kit cKit C-Fgr cFgr FLT3 FLT-3 PDFRβ PDFR-β VEGFR1 VEGF2 nitric oxide synthase eNOS apoptosis cancers angiogenesis signal transduction Staurosporine 31.461705033762
10011332 Plerixafor (hydrochloride hydrate) 155148-31-5 ≥98% 2009-02-10 58.760906077348 plerixafor-hydrochloride-hydrate Mobozil™; SID 791; JM 3100; AMD 3100 stem cells hematopoiesis HIV lymphocyte replication metastasis cancers growth antagonist CXCR4 SDF-1 SDF1 CXCL12 ireversible virus inhibits inhibition inhibitor 58.760906077348
13786 PMS2 Monoclonal Antibody (Clone 163C1251) - 2010-05-10 0E-12 pms2-monoclonal-antibody-clone-163c1251 PMS1 Protein Homologue 2; DNA Mismatch Repair Protein PMS2; Mismatch Repair Endonuclease PMS2 antibodies PMS-1 PMS 1 PMS 2 PMS-2 proteins DNA cancers HNPCC hereditary nonpolyposis non-polyposis western blots blotting immunoblotting WB cancer DNA damage repair 0E-12
11004 Podoplanin Monoclonal Antibody (Clone NZ-1.2) - 2011-08-05 0E-12 podoplanin-monoclonal-antibody-clone-nz-1-2 Aggrus; gp38; T1A mucin glycoproteins T1A gp38 aggrus tumors cells ligands CLEC-2 metastases tissues Th17 CD4+ humans PBMC antibodies 0E-12
11005 Podoplanin Monoclonal Antibody (Clone pmab-1) - 2011-08-05 0E-12 podoplanin-monoclonal-antibody-clone-pmab-1 gp38; Aggrus; T1A gp38 glycoproteins tissues lymphatic endothelial cells tumors lymphangiogenesis Th17 autoimmune diseases antibodies myelin antigens migration inflammation 0E-12
13198 PP2 172889-27-9 ≥98% 2010-09-20 30.762276243094 pp2 AGL 1879 PTK inhibitors inhibits inhibition Src kinase T cells T-cells enzymes AG1879 AG 1879 PP-2 PP 2 signalling tyrosine kinases tyrosine focal Tyr 577 adhesion kinases AG-1879 AGL1879 AGL 1879 thaliana Proteins Arabidopsis Proteins Arabidopsis thaliana Arabidopsis thaliana Proteins Hemagglutinins Plant Thale Cress Proteins Plant Hemagglutinins Arabidopsis Proteins Agglutinins Plant Plant Agglutinins Proteins Plant Phytagglutinins Plant Proteins Lectins Plant Plant Lectins 30.762276243094
13643 PP242 1092351-67-1 ≥95% 2011-04-22 23.734631237393 pp242 mTORs mTORC1 mTORC2 inhibitors cancer leukemia rapamycin PP 242 PP-242 inhibited inhibition 23.734631237393
11209 PRDM9 (human recombinant) Exclusive New - ≥65% ✓ 2012-01-11 67.674953959484 prdm9-human-recombinant PR Domain-containing Protein 9; MSBP3; ZNF899; PFM6; Meisetz histones methyltransferases zinc-fingers hotspots recombination genomes genetics meiosis trimethylation H3K4 nucleosomes PR/SET HTMase c-terminal C2-H2 PR domain zinc finger protein 9 67.674953959484
63520 PRIMA-1 5608-24-2 >95% 23.216282557221 prima-1 DNA binding anti-oncogenic apoptosis cancer p53 re-activator reactivator induces apoptotic re-activation reactivation antioncogenic cancers 2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one 23.216282557221
10350 PRMT1 (human recombinant) - ≥80% 2011-01-25 81.133581952118 prmt1-human-recombinant Protein Arginine Methyltransferase 1 PRMT1 brucei Prmt1 TbPRMT1 brucei Silencing Factors Transcriptional Transcriptional Silencing Factors Transcription Factors Repressor Molecules Proteins Repressor Repressor Proteins arginine methyltransferase histones modification glycine arginine rich GAR motifs SAM-dependent GST-tagged 81.133581952118
10750 PRMT4 (human recombinant) New - ≥70% 2011-12-21 54.412891344382 prmt4-human-recombinant Protein Arginine Methyltransferase 4; CARM1; Coactivator-associated Arginine Methyltransferase 1 PRMT arginine methyltransferases epigenetics PRMT4 CARM1 SAM MMA aDMA Arg-17 Arg-26 proteins enzymes catalytic domains S-adenosyl-L-methionine histones H3 binding binds p160 SRC-1 SRC1 GRIP1 TIF2 pCIP RAC3 ACTR AIB1 TRAM1 nuclear receptors phosphorylation Ser217 hormones regulation lipids metabolism ω-NG,NG-dimethylarginine ω-NG-monomethylarginine 54.412891344382
13552 PRMT4 Polyclonal Antibody - 2009-07-24 20.740740740740 prmt4-polyclonal-antibody CARM1; Protein Arginine Methyltransferase 4 antibodies WB western immunoblotting blots coactivator associated arginine methyltransferase 1 steroids receptors SRC proteins co-activators blotting 20.740740740740
13559 PRMT5 Polyclonal Antibody - 2009-07-24 22.960031716799 prmt5-polyclonal-antibody Protein Arginine Methyltransferase 7; Skb1HS; JBP1 proteins PRMTs signaling WB western immunoblotting blots ADMA blotting janus kinase-binding kinase binding fission yeast 1 22.960031716799
10752 PRMT6 (human recombinant) New - ≥80% 2012-01-24 90.398209978586 prmt6-human-recombinant Protein Arginine Methyltransferase 6; HRMT1L6; Histone Arginine N-methyltransferase PRMT6; Heterogeneous Nuclear Ribonucleoprotein Methyltransferase-like Protein 6 PRMTs arginine methyltransferases epigenetics PRMT6 histones SAM MMA aDMA H3R2 HMA H3K4 MLL HMGA1a 90.398209978586
13558 PRMT6 Polyclonal Antibody - 2009-07-24 22.960031716799 prmt6-polyclonal-antibody Protein Arginine Methyltransferase 6 antibodies WB HeLa proteins western immunoblotting blots blotting 22.960031716799
13551 PRMT7 Polyclonal Antibody - 2009-07-24 22.960031716799 prmt7-polyclonal-antibody Protein Arginine Methyltransferase 7 PRMTs antibodies proteins western blotting immunoblotting blots SRC steroid receptor co-activator coactivator GRIP-1 GRIP1 WB 22.960031716799
10009762 Progesterone Receptor (Phospho-Ser190) Monoclonal Antibody - 2007-04-05 125.122596685083 progesterone-receptor-phospho-ser190-monoclonal-antibody antibodies WB western blots phospho-specific Progesterones receptors phosphorylation Ser190 cancers breast mammary glands endocrinology blotting immunoblotting IHC immunohistochemistry 125.122596685083
10009763 Progesterone Receptor (Phospho-Ser294) Monoclonal Antibody - 2007-04-05 125.122596685083 progesterone-receptor-phospho-ser294-monoclonal-antibody antibodies WB western blots phospho-specific progesterone receptors cancers breast mammary glands endocrinology blotting immunoblotting IHC immunohistochemistry 125.122596685083
13365 Programmed Cell Death Protein 4 (C-term) Blocking Peptide - 2008-08-25 0E-12 programmed-cell-death-protein-4-c-term-blocking-peptide PDCD4 antibodies antibody peptides antiserum antisera blocking immunoblotting WB western blots PDCD4 PCDC-4 PDCDP4 PDCDP-4 0E-12
10250 Programmed Cell Death Protein 4 (C-Term) Polyclonal Antibody - 2008-09-15 2.868508287292 programmed-cell-death-protein-4-c-term-polyclonal-antibody PDCD4; Neoplastic Transformation Inhibitor western blots WB KLH genes tumors antibodies antiserum antisera PDCD4 PCDC-4 PDCDP4 PDCDP-4 blotting immunoblotting 2.868508287292
500940 Progranulin (human) EIA Kit - 2011-04-26 27.290078623034 progranulin-human-eia-kit PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants 27.290078623034
500950 Progranulin (mouse) EIA Kit - 2011-04-26 36.071109064866 progranulin-mouse-eia-kit murine mice PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants 36.071109064866
10010 Prostaglandin A1 14152-28-4 >98% 139.226084254143 prostaglandin-a1 PGA1 prostaglandins renal vasodilation pge1 dehydration semen antimitotic antiproliferative 139.226084254143
9000184 Prostaglandin A1 methyl ester Exclusive 26771-94-8 ≥98% ✓ 2010-11-08 18.494516574585 prostaglandin-a1-methyl-ester PGA1 methyl ester hypertension cancers lipophilic analogs PGA1 prostaglandins 18.494516574585
12010 Prostaglandin D2 41598-07-6 >99% 180.514980639373 prostaglandin-d2 PGD2 Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry 180.514980639373
512031 Prostaglandin D2 EIA Kit - 2010-07-19 268.101938305709 prostaglandin-d2-eia-kit PGD2 ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 268.101938305709
512041 Prostaglandin D2 Express EIA Kit - 2010-07-19 125.652167445813 prostaglandin-d2-express-eia-kit PGD2 Express ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 125.652167445813
10007202 Prostaglandin D2 Lipid Maps MS Standard 41598-07-6 >99% 2008-10-27 18.350641733956 prostaglandin-d2-lipid-maps-ms-standard PGD2 Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry mass spectrometry standards GC LC MS 18.350641733956
10007939 Prostaglandin E Synthase-1 (microsomal) (human recombinant) - 16,000 x g supernatant 2009-03-15 25.421565377532 prostaglandin-e-synthase-1-microsomal-human-recombinant Membrane-Associated PGES-1; Prostaglandin H/E Isomerase; PIG12; mPGE Synthase-1; MGST1-L1 enzymes proteins PGs prostaglandins catalyzes conversion PGH2 PGE2 membrane-associated eicosanoids glutathiones metabolisms MAPEG expression proinflammatory stimuli stimulus IL-1.beta. IL-1b interleukins glucocorticoids synovial tissues primary synoviocytes rheumatiod arthritis fever onset drugs anti-inflammatory therapy therapies E. coli mPGES mPGES-1 mPGES1 25.421565377532
10009734 Prostaglandin E Synthase-1 (microsomal) Western Ready Control - 2007-05-01 8.713128453038 prostaglandin-e-synthase-1-microsomal-western-ready-control PIG12; mPGE Synthase-1; MGST-L1; Prostaglandin H/E Isomerase; Memebrane-Associated PGES-1 western blot WB prostaglandins renal failure synthase inhibitors mPGES mPGES-1 mPGES1 8.713128453038
10011237 Protein Phosphatase 2A C subunit (human recombinant; L309 deletion) Exclusive - ✓ 2008-07-17 15.944143646408 protein-phosphatase-2a-c-subunit-human-recombinant-l309-deletion PP2A Cα; PP2A Δ309; PP2A L309 proteins phosphatases serine threonine cellular tumors enzyme kinetics regulations substrates phosphorylasion PP2As octahistidine-tag streptactin-tag 15.944143646408
10010896 Protein Tyrosine Phosphatase 1B (human recombinant) - ≥95% 2008-08-25 4.471215469613 protein-tyrosine-phosphatase-1b-human-recombinant PTP1B proteins recombinant PTPs phosphates tyrosines pNPP enzymes diabetes insulin leptin signaling signalling 4.471215469613
13527 Pseudolaric Acid B 82508-31-4 ≥98% 2009-12-04 9.385994475137 pseudolaric-acid-b PAB Pseudolarix kaempferi traditional Chinese fungal fungus infections cancers apoptosis angiogenesis tumors inhibits inhibitors inhibition P. therapy apoptosis cells 9.385994475137
10009817 PtdIns-(3,4,5)-P3 Binding Protein - ≥95% 2008-02-14 0.694779005524 ptdins-3-4-5-p3-binding-protein PI(3,4,5)-P3; Phosphatidylinositol-(3,4,5)-triphosphate; GRP1 PH Domain; PIP3 lipids recognition proteins GST-tagged PIPs phosphatidylinositols triphosphates 0.694779005524
10009815 PtdIns-(4,5)-P2 Binding Protein - ≥95% 2008-02-13 2.467911602210 ptdins-4-5-p2-binding-protein PIP2; PI(4,5)-P2; Phosphatidylinositol-(4,5)-diphosphate; PLC-δ1-PH Domain lipid recognition protein human recombinant GST-tagged proteins E. coli PIPs phosphatidylinositols diphosphate PLCdelta PLCd 2.467911602210
10009241 PtdIns-(4)-P1 Binding Protein - ≥90% 2008-02-21 0.457182320442 ptdins-4-p1-binding-protein SidC; PIP; PI(4)-P1; SidC 3C GST-tagged EDTA PIPs PtdIns phosphoinositols PIP2 PIP3 PI3-kinase cancers proteins 0.457182320442
10007073 PTEN Blocking Peptide - 2005-06-28 1.731270718232 pten-blocking-peptide Phosphatase and Tensin Homology on Chromosome 10 western blotting blots signaling signalling WB IHC immunohistochemistry formalin-fixed paraffin-embedded sections controls proteins dephosphorylates lipids AKT phosphatidylinositols triphosphates PIP3 tissues acids regulates cells division migrations apoptosis mutations cancers melanomas prostates carcinomas A431 HEK293 signals transductions 1.731270718232
10009746 PTEN (human recombinant) - ≥95% 2008-09-04 7.611226519336 pten-human-recombinant TEP1; Phosphatidylinositol 3-phosphatase; MMAC1; Phosphatase and Tensin Homology on Chromosome 10 proteins PTENs phosphatase homology tensin chromosomes enzymes lipids Sf21 cells recombinant N-terminal tumor suppressor cancers phosphoinositide hexahistidine His-tag His-tagged 7.611226519336
10005059 PTEN Polyclonal Antibody - 2005-05-04 4.439481512962 pten-polyclonal-antibody TEP1; Phosphoinositide 3-phosphatase; MMAC1; Phosphatase and Tensin Homolog on Chromosome 10 proteins antibodies antisera antiserum wb western blots blotting IHC immunohistochemistry dephosphorylates lipids AKT phosphatidylinositols triphosphates PIP3 tissues acids regulates cells division migrations apoptosis mutations cancers melanomas prostates carcinomas A431 HEK293 signals transductions cancers endocrinology immunoblotting 4.439481512962
10009747 PTEN Western Ready Control - 2007-05-30 0E-12 pten-western-ready-control TEP1; MMAC1; Phosphatidylinositol 3-phosphatase; Phosphatase and Tensin Homology on Chromosome 10 western blot WB AKT phosphatidylinositol 3,4,5-triphosphate PIP3 enzyme transduction pathway endocrinology 0E-12
13000 Pterostilbene 537-42-8 ≥98% 2009-09-09 34.272707182320 pterostilbene 3',5'-Dimethoxy-4-Stilbenol; trans-3,5-Dimethoxy-4'-Hydroxystilbene resveratrol blueberries antioxidant PGE2 prostaglandins E2 cells proliferation ERK1/2 ERK 1/2 p38 MAPK PI3K/Akt NF-kB NFkB NF-κB NFκB AP-1 AP1 transcriptional activation cancers inflammation diabetes inflammatory 34.272707182320
10005169 Quercetin 117-39-5 >95% 2004-08-04 6.795322283609 quercetin flavonoid plants fruits glycosides carcinogens carcinogenic inhibits inhibitors inhibition phosphodiesterases antioxidants rutin 6.795322283609
10011620 Raloxifene (hydrochloride) 82640-04-8 ≥98% 2009-01-07 5.901491712706 raloxifene-hydrochloride Evista; LY156758; Keoxifene (hydrochloride) breasts cancers osteoporosis SERM estrogen evista bone remodeling formation IL-6 IL6 25-OH vitamin D parathyroid hormones cardiovascular protection 5.901491712706
13346 Rapamycin 53123-88-9 ≥95% 2009-10-21 71.548611281632 rapamycin Sirolimus immunosuppresssants transplants rejection inhibitors IL-2 lymphocytes B cells T FKBP12 mTOR mTORC1 cancer adipogenesis diabetes tuberous sclerosis cardiovascular diseases 71.548611281632
10947 RbBP5 (human recombinant) New - ≥90% 2012-01-06 90.297053406998 rbbp5-human-recombinant Retinoblastoma binding Protein 5; SWD1, Set1c WD40 repeat protein, homolog; RBQ3 epigenetics methyltransferases histones H3K4 genes regulation MLL proteins complex subunits nuclear WD40 domains tumors supressors RB cells proliferation E1A SET1 lysine MLL1 MLL1-4 dimethylation trimethylation H3 H3K4me2/me3 retinoblastoma-binding protein RBQ-3 RBBP-5 RBBP5 90.297053406998
10010172 (R)-Equol Exclusive 221054-79-1 ≥98% ✓ 2009-08-27 7.679378453039 -r-equol Isoequol; (+)-Equol phytoestrogens estrogens daidzen genistein receptors cancers R-Equol +equol + equol agonist activity R equol (R) equol 7.679378453039
11017 Retinoic Acid New 302-79-4 ≥98% 2011-10-25 11.043295402707 retinoic-acid ATRA; Tretinoin; NSC 122758; Vitamin A Acid; all-trans Retinoic Acid; NSC 122578 ligans receptor cancers development reproduction immunity gene expressions 7005-78-9 56573-65-0 187175-63-9 NSC-122758 NSC122758 AGN 100335 AGN100335 AGN-100335 aberel airol aknoten atragen cordes vas dermairol epi-aberel eudyna NSC 122578 NSC-122578 NSC122578 renova retacnyl retin A ro 1-5488 tretin M vesanoid vesnaroid vitamins A1 all trans 11.043295402707
10006606 Retreversine - >98% 2005-09-15 23.657002762430 retreversine inactive isomers reversine purine analogs cells stem organogenesis derivatives C2C12 myoblasts osteogenic bones adipogenic adipose de-differentiation dedifferentiation re-differentiation progenitors 23.657002762430
10004412 Reversine 656820-32-5 >98% 2005-03-25 34.457569060773 reversine purine analogs cells stem organogenesis derivatives C2C12 myoblasts osteogenic bones adipogenic adipose de-differentiation dedifferentiation progenitors fate cancers 34.457569060773
10010309 RG-13022 149286-90-8 >98% 2008-01-24 2.561519337016 rg-13022 protein tyrosine kinase PTK inhibitors inhibits inhibition antiproliferatives tyrphostin epidermal growth factors EGFs receptors cancers 2.561519337016
10010310 RG-14620 136831-49-7 >98% 2008-02-08 2.255949851253 rg-14620 protein tyrosine kinases PTKs inhibitors inhibits inhibition antiproliferative tyrphostin epidermal growth factors EGFs receptors proliferation cancers 2.255949851253
13293 Rhapontigenin Exclusive 500-65-2 ≥98% ✓ 2009-11-10 28.590690607734 rhapontigenin resveratrols antioxidants cancers cytochromes P450 CYP450 proliferation anti cancers anti-oxidants 28.590690607734
160785 RICK Polyclonal Antibody - 8.515303867402 rick-polyclonal-antibody Ripk2; Rip2; CARDIAK apoptosis antibodies kinase CARD domains RIP Fas western blots blotting WB antisera antiserum RIP-2 cancers immunoblotting CCK CCKs CCCK 8.515303867402
10006426 RITA 213261-59-7 >98% 2006-01-11 28.073474524248 rita NSC 652287; 2,5-bis(5-hydroxymethyl-2-thienyl) Furan HDM-2 human double minute-2 MDM-2 mouse murine negative regulator p53 proteasomal degradation tumors cancers apoptosis cells reactivation molecules inhibitors wild-type DNA-protein human renal SCID mice HCT116 A-498 xenografts nude HDM2 HDM-2 MDM2 28.073474524248
10311 (R)-(−)-Mellein New 480-33-1 ≥98% 2012-01-13 68.888888888889 -r-mellein Ochracin antibacterial antimalarial antifungal anticancer dihydroisocoumarin A. ochraceus wilhelm proliferation humans breasts cancers melanoma cells 21499-22-9 isocoumarin R-mellein MCF-7 MDA-MB-468 SK-MEL-28 (R)-mellein malme-3M 68.888888888889
13697 (R)-MG132 Exclusive 1211877-36-9 ≥98% ✓ 2010-06-22 93.183756906077 -r-mg132 ubiquitin proteasomes inhibitors proteolytic degradation inflammation cells cycle regulation cancers NF-κB apoptosis inhibition inhibited 93.183756906077
10006415 Ro 48-8071 161582-11-2 >98% 2005-06-01 6.522028413575 ro-48-8071 monooxidosqualenes cyclases inhibitors OSC cholesterols lowering activity microsomal enzymes catalyzes lanosterol synthetic pathway LDL low-density lipoproteins human livers microsomes HepG2 cells HDL high-desity toxicity CYP3A mRNA proteins hepatocytes cultures atherosclerosis 6.522028413575
10009569 (R)-Roscovitine 186692-46-6 >98% 2007-09-04 13.673075506446 -r-roscovitine Seliciclib cell cycle cyclin-dependent kinase cdk proliferation cancer renal disease 13.673075506446
13664 S32826 1096770-84-1 ≥98% 2010-06-18 27.989850828728 s32826 Autotaxins lysophospholipase D lysophosphatidylcholine lysophosphatidic acids LPAs inhibitors src phosphatase 1B adipocytes plasma inhibited inhibition inhibits Esters, Phosphonic Acid Phosphonic Acid Esters Phosphonic Acids Phosphonates 27.989850828728
13603 S-Adenosylhomocysteine 979-92-0 ≥98% 2010-04-22 9.582690607734 s-adenosylhomocysteine SAH; AdoHcy amino acids derivatives cysteine methyl cycle biosynthesis risk factors metabolic pathways cancers by-products by products neurodegenerative diseases Adenosylhomocysteine, S S-Adenosylhomocysteine S Adenosylhomocysteine 9.582690607734
9000372 S-Adenosylhomocysteine-d4 Exclusive - ≥99% deuterated product ✓ 2009-12-02 18.445248618784 s-adenosylhomocysteine-d4 SAH-d4 deuteriums GC/MS LC/MS mass spectrometry GC-MS LC-MS deuterateds amino acids derivative cysteine methyl cycle biosynthesis 979-92-0 risk factors s-adenosyl-l-homocysteine-d4 18.445248618784
10009929 SAHA 149647-78-9 >98% 2007-08-07 164.175228067366 saha Vorinostat; Suberoylanilide Hydroxamic Acid; Zolinza™ HDACs inhibitors cancers inhibits inhibition 164.175228067366
13178 Salermide 1105698-15-4 ≥98% 2009-04-27 20.206550907655 salermide Sirtuin SIRT1 SIRT2 inhibitors cancers apoptosis leukemias histone deacetylases HDACS inhibition inhibited 20.206550907655
13628 Salidroside 10338-51-9 ≥97% 2010-05-28 12.325948434623 salidroside Rhodioloside glycosides plants Rhodiola Chinese medicine memory infections inflammation cancers diabetes fatigue apoptosis Glucosides 12.325948434623
13579 Salinomycin (sodium salt) 55721-31-8 ≥90% 2011-03-14 8.068784530387 salinomycin-sodium-salt cancers stem cells breasts inhibitors tumors anticancer pyrans anti-cancer inhibited inhibits inhibition CSCs 8.068784530387
13031 SB 431542 301836-41-9 ≥98% 2009-08-10 84.917826887661 sb-431542 inhibitors inhibits inhibitions TGF-β1 TGFβ1 receptors ALK5 ALK4 ALK7 ALKs BMP ALK2 ALK3 ALK6 kinases Smad fibrosis cancers renewal embryonic stems cells induced pluripotent differentiation SB431542 84.917826887661
10443 SB 939 New 929016-96-6 ≥98% 2012-02-06 103.307489257213 sb-939 3-[2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl]-N-hydroxy-(2E)-2-propenamide; Pracinostat inhibits inhibitions inhibitor HDACs pan-HDAC panHDAC SB939 SB-939 histones deacetylase proliferation voronistat cancers tumors SAHA 103.307489257213
10011561 SC-51089 146033-02-5 ≥95% 2010-02-02 7.626353591159 sc-51089 CID132748 prostaglandins E2 PGE2 receptors EP1 pain antagonists analgesia glioma cells cancers tumors growth neuroprotection neurons oxidative stress SC51089 SC 51089 PGs Oxazepines 7.626353591159
10876 SC-66 871361-88-5 ≥98% 2011-06-21 17.491287292817 sc-66 SC66 SC 66 analogs cyclohexanone curcumin cancers Akts inhibitors inhibits inhibition cancers ubiquitination cells death tumors tumorigenesis 17.491287292817
10010173 (S)-Equol 531-95-3 ≥98% 2009-08-27 11.167541436464 -s-equol 4',7-Isoflavandiol; 4',7-Dihydroxyisoflavan; (-)-Equol phytoestrogen estrogens daidzen genistein receptors cancers (S) equol S-equol -Equol (-) Equol antagonist 11.167541436464
10005260 Serine Palmitoyltransferase Polyclonal Antibody - 2004-12-02 27.718979742173 serine-palmitoyltransferase-polyclonal-antibody Serine-palmitoyl-CoA transferase, long chain base subunit 2; SPT antibodies antisera western blots blotting WB sphingolipids SPT2 immunohistochemistry immunohistochemical analysis IHC nuclear proteins nucleus immunoblotting 27.718979742173
13780 SET7/9 (FL) Polyclonal Antibody - 2010-03-08 6.435856353591 set7-9-fl-polyclonal-antibody SET Domain-Containing Protein; KMT7; SETD7/9 antibodies SET 7/9 SET-7/9 7 9 histones H3 lysines 4 western blotting WB blots immunoblotting 6.435856353591
10320 SET7/9 (human recombinant) - ≥95% 2009-08-11 19.305526703498 set7-9-human-recombinant KMT7; SETD7/9; SET Domain-containing Protein 7/9 SET-7/9 SET 7/9 7 9 recombinant His-tagged proteins SETs methylation methyltransferase 19.305526703498
700270 SET7/9 Methyltransferase Inhibitor Screening Assay Kit - 2009-12-04 20.979366833289 set7-9-methyltransferase-inhibitor-screening-assay-kit methyltransferases SET Domain-containing Protein 7/9 lysines 7 KMT7 methylation signal transduction biosynthesis proteins repair genes silencing chromatins S-adenosylmethionine SAM AdoMet methyl donors Alzheimer's depression Parkinson's Diseases multiple sclerosis liver cancers substrates histones histone 3 lysine residue 4 H3K4 p53 transcription factors TAF10 mono-methylated mono-methylase DNA damage acetylation human tumorigenesis inhibitors acceptor peptides S-adenosylhomocysteine S-ribosylhomocysteine adenine nucleosidase hypoxanthine deaminase urate hydrogen peroxide H2O2 ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin fluorescence measures measurement assays kits 20.979366833289
10319 SET8 (human recombinant) - ≥95% 2010-01-07 27.020558624923 set8-human-recombinant SETD8; SET domain-containing (lysine methyltransferase) 8; KMT5a; PR-Set7 SET-8 SET 8 recombinant His-tagged proteins SETs methylation methyltransferase MTs domain containing 27.020558624923
700350 SET8 Methyltransferase Inhibitor Screening Assay Kit - 2010-03-09 16.235835998836 set8-methyltransferase-inhibitor-screening-assay-kit SET domain-containing (lysine methyltransferase) 8; PR-Set7; SETD8 assays kits measures measurement methyltransferases MTs inhibits inhibitors inhibition methylation signal transduction biosynthesis protein repair genes silencing chromatins regulation S-adenosylmethionine (SAM)-dependent AdoMet DNA deoxyribonucleic acids Alzheimer's diseases depression Parkinson's multiple sclerosis livers cancers KMT5A lysines PR-Set 7 methylates histones H4 residues 20 H4K20 transcriptional p53 tumors suppressors tumorigenesis inhibits inhibition inhibitors peptides S-adenosylhomocysteines S-ribosylhomocysteines adenines nucleosidases hypoxanthines deaminases hydrogen peroxides H2O2 ADHP 10-acetyl-3,7-dihydroxyphenoxazines fluorescent fluorescence resorufin 16.235835998836
13332 (S)-Glycyl-H-1152 (hydrochloride) Exclusive 913844-45-8 ≥98% ✓ 2010-01-27 51.846950276243 -s-glycyl-h-1152-hydrochloride Rho Kinase Inhibitor IV Rho kinases ROCK-I p160ROCK ROCK-II G protein Rho cytoskeletons adhesions proliferation smooth muscles contraction stem cells inhibitors inhibition inhibited Fasudil hydrochloride ROCK IV h1152 h-1152 h 1152 51.846950276243
13277 (S)-HDAC-42 935881-37-1 ≥95% 2009-12-03 43.209490484960 -s-hdac-42 AR42 histones deacetylases HDACs cancers inhibitors prostate p21 Akt Bcl-XL tumors inhibition inhibits OSU-HDAC-42 43.209490484960
10006211 Silybin 22888-70-6 >98% 2005-02-16 14.048287292817 silybin Silymarin; Silibinin flavanoids flavonoids 5-LOs 5-lipoxygenases inhibits inhibitors inhibition flavonolignans Silybum marianum superoxides Kupffer cells leukotrienes LTB4 synthesis PMA-activated milk thistle 14.048287292817
10011190 SIRT1 (human recombinant) - ≥60% 2008-09-24 14.804068916183 sirt1-human-recombinant Silent Information Regulator 2; Sirtuin 1; SIR2-like Protein 1; SIR2L1; NAD-dependent Deacetylase 1 SIRT 1 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers GST-tags GST-tagged sirtuin silent mating type information regulation 2 homolog 1 SIR2alpha sirtuin type 1 14.804068916183
700280 SIRT2 Direct Fluorescent Screening Assay Kit - 2009-12-10 31.440029078219 sirt2-direct-fluorescent-screening-assay-kit Nucleosomes chromosomal deoxyribonucleases DNA histones H2A H2B H3 H4 octameric cores transcription amino termini acetylation phosphorylation methylation ε-amino lysines acetyltransferases HATs chromatins genes activation deacetylases HDACs catalyzes hydrolytic acetyls sirtuins trichostatins A-insensitive lysyl-deacetylases class III catalyzes deacetylation nicotinamides O-acetyl-ADP-ribose NAD+ human SIRT1 SIRT2 SIRT3 SIRT4 SIRT5 SIRT6 SIRT7 cytoplasmic proteins H4 lysine-16 lysine-40 α-tubulin a-tubulin alpha-tubulin HDAC6 microtubules mitotic chromosomal hyperpolid cells tissues skeletal muscle heart oligodendroglia brain tumor suppressor gliomas Down-regulation gene chromosomal region diagnostic marker fluorescence-based inhibitors activators p53 Gln-Pro-Lys-Lys(ε-acetyl)-AMC recombinant NAD+ fluorescent fluorescence kits assays measures measurement 31.440029078219
10011191 SIRT2 (human recombinant) - ≥90% 2009-07-31 13.555312542806 sirt2-human-recombinant Silent Information Regulator 2; Sirtuin 2; SIR2-like Protein 2; NAD-dependent Deacetylase 2; SIR2L2 SIRT 2 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers His-tagged His tag sirtuin silent mating type information regulation 2 homolog 2 sirtuin type 2 13.555312542806
10011194 SIRT3 (human recombinant) - ≥90% 2008-12-15 17.771777727044 sirt3-human-recombinant SIR2L3; Mitochondrial Nicotinamide Adenine Dinuclear-dependent Deacetylase; SIR2-like Protein 3; NAD-dependent Deacetylase 3; Silent Information Regulator 3; Sirtuin 3 SIRT 3 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers GST-tags GST-tagged sirtuin silent mating type information regulation 2 homolog 3 sirtuin type 3 sir2-like 3 17.771777727044
10317 SIRT4 (human recombinant) - ≥95% 2010-01-06 4.168820297398 sirt4-human-recombinant Sirtuin 4; Silent Information Regulator 4; SIR2L4; NAD-dependent ADP-ribosyltransferase Sirtuin 4; SIR2-like Protein 4 SIRTs Sirtuins HDACs proteins His-tagged hexahistidines HDACS histone decatylases GDH glutamate dehydrogenase sirtuin silent mating type information regulation 2 homolog 4 sirtuin type 4 4.168820297398
10318 SIRT5 (human recombinant) - ≥90% 2009-07-31 16.866463449157 sirt5-human-recombinant Silent Information Regulator 5; Sirtuin 5; NAD-dependent Deacetylase 5; SIR2L5; SIR2-like Protein 5 SIRTs proteins HDACs CSP1 GST-tagged silent mating type information regulation 2 homolog 5 sirtuin type 5 16.866463449157
700290 SIRT6 Direct Fluorescent Screening Assay Kit - 2010-02-18 41.783069751381 sirt6-direct-fluorescent-screening-assay-kit SIRT 6 SIRT-6 assays kits measures sirtuins trichostatins A-intensive lysyl-deacetylases class III HDACs human mitochondrial nuclear proteins mitochondrias translocated nucleus cells cellular stress lysine deacetylation nicotinamides O-acetyl-ADP-ribose NAD+ abstracted ADP-ribosyl transferases deacetylases telomeres chromatins NF-κB NF-kappaB NF-.kappa.B signaling signalling mammalian cells Werner Syndromes aging disorders anti-cancers anti-inflammatory drugs apoptosis screening fluorescence activators Arg-His-Lys-Lys(ε-acetyl)-AMC fluorescent fluorometric 41.783069751381
10315 SIRT6 (human recombinant) - ≥95% 2009-07-31 11.980524861878 sirt6-human-recombinant Sirtuin 6; NAD-dependent Deacetylase 6; Silent Information Regulator 6; SIR2L6; SIR2-like Protein 6 SIRTs Sirtuins HDACs proteins His-tagged hexahistidine silent mating type information regulation 2 homolog 6 sirtuin type 6 11.980524861878
10316 SIRT7 (human recombinant) - ≥85% 2009-12-22 9.669181681201 sirt7-human-recombinant SIR2L7; Sirtuin 7; Silent Information Regulator 7; SIR2-like protein 7; NAD-dependent deacetylase 7 SIRTs Sirtuins HDACs proteins His-tagged hexahistidine histone deacetylases silent mating types information regulators 2 homologs 9.669181681201
10822 SMAD1/5/8/9 Polyclonal Antibody - 2011-04-14 1.483314917126 smad1-5-8-9-polyclonal-antibody WBs western blots immunoblotting SMADs 1 5 8 9 SMAD-1-5-8-9 1/5/8/9 antibodies serum 1,5,8,9 1.483314917126
10821 SMAD1/5/8/9 Polyclonal Antiserum - 2011-03-31 0.422541436464 smad1-5-8-9-polyclonal-antiserum WBs western blots immunoblotting SMADs 1 5 8 9 SMAD-1-5-8-9 1/5/8/9 antibodies serum 0.422541436464
10823 SMAD2 Polyclonal Antibody - 2011-05-05 0.422541436464 smad2-polyclonal-antibody WBs western blots immunoblotting SMADs SMAD-2 SMAD 2 antibodies serum IHC immunohistochemistry TGF-β TGFβ cancers 0.422541436464
10832 SMAD3 Polyclonal Antibody - 2011-05-03 1.165082872927 smad3-polyclonal-antibody WBs western blots immunoblotting SMADs SMAD-3 SMAD 3 antibodies serum IHC immunohistochemistry TGF-β TGFβ Tcells signaling TGF-β MH1 domains DNA proteins SARA ECM apoptosis proliferation differentiation 1.165082872927
10838 SMAD4 Polyclonal Antibody - 2011-05-05 1.154475138121 smad4-polyclonal-antibody WBs western blots immunoblotting SMADs SMAD-4 SMAD 4 antibodies serum IHC immunohistochemistry TGF-β TGFβ cancers 1.154475138121
10839 SMAD6 Polyclonal Antibody - 2011-05-02 0.422541436464 smad6-polyclonal-antibody WBs western blots immunoblotting SMADs MAD SMAD-6 SMAD 6 antibodies serum IHC immunohistochemistry TGF-β TGFβ Tcells intracellular proteins signaling serine threonine apoptosis bones cancers genes signal transduction 0.422541436464
10845 SMAD7 Polyclonal Antibody - 2011-05-05 0.422541436464 smad7-polyclonal-antibody WBs western blots immunoblotting SMADs SMAD-7 SMAD 7 antibodies serum TGF-β TGFβ Tcells 0.422541436464
10840 SMAD7 Polyclonal Antibody (azide-free) - 2011-05-05 0.422541436464 smad7-polyclonal-antibody-azide-free WBs western blots immunoblotting SMADs SMAD-7 SMAD 7 antibodies serum TGF-β TGFβ Tcells 0.422541436464
10012628 (S)-MG132 133407-82-6 ≥98% 2009-02-18 192.178839779005 -s-mg132 Z-Leu-Leu-Leu-CHO ubiquitin proteasome inhibitors inhibits inhibition proteolytic degradation inflammation cell cycle regulation cancers NF-kB NFkB apoptosis NF-κB mg 132 mg-132 2-LLL-CHO 192.178839779005
13121 Sodium Butyrate 156-54-7 ≥95% 2009-07-31 79.349723756906 sodium-butyrate Butyric Acid (sodium salt) fatty acids short chains inhibitors inhibits inhibition histones deacetylases HDACs epigenetics growth arrest differentiation apoptosis cancers inflammation genes expressions pro-inflammatory proinflammatory cytokines IFN-γ IL-6 IFNγ IL6 IL-1β IL1β IFNg 79.349723756906
10010466 SP 600125 129-56-6 ≥98% 2009-01-07 11.958232044199 sp-600125 1PMV; Pyrazolanthrone; NSC 75890 c-Jun cJun JNKs inhibitors inhibits inhibition reversible cell-permeable cells COX-2 COX2 MAP kinase MAPK genes expressions apoptosis autophagy differentiation IL-10 IL10 TNF-α TNFα IFN-γ IFNγ T-cells Tcells HeLa sp600125 11.958232044199
10348 Sphingosine Kinase 1 (human recombinant) - ≥90% by SDS-PAGE 2011-04-12 43.972817679558 sphingosine-kinase-1-human-recombinant SPHK1; SK1 sphingosines phosphates ceramides apoptosis acids cells death kinases sphingomyelin growth calcium 43.972817679558
700430 Sphingosine Kinase 1 Inhibitor Screening Assay Kit - 2010-09-16 60.338084714548 sphingosine-kinase-1-inhibitor-screening-assay-kit SPHK 1 kits assays measures measurements SK1 SPHK1 sphingolipids metabolic pathways phosphorylates D-erythro-sphingosines sphingosine-1-phosphates S1P cells proliferations migrations cytoskeletal morphogenesis SPHK2 2 mammalian signalling signaling masts TNF-a TNFa TNF-alpha TNFalpha TNF-α TNFα-triggered Tumors Necrosis Factor-α fibroblasts epithelial mRNA messenger ribonucleic acids levels brains oncogenics erythroleukemias therapy therapeutics cancers inflammation up-regulated phagocytes peritoneal sepsis mice murine mouse inhibition inhibitors inhibits septic shock fluorescence-based fluorescent ATP adenosine triphosphates phosphorylates phosphorylation C-18 ADP diphosphates hydrogen peroxides H2O2 resorufin 60.338084714548
10006822 Sphingosine Kinase 1 Polyclonal Antibody - 2006-12-21 39.460479790636 sphingosine-kinase-1-polyclonal-antibody SPHK 1 proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry sphingosines kinases enzymes sphingolipids metabolisms catalyzes phosphorylation sphingosine-1-phosphates cells proliferation death tissues kidneys livers spleen hearts platelets tumors cytosolic membranes amino acids post translational modifications SK1 SPK1 cancers immunoblotting 39.460479790636
10012201 Sphingosine Kinase 1 Polyclonal FITC Antibody Exclusive - ✓ 2008-06-06 7.574102209944 sphingosine-kinase-1-polyclonal-fitc-antibody SPHK 1 SPHK-1 metabolism sphingolipids phosphorylation sphingosine-1-phosphate cell proliferation death immunofluorescence IF flow cytometry FC western blots WB SPHKs blotting immunoblotting 7.574102209944
10009237 Sphingosine Kinase 2 (human recombinant) - >80% by SDS-PAGE 2007-01-18 30.875382794001 sphingosine-kinase-2-human-recombinant SPHK 2; SK2 signalling inflammatory enzymes proteins GenBank Accession No AF245447 SK2 SPK2 kinases sphingolipids SPHKs D-erythro-sphingosines phosphorylates sphingosine-1-phosphates S1Ps isoforms mammalian cells signals signaling pathways cancers inflammation proliferation apoptosis calcium homeostasis angiogenesis vascular maturation diseases 30.875382794001
10009222 Sphingosine Kinase Inhibitor 2 312636-16-1 >95% 2007-01-18 47.506755399296 sphingosine-kinase-inhibitor-2 SKI II; SPHK 2 cancers Anti-proliferative Sphingosine-1-phosphates S1Ps SK1 SK2 SKI2 SPHK1 SPHK2 sphingosines sphingolipids inhibits inhibitors inhibition proliferation 47.506755399296
13084 STF-62247 315702-99-9 ≥98% 2009-10-07 36.305745856353 stf-62247 autophagy lethality renal cells carcinoma cancers von Hippel-Lindau VHL tumors supressors genes growth rates kidneys metastasize syndrome diseases 36.305745856353
13338 SU 6656 330161-87-0 ≥95% 2009-08-04 27.395160220994 su-6656 inhibitors Src kinases Src Yes Lyn Fyn cells growth development nervous system fibrosis cancers inhibits inhibition CNS SU6656 27.395160220994
10574 Suberohydroxamic Acid 38937-66-5 ≥98% 2010-09-28 48.574947820749 suberohydroxamic-acid Suberic bis-Hydroxamic Acid; SBHA histones deacetylases HDACs inhibitors genes expression regulation epigenetics nucleosomes HDAC1 HDAC3 differentiation cells cycle arrest apoptosis cancers suberodihydroxamic acid suberoyl bishydroxamic acid inhibited inhibition Warner-Lambert Brand of Mefenamic Acid Warner Lambert Brand of Mefenamic Acid Pharmascience Brand of Mefenamic Acid First Horizon Brand of Mefenamic Acid Parke Davis Brand of Mefenamic Acid Farmasierra Brand of Mefenamic Acid Ashbourne Brand of Mefenamic Acid Pinewood Brand of Mefenamic Acid Nu-Pharm Brand of Mefenamic Acid Nu Pharm Brand of Mefenamic Acid Chemidex Brand of Mefenamic Acid Gödecke Brand of Mefenamic Acid Clonmel Brand of Mefenamic Acid Antigen Brand of Mefenamic Acid Pfizer Brand of Mefenamic Acid Apotex Brand of Mefenamic Acid Rowa Brand of Mefenamic Acid Elan Brand of Mefenamic Acid APS Brand of Mefenamic Acid PMS-Mefenamic Acid PMS Mefenamic Acid Acid Mefenaminic Mefenaminic Acid Acid Mefenamic Mefenamic Acid Forte Ponstan Ponstan Forte Apo-Mefenamic Apo Mefenamic Nu-Mefenamic Nu Mefenamic ApoMefenamic NuMefenamic Pinalgesic Contraflam Ponalgic Parkemed Ponstel Ponstan Ponalar Mefacit Pontal Ponsyl Ponmel Dysman Coslan Mefic Mefac 48.574947820749
10928 SUCNR1 Polyclonal Antibody New - 2011-11-03 1.638000000000 sucnr1-polyclonal-antibody GPR91 membranes receptors G-proteins coupled 1 family cells communications citric acids cycles succinate developments injury angiogenic factors VEGF proliferative ischemic retinopathy diabetic Western blots blotting immunohistochemistry IHC WB SUCNR-1 SUCNRs 1.638000000000
10763 SUV4-20H1 (human recombinant) - ≥60% 2011-07-13 16.676878453038 suv4-20h1-human-recombinant KMT5B; Suppressor of Variegation 4-20 Homolog 1; Lysine N-methyltransferase 5B methyltranferases histones H3K20 SET-domain containing s-adenosylmethionine s-adenosylhomocysteine lysines methylation epigenetics genes regulations KMT5B trimethylation H4K20 GRIP1 KMT5C KMT-5B KMT-5C KMTs 16.676878453038
10764 SUV4-20H2 (human recombinant) - ≥95% 2011-06-06 17.167900552486 suv4-20h2-human-recombinant Suppressor of Variegation 4-20 Homolog 2; KMT5C methyltransferases histones H3K20 SET-domain containing s-adenosylmethionine s-adenosylhomocysteine lysine methylation epigenetics genes regulation SETD8 Pr-SET7 SUV420H2 SUV-420H2 SUV 420H2 SUV420H1 SUV-420H1 SUV 420H1 17.167900552486
16860 Swainsonine 72741-87-8 ≥98% 2009-06-12 211.568867403315 swainsonine Tridolgosir Alkaloid N-linked glycoside hydrolases asparagine-linked glycoproteins glycoproteins inhibitor lysosomal α-mannosidase glycosidases Golgi α-mannosidase II N-linked glycosylation antiproliferative proliferation growth antimetastatic metastasis cancer α-mannosidase lysosomes oligosaccharides glycoproteins lysosomal storage disease toxicity locoism 211.568867403315
13258 Tamoxifen 10540-29-1 ≥98% 2010-01-21 80.836114180478 tamoxifen nuclear receptors 17β-estradiol estrogen ERα ERβ modulators antagonists breast cancers tumors agonists bones osteoporosis cardiovascular disease menopause women uterus uterine endometrial carcinomas Nolvadex Istubal Valodex Savient brand of Tamoxifen Citrate Citrate Tamoxifen Tamoxifen Citrate Zitazonium Tomaxithen ICI-4 474 ICI 46 474Tamoxifen ICI-47699 ICI-46474 ICI46474ICI 47699 ICI 46474 Soltamox Novaldex Nolvadex ICI47699 ICI46474 80.836114180478
10009911 Tangeritin 481-53-8 ≥98% 2008-12-16 11.958232044199 tangeritin Ponkanetin; NSC 618905; NSC 53909 flavone cancers tumors cholesterol atherosclerosis ERKs p38 MAPKs JNKs AKTs LDLs triacylglycerol estradiol MDR1 pregnane X receptors IL-1 IL1 IL 1 melanoma insulinoma 11.958232044199
13085 Tenovin-1 Exclusive 380315-80-0 ≥98% ✓ 2008-09-18 28.501252302025 tenovin-1 histones sirtuins cancers p53 cell growth tumors SIRT1 SIRT2 inhibitors inhibits inhibition melonoma lymphoma 28.501252302025
13086 Tenovin-6 1011557-82-6 ≥95% 2009-02-12 62.548839779006 tenovin-6 histones sirtuins cancers p53 cell growth tumors SIRT1 SIRT2 inhibitors inhibits inhibition SIRTs transcription factors TFs 62.548839779006
10011619 Terbinafine (hydrochloride) 78628-80-5 ≥98% 2010-02-16 4.016298342541 terbinafine-hydrochloride antifungals squalene epoxidase antitumor tumors antiangiogenic anticancer cancers inhibitors inhibits inhibition Naphthalenes 4.016298342541
10007565 Tetradecyl Phosphonate 4671-75-4 >98% 2005-10-17 43.010149960536 tetradecyl-phosphonate pan-antagonists LPA receptors lysophosphatic acids lipids signalling molecules hydrolysis lysophospholipase D autotoxin signals GPCRs G-protein coupled LPA1/EDG-2 LPA2/EDG-4 LPA3/EDG-7 LPA4/GPR23 activates activation PPAR.gamma. peroxisomes proliferator-activated inhibits inhibition LPA-induced calcium mobilization activates reporter 43.010149960536
70302 tetramethyl Nordihydroguaiaretic Acid Exclusive 24150-24-1 ≥98% ✓ 2008-09-24 5.184364640883 tetramethyl-nordihydroguaiaretic-acid tetramethyl NDGA; TMNDGA; Tetrameprocol; M4N; EM-1421 tumors inhibitor inhibits inhibition cancers NDGAs survivin apoptosis Cdc2 HIV growing growth glioma brains antitumor organic melonomas 5.184364640883
10007207 tetranor-12(S)-HETE 121842-79-3 ≥98% 2005-12-07 36.477127071823 tetranor-12-s-hete neuroscience peroxisomes metabolites arachidonic acids metabolisms 12-lipoxygenases 12-LOs platelets leukocytes smooth muscle cells tumors adhesion endothelial fibronectin subendothelial matrix b-oxidation .beta.-oxidation tissues Lewis lung carcinomas controlling inflammations inflammatory responses injured corneas Zellweger's syndromes peroxisomal abnormalities inability metabolizes symptoms diseases derivatives reasearch tools elucidations metabolic fate cancers ophthalmology 36.477127071823
10522 Thapsigargin New 67526-95-8 ≥97% 2011-09-23 105.820852192546 thapsigargin calcium, ATPases, sarco/endoplasmic calcium ATPases SERCAs cells signaling activation histamine cancers tumorigenesis inflammation reticula sarcoplasmic endoplasmic 105.820852192546
10009813 thio-Miltefosine - >98% 2007-08-13 10.919558011049 thio-miltefosine analogs inhibitors inhibit inhibition CTP phosphocholine cytidylyl transerases antimetastatic antiproliferatives ceramides apoptosis antiprotazoal thiomiltefosine sulfurs thios 10.919558011049
10038 TMS 24144-92-1 >98% 54.550773480662 tms 2,3',4,5'-Tetramethoxystilbene cytochromes inhibitors tetramethoxystilbene antimutagenesis CYP450-1B1 inhibits selective selectivity apoptosis cell growth 54.550773480662
11105 TNF Receptor-Associated Protein 1 (human recombinant) New - ≥95% 2011-11-29 19.536402701043 tnf-receptor-associated-protein-1-human-recombinant Hsp90L; Hsp75; TRAP1; Mitochondrial Heat Shock Protein 75 kDa metabolism insulin non-insulin-dependent (type 2) diabetes mellitus glucose kinases tumors necrosis factor type 1 receptors-associated proteins TNFR-associated protein 1 ATP mitochondrial HSP90 heat shock ATPase cancers cardiomyocytes geldanamycin SNX-0723 SNX0723 SNX 0723 TNFR1 19.536402701043
700240 Total Phosphatidic Acid Assay Kit - 2009-08-24 68.693709550118 total-phosphatidic-acid-assay-kit PA Assay Kit assays kits measures fluorescence-based cells cellular phospholipids phosphatidate membranes storage de novo synthesis phospholipases PLD PLA hydrolysis phosphodiesters phosphatidylcholines PC phosphorylation diacylglycerol DAG DAGK lysophosphatidic LPA lysoPA-acyltransferase LPAAT phosphates phosphohydrolases LPPs intracellular signal transduction mammalian rapamycin mTOR signaling cycle progression growth disregulation human diseases cancers bacterial FKBP12 Raf-1 kinases sphingosines cAMP Adenosines 3',5' cyclic mononucleotides phosphodiesterases 4A1 translocation proteins PKC tyrosines SHP-1 guanine nucleotides Son of sevenless glycerol-3-phosphate oxidized oxidases hydrogen peroxides H2O2 peroxidases ADHP 10-acetyl-3,7-dihydroxyphenoxazines resorufin 68.693709550118
160750 TRAIL Polyclonal Antibody - 0E-12 trail-polyclonal-antibody Apo-2L apoptosis cell death TNF DR4 DR5 NF-.kappa.B NF-kappab NF-kappab antisera antiserum antibodies WB western blots blotting cancers immunoblotting 0E-12
9000784 (−)-trans-C75 Exclusive 1234694-22-4 ≥98% ✓ 2011-07-20 11.679447513812 -trans-c75 (2S,3R)-C75 trans C75 transC75 inhibitors inhibits inhibition fatty acids synthases FAS apoptosis cancers obesity C-75 apoptosis 11.679447513812
9000783 (+)-trans-C75 Exclusive 1234694-20-2 ≥98% ✓ 2011-07-20 11.679447513812 -trans-c75 (2R,3S)-C75 transC75 trans C75 fatty acids synthases FAS apoptosis cancers obesity inhibitors inhibits inhibition C-75 11.679447513812
10188 trans-trismethoxy Resveratrol 22255-22-7 >98% 2004-03-03 20.739167020824 trans-trismethoxy-resveratrol (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS Prostaglandins synthases antioxidants oxidative injury stress sirtuins 3,5,4'-trihydroxy stilbene 3,5,4'-trihydroxystilbene 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene trimethoxy AHR antagonists aryl hydrocarbon receptors 20.739167020824
13129 trans-trismethoxy Resveratrol-d4 - ≥99% deuterated product 2009-02-09 17.114249539594 trans-trismethoxy-resveratrol-d4 (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol-d4 deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometrysirtuins AHR antagonists aryl hydrocarbon receptors 17.114249539594
13791 TRF2 Polyclonal Antibody - 2010-06-24 0E-12 trf2-polyclonal-antibody TTAGGG Repeat Binding Factor 2; TRBF2; Telomeric Repeat Binding Factor 2; TERF2 antibodies proteins TRF-2 TRF 2 factors repeat DNA binding cells apoptosis western blots blotting immunoblotting telomere WB ICC IP ChIP IF immunoprecipitation immunofluorescence immunocytochemistry cancers apoptosis 0E-12
89730 Trichostatin A 58880-19-6 >98% 156.614143646409 trichostatin-a TSA reversible inhibitors histone deacetylase nuclear receptors inhibitions inhibits hdacs TSAs cancers 156.614143646409
10010237 Triciribine 35943-35-2 >98% 2007-09-11 7.209392265193 triciribine Tricyclic Nucleoside; NSC 154020; API 2 Akt cancers inhibitors inhibition inhibits Akt-1 Akt1 Akt-2 Akt2 Akt-3 Akt3 PI3-kinase PI3kinase PI3K PI-3-kinase phosphorylation activation signalling pathway signaling 7.209392265193
10009083 Trimidox Exclusive 95933-74-7 >98% ✓ 2008-02-13 5.938674033149 trimidox VF 233 apoptosis ribonucleotide reductases cells cycles cancers dNTP HIV caspase DNA synthesis chemotherapy dGTP HL-60 5.938674033149
10011124 Trimidox (hydrochloride) Exclusive - >98% ✓ 2008-06-10 5.938674033149 trimidox-hydrochloride CF 233 (hydrochloride) apoptosis ribonucleotides reductases cells cycles cancers dNTP HIV caspases DNA synthesis chemotherapy dGTP HL-60 HCls 5.938674033149
10011659 Trolox 53188-07-1 ≥98% 2008-12-02 295.447856353591 trolox 6-hydroxy-2,5,7,8-tetramethylchroman-2-Carboxylic Acid antioxidants vitamins E oxidative injury injuries neurodegeneration aging cancers adjunctive 295.447856353591
10774 UTX (human recombinant) - ≥85% 2011-05-24 5.626011049723 utx-human-recombinant Ubiquitously Transcribed Tetratricopeptide Repeat X; KDM6A epigenetics histones lysines demthylases chromatins regulators dioxygenases JmjC proteins enzymes recombinants UTY genes chromosomes 5.626011049723
13033 Valproic Acid (sodium salt) 1069-66-5 ≥95% 2009-10-21 27.022965009207 valproic-acid-sodium-salt Sodium Valproate; 2-Propylvaleric Acid valeric acids anticonvulsant seizures inhibitors histones deacetylases HDAC glycogen synthase kinases GSK3 inositol-1,4,5-trisphosphate IP3 combination therapy cancers Alzheimer's diseases stem differentiation self-renewal 27.022965009207
160840 VE-Cadherin Polyclonal Antibody - 26.912154696132 ve-cadherin-polyclonal-antibody Cadherin-5; CD144 Western blots blotting antibodies WB antisera antiserum ICC IP immunocytochemistry immunoprecipitation apoptosis cancers immunoblotting 26.912154696132
13131 VER-49009 Exclusive 940289-57-6 ≥98% ✓ 2010-07-09 3.563255985266 ver-49009 heat shock proteins Hsp90 inhibitors Hsp27 Hsp72 cells cycle arrest apoptosis inhibits inhibition isoxazole survivin C-RAF B-RAF PRMT5 molecular chaperones folding signalling signaling VER49009 VER 49009 cancers pyrazoles 3.563255985266
13132 VER-50589 Exclusive 747413-08-7 ≥98% ✓ 2010-04-06 2.552573664825 ver-50589 heat shock proteins Hsps Hsp90 cancers inhibitors inhibits inhibition Hsp27 Hsp72 C-RAF B-RAF survivin PRMT5 cells cylce arrest apoptosis tumors growth glioblastoma molecular chaperones protein folding signaling signalling pharma Isoxazoles 2.552573664825
10944 WDR5 (human recombinant) - ≥95% 2011-08-05 37.402271332105 wdr5-human-recombinant SWD3, Set1c WD40 repeat protein, homolog; BMP2-induced 3-kb Gene Protein; WD-Repeat Protein 5; BIG3 epigenetics binding proteins methyltransferase MLL complex subunits 37.402271332105
10010591 Wortmannin 19545-26-7 ≥98% 2008-11-21 43.700611040279 wortmannin KY 12420 phosphoinositide 3-kinase PI3K cells growth differentiations cancers motility inhibitors inhibits inhibition irreversible polo-like kinases PLK1 PLK3 mTOR DNA-PK DNAPK PL4K MLCK p38 MAPK 43.700611040279
13671 Wortmannin-Rapamycin Conjugate - ≥98% 2010-05-11 25.089822999795 wortmannin-rapamycin-conjugate phosphoinositides 3-kinases PI3K mammalian targets mTOR cancers inhibitors inhibits inhibition complex 1 mTORC1 tumors bevacizumab VEGF colons A498 HT29 53123-88-9 sirolimus prodrug linkers links 19545-26-7 KY 12420 renal phosphatidyl inositols 25.089822999795
10008883 WST-1 Cell Proliferation Assay Kit - 2006-09-07 68.871443443518 wst-1-cell-proliferation-assay-kit assays cells proliferation induction inhibitors inhibition inhibits growth factors signaling signalling molecules cycles regulatory factors cytokines mitogens drugs microtiter plates in vitro enzymes enzymatic cleavage tertrazolium salts formazan cellular mitochondrial dehydrogenases screen kits measures measurements cancers cell-based assay cell based assay cba 68.871443443518
10010199 WST-8 Cell Proliferation Assay Kit - 2007-09-11 77.795786831703 wst-8-cell-proliferation-assay-kit assays cells proliferation induction inhibitors inhibition inhibits growth factors signaling signalling molecules cycles regulatory factors cytokines mitogens drugs microwell plates in vitro enzymes enzymatic cleavage tertrazolium salts formazan cellular mitochondrial dehydrogenases screen kits measures measurements special:quarterly specialdiscount:50 specialstart:2007-12-01 specialend:2008-02-29 cell-based assay cell based assay cba 77.795786831703
13604 WYE-354 New 1062169-56-5 ≥98% 2012-01-12 80.628722529159 wye-354 mTOR mTORC1 mTORC2 inhibitors inhibits inhibition PI3K cancers cells growth PTENs tumors rapamycin complex 1 2 G1 phosphatidylinositol 3-kinase α PI3Kα kinases 80.628722529159
13639 WZ811 55778-02-4 ≥95% 2010-03-22 14.248908839779 wz811 CXC chemokines receptors CXCR4 stromal cell-derived factor-1 SDF-1 CXCL12 hematopoietic stem cells chemotaxis lymphocytes growth metastasis cancers T cells HIV infection inhibitors antagonist cAMP Matrigel invasion breast cancer adenocarcinoma inhibition alpha-Aminotoluene alpha Aminotoluene Phenylmethylamine Benzylamines 14.248908839779
10010895 Xanthine Oxidase Assay Kit - 2008-03-13 230.411895553801 xanthine-oxidase-assay-kit XO Assay Kit; Xanthine Oxidoreductase Assay Kit assays kits plasma serum tissues homogenates oxidoreductases molybdoflavoenzymes human purine catabolism catalyzing catalyzes hydroxylation hypoxanthine uric acids NADH superoxides reactive oxygen species ROS hydrogen peroxides H2O2 inschemia-reperfusion injury molecular cells death degeneration apoptosis mammalian livers intestines diseases horseradish HRP ADHP fluorescence fluorescent resorufin excitation emission wavelengths special:quarterly specialdiscount:50 specialstart:2007-03-01 specialend:2008-05-31 fluorometric 230.411895553801
13596 XAV939 284028-89-3 ≥98% 2009-12-03 13.680441988950 xav939 Wnt cancers β-catenin APC axin GSK3 poly-ADP-ribosylation tankyrases TNKS1 TNKS2 inhibitors inhibition inhibits 13.680441988950
10010200 XTT Cell Proliferation Assay Kit - 2007-09-11 57.722205716685 xtt-cell-proliferation-assay-kit assays cells proliferation induction inhibitors inhibition inhibits growth factors signaling signalling molecules cycles regulatory factors cytokines mitogens drugs microtiter plates in vitro enzymes enzymatic cleavage tertrazolium salts formazan cellular mitochondrial dehydrogenases screen kits measures measurements special:quarterly specialdiscount:50 specialstart:2007-12-01 specialend:2008-02-29 cell-based assay cell based assay cba 57.722205716685
11168 (−)-YK-4-279 New - ≥98% 2011-12-19 62.516298342541 -yk-4-279 ES-FLI1 oncogenes Ewing's sarcomas RNA helicases tumors cancers inhibitors apoptosis ETS transcription factors ERG ETV1 prostate fusion proteins diseases YK4279 YK 4279 growth xenografts cells chemotherapy resistant Ewings ESFLI1 ES FLI1 prostate 62.516298342541
11167 (+)-YK-4-279 New 1261038-93-0 ≥98% 2011-12-16 60.849631675875 -yk-4-279 ES-FLI1 oncogenes Ewing's sarcomas RNA helicases tumors cancers inhibitors apoptosis ETS transcription factors ERG ETV1 prostate YK4279 YK 4279 fusion proteins diseases growth orthotopic xenografts cells chemotherapy resistant Ewings EWS-FLI1 reduces in vitro in vivo family prostate cancers enantiomers EWSFLI1 EWS FLI1 60.849631675875
13661 YK-4-279 1037184-44-3 ≥98% 2010-02-05 44.477041129527 yk-4-279 ES-FLI1 oncogene Ewing's sarcomas RNA helicases A RHAs tumors cancers inhibitors apoptosis inhibition inhibited Ewings YK 4-279 YK4279 YK 4279 YK 4 279 Pentaacetic Acid, Diethylenetriamine Acid, Diethylenetriamine Pentaacetic Diethylenetriamine Pentaacetic Acid calcium trisodium pentetate Pentetic Acid DTPA pentacin penthanil 44.477041129527
10975 Zebularine New 3690-10-6 ≥98% 2011-08-23 14.907058546404 zebularine DNMTs inhibitors DNA methyltransferases cancers cells analogs cytidines methylation carcinomaTK6 jurkat KG-1 HCT116 14.907058546404
71800 (Z)-Guggulsterone 39025-23-5 ≥98% 2009-12-01 0.489963167587 -z-guggulsterone anti flammatory cancers FXR bile acids LDL cholesterol tumors IL-6 STAT3 VEGF Akt 0.489963167587
10010367 ZM 336372 208260-29-1 >98% 2008-01-09 2.221577096936 zm-336372 Raf-1 c-raf inhibitors inhibition inhibits cancers anti-cancer MEK 1/2 MAPK signals transductions proliferations cells cycles ERK1 ERK2 ERK1/2 ATP adenosine triphosphate signaling carcinoid tumor 2.221577096936
13601 ZM 447439 331771-20-1 2010-08-03 3.186491712707 zm-447439 auroras A B C kinases mitosis cytokinesis centromere inhibitors inhibits inhibition cancers Benzamides 3.186491712707
300013 β-Catenin Blocking Peptide - 3.482375690607 -catenin-blocking-peptide b-catenin beta-catenin immunoanalysis western blots immunoblotting controls peptides cancer cell .beta.-catenin wb 3.482375690607
100029 β-Catenin Polyclonal Antibody - 3.394435674822 -catenin-polyclonal-antibody antibodies antisera antiserum western blots blotting wb icc immunocytochemistry b-catenin cancers cell immunoblotting IHC immunohistochemistry 3.394435674822
10009137 β-Gal-NONOate 357192-77-9 ≥98% 2007-11-10 26.061298342541 -gal-nonoate nitric oxides NOs donors anti-cancer anticancers .beta.-galatosidases cytoxic bactericidal cell-lines genes cytotoxicity 26.061298342541
10010621 γ-CEHC EIA Kit (plasma and serum) - 2008-03-21 21.699220994475 -cehc-eia-kit-plasma-and-serum 2,7,8-trimethyl-2-(β-Carboxy-Ethyl)-6-Hydroxychroman EIA Kit solid plates competitive quantification kits eias enzymes immunoassays gammaCEHC gCEHC gamma-CEHC g-CEHC tocopherol tocotrienols vitamins E g-tocopherols .gamma.-tocopherol gamma-tocopherol lipid soluble antioxidants diets metabolites livers cytochrome p450 CYP450 natriuretic acitvity nitric oxides NO radicals inhibits inhibitions inhibitors COX cyclooxygenases macrophages epithelial cells plasma serums blood cardiovascular diseases prostate cancers assays 21.699220994475
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?